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Abstract 
Both mefenamic acid (MA) and tolfenamic acid (TA) are polymorphic with three and 
five forms respectively. MA and TA are structurally similar molecules that differ in the 
replacement of a methyl on MA with a chloro group on TA. This thesis uses a joint computational 
and experimental approach to investigate the polymorphism of MA and TA and explores 
differences in the packings upon chloro-methyl replacement.  
To compliment an earlier crystal structure prediction (CSP) study on TA, the crystal 
energy landscape of MA was computed. Analysis showed there were a number of predicted 
structures that were competitive in energy with the known forms of MA. 
Isostructural relationships between MA and TA that were identified from the observed 
polymorphs and the predicted forms from the CSP studies were investigated in a range of 
templating experiments. The isostructural, not isomorphous, relationship between MA I and TA 
IV was explored and a solid solution series, isomorphous with MA form I, was obtained from 
ethanol and characterised by low temperature single crystal X-ray diffraction (SCXRD). Seeding 
an ethanol solution of TA with MA form I seeds nucleated a new polymorph of TA (VI) that was 
characterised by SCXRD and was isomorphous with MA form I.  
A second new form of TA (VII) was discovered, and identified by powder X-ray 
diffraction, when exploring the sublimation of TA onto a copper surface. Thermal analysis 
showed that TA VII transformed to TA I upon heating. Using a similar sublimation procedure, it 
was observed that if MA was sublimed onto copper, form I was obtained, yet if MA was sublimed 
onto glass, form II was obtained. 
The CSP methodology was tested by participation in the CCDC blind test and was 
successful in predicting the observed crystal structure of the cocrystal XXV as the global 
minimum. 
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1 Introduction 
1.1 Polymorphism 
Polymorphism is the ability of a compound to crystallise in multiple crystal forms, each 
with a unique unit cell. There are two main types of polymorphism (packing and conformational) 
that are exhibited depending on the compound in question. Packing polymorphism is the only 
type of polymorphism that rigid molecules can display and is observed when a fixed molecular 
conformation is found in different packing arrangements within the crystal lattices of different 
polymorphs. Additionally, flexible molecules can display conformational polymorphism where 
the molecule is found in different conformations in different polymorphs.1 
Although polymorphs of a particular compound are identical in chemical composition, 
they can have differing physical properties. Research surrounding the phenomenon of 
polymorphism is mainly concerned with predicting, controlling and characterising polymorphic 
systems in order to determine the relevant crystalline form for a specific application within 
different industries including the fields of explosives, agrochemicals, dyestuffs, foods, pigments 
and pharmaceuticals.  
One of the difficulties within the field of polymorphism is the ability to predict whether 
a compound will exhibit polymorphism or not. A recent statistical study by Cruz-Cabeza et al.2 
analysed crystallographic data from the Crystal Structure Database (CSD, a community built 
database of crystallographic data hosted by the Cambridge Crystallographic Data Centre, CCDC) 
and concluded that one in three compounds display polymorphism.  Similar analysis by Cruz-
Cabeza on two industrial solid form screens (conducted at Hoffmann-La Roche and Eli Lilly). 
showed that at least one in two compounds display polymorphism.2 Furthermore, they found 
no correlation between either molecular flexibility or the size of the molecule and the ability of 
the compound to be polymorphic. Cruz-Cabeza et al. also noted that each compound is unique 
and without appropriate experimentation, there is no way of knowing how many crystal forms 
will exist for a given system. There is also no way of knowing which crystallisation methods 
should be attempted in order to obtain potential polymorphs or know what the physical 
properties of the polymorphs might be, should they exist. 
Within the pharmaceutical industry, the dissolution rate and solubility of different 
polymorphs can affect the bioavailability of a drug that is administered in the solid form.3 
Therefore, it is important to understand and fully characterise polymorphic systems of active 
pharmaceutical ingredients (APIs) to ensure that the most appropriate polymorph of an API is 
developed in terms of application, storage and production and that the chosen form is safe for 
use and effective when administered to a patient.4  
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It is important to screen compounds for polymorphism in order to avoid cases where 
the late discovery of a new polymorph can compromise the use of medication and cause a 
company to incur great costs. In 1998, two years after Ritonavir, a treatment for Acquired 
Immunodeficiency Syndrome (AIDS), had originally been marketed, a new, more stable, crystal 
form was discovered when a batch failed the dissolution requirements.5, 6 The late nucleation of 
this more stable form highlighted a lack of control in the production process. Accidental seeding 
of the marketed form (form I) with even just a trace of the more stable form (form II) resulted 
in form I transforming to the less bioavailable form II.6  
The Ritonavir case highlights the risk that a thermodynamically stable polymorph can 
remain elusive for a length of time. It also provides an example of the phenomenon of 
“disappearing polymorphs”;7, 8 that once a more stable form has been obtained, it may not be 
possible to reliably reproduce the original form even when following an exact experimental 
recipe. This was also the case with the disappearing enantiomorphic form II of progesterone 
which was eventually re-discovered by the novel route of fusion with the structurally similar 
pregnenolone. This highlighted the possible role of impurities in the original synthesis of 
progesterone form II when it was routinely being reproduced.9 
1.2 Polymorph and Solid Form Screening  
Pharmaceutical companies subject potential drug formulations to rigorous polymorph 
screening to ensure repeats of the Ritonavir case are avoided. Solid form screening is also a 
licensing requirement for the formulation of new APIs.10 Solid form screening methods are 
continually developed to incorporate a broad variety of experimental methods and 
crystallisation techniques so that as many polymorphs, hydrates and solvates as possible can be 
characterised in order to enable the optimal form of an API be identified and developed.11 
Pharmaceutical companies also carry out extensive polymorph screening to protect their 
intellectual property.  
To date, there is not one universal screening method that can guarantee to ascertain 
the extent of polymorphism. This makes it hard to know how thorough a solid form screen 
should be and when to decide to stop screening for polymorphs experimentally.12, 13 Braun et 
al.14 suggest that before you can consider how exhaustive your polymorph screen should be, 
you need to consider the purpose of your polymorph screen. For example, do you want to 
confirm that the most thermodynamically stable form at 25 °C has been found or do you want 
identify all accessible solid forms in order to select a metastable form with superior properties?  
It is also important to consider time limitations, costs, the availability of material and any 
stability issues alongside the knowledge that it is impractical to sample all the possible 
nucleation conditions for a given compound. Braun et al. suggest that a solid form screen should 
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be sufficiently diverse so that the thermodynamically most stable polymorph is obtained as well 
as hydrate form(s) and any metastable forms that are kinetically stable at ambient conditions. 
Furthermore, other crystallisation products including intermediates, amorphous product and 
solvates should also be identified and any transformation pathways need to be characterised.14 
 
1.2.1 Pure Compound Screening 
This section goes into detail about some of the different experimental techniques that 
can be used during a solid form screen.  
  
Table 1. Methods used to generate various solid forms.11  
 
Method Degrees of freedom 
Crystallisation by cooling a solution Solvent, cooling proﬁle, concentration, mixing 
 
Solvent Evaporation Solvent, initial concentration, evaporation rate, 
temperature, pressure, ambient relative humidity 
Precipitation Solvent, anti-solvent, rate of anti-solvent addition, 
mixing, temperature 
Vapour diffusion Solvent, anti-solvent, temperature, concentration 
 
Suspension equilibration Solvent, temperature, solubility, temperature 
programs, mixing, equilibration time 
Crystallisation from the melt Temperature changes (min, max, gradients) 
 
Quench cooling the melt Cooling rate 
 
Heat induced transformations Temperature changes 
 
Sublimation Temperature gradient, pressure, surface type 
 
Desolvation of solvates Temperature, pressure 
 
pH change Temperature, rate of change, acid/conjugate base 
ratio 
 
Mechanical treatment  
(e.g. milling, cryo-grinding) 
Milling time, mill type, solvent 
Freeze-drying Solvent, concentration, temperature programs 
 
Spray drying Solvent, concentration, drying temperature 
 
 
Different polymorphs are often found upon changing the conditions of crystallisation. 
Therefore, in order to conduct a reliable polymorph screen, solvent type (polar, non-polar, protic 
and aprotic), crystallisation conditions and crystallisation environments need to be varied as 
much as possible since they have a major influence over what solid form is produced.15 Table 1 
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highlights some of the numerous experimental techniques, methods and variables that can 
affect the solid form of an API.  
However, it is not only different crystallisation methods that can produce different 
polymorphs. Ostwald’s Rule of Stages states that during a crystallisation process, a series of 
polymorphs should be obtained, starting with the least and ending with the most, 
thermodynamically stable polymorph.16 Therefore, if a compound displays phase 
transformations during the crystallisation process, then the polymorph obtained will depend on 
the point in the crystallisation process that the particular solid form was harvested. Rapid 
transformation from one metastable form to the next may result in only the most stable form 
being isolated, though further measurement may be required to confirm this. 17 
 
1.2.2 Heterogeneous Nucleation 
Although Table 1 provides a good overview of potential crystallisation methods, it 
should not be considered a comprehensive list as it only indicates crystallisation approaches that 
start from the pure compound. A thorough solid form screen would include the crystallisation 
methods listed in Table 1, but would also need to consider the role of heterogeneous nucleation, 
such as seeding, impurities, additives and surfaces, as a route to obtain desired polymorphs.  
 
1.2.2.1 Seeding, Impurities and Additives 
Seeding is generally thought of as the addition of previously nucleated solid particles 
of the compound in the desired solid form (homo-seeding) to the crystallisation process to 
induce crystal growth in the preferred form.11 Depending on the size of the seed, either micro-
seeding or macro-seeding (seed transfer) can be used, often alongside other optimisation 
techniques,18 to produce more crystals of the desired form. Seeding can reduce the kinetic 
barrier to nucleation by providing a surface for the compound to nucleate upon.  
The presence of impurities or additives (hetero-seeding) can induce the crystallisation 
of new and different solid forms of a compound.11, 19-22 Heterogeneous particles provide surfaces 
for crystals to grow upon, removing the energy barrier to nucleation. A wide variety of additives 
and impurities have been shown to influence the polymorphism exhibited by a molecule. These 
range from the addition of structurally related compounds to the addition of polymers.23 
Modifying the crystallisation process to include the use of a hetero-seed can be a useful route 
to obtaining metastable forms of compounds as the additive surface can facilitate 
heteronucleation by kinetic control.11, 22  
If the chemical purity of the compound is in dispute then the role of impurities in the 
crystallisation process should not be overlooked. Therefore, it is reasonable to suggest that 
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successful experimental screening should take place once the chemical purity of the compound 
has been optimised to ensure all forms starting from the pure compound are found.  
Additives are different to impurities as they are specifically chosen to perform a role 
in the crystallisation process. In comparison, impurities can be present in crystallisations, but 
are often unwanted or unknown as mentioned previously in relation to progesterone and 
disappearing polymorphs.  
 
  
(a) (b) 
Figure 1 Diagrams showing structural similarity of (a) mefenamic acid and (b) flufenamic acid.  
 
Structurally related additives have been used to obtain metastable forms of 
mefenamic acid (MA) and sulfamerazine. In the case of MA, a metastable phase, form II, was 
obtained by cooling a supersaturated solution of MA that contained a small amount of 
flufenamic acid form I (FFA) additive22 (see Figure 1 for structural similarities between MA and 
FFA). In the case of sulfamerazine, structurally related N4-acetylsulfamerazine, sulfamethazine 
and sulfadiazine (Figure 2) were all used as additives to isolate metastable sulfamerazine.19 
These examples show how structurally related additives can affect the kinetics of crystallisation 
so that nucleation of a metastable polymorph is preferred.  
 
    
(a) (b) (c) (d) 
Figure 2. Diagrams showing the structural similarity of (a) sulfamerazine, (b) N4-acetylsulfamerazine, (c) 
sulfamethazine and (d) sulfadiazine. 
 
Other examples of the use of structurally related additives can be observed in cases 
that consider a chloro-methyl interchange. Chlorine and methyl substituents have similar van 
der Waals volumes and can therefore be thought to be interchangeable24, 25 within crystal 
lattices. This chloro-methyl exchange was exploited to obtain a new polymorph of para-methyl 
benzyl alcohol (p-MeBA I) via heteronucleation with microseeds of para-chloro benzyl alcohol 
(p-ClBA).21 The new polymorph of p-MeBA was isomorphous to the form of the microseeds of 
p-ClBA that were used as an additive. Interestingly, seeding p-ClBA with p-MeBA did not yield a 
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new polymorph but investigations into mixed crystals of p-MeBA and p-ClBA showed that a solid 
solution was formed.  
Similarly, cocrystallisation of o-toluic acid (o-methylbenzoic acid) and o-chlorobenzoic 
acid also formed a solid solution of the two compounds.20 Complimentary computational studies 
on o-toluic acid and o-chlorobenzoic acid have indicated that there are no large structural 
differences upon the substitution of the chloro and methyl groups yet heteroseeding failed to 
produce crystals that were isomorphous.20 This could be because the inductive effects of Cl and 
CH3 are different21 or because the formation of Cl···Cl interactions could prevent the 
development of isomorphous crystal structures of isostructural molecules.25 Even though 
research into heteroseeding using isostructural molecules with either CH3 or Cl substituents has 
not always yielded new results, successes have shown that the incorporation of heteroseeding 
with structurally related molecules should be considered a useful technique in polymorph 
screening. 
 
1.2.2.2 Polymer-Induced Heteronucleation  
The use of polymers, specifically polymer-induced heteronucleation (PIHn),23 has led 
to the discovery of new polymorphs of a large range of small organic molecules and proteins 
and is a useful technique to incorporate into polymorph screening. The polymers utilised in PIHn 
are highly cross linked and tend to be insoluble so they interact with molecules at the solid-liquid 
interface providing a range of surfaces upon which to nucleate. As nucleation is a decisive step 
in determining the crystal form of a compound,23 a range of different polymer surfaces can lead 
to the production of a range of different polymorphs. The range of polymer surfaces can be 
explored using either singular polymers in each crystallisation experiment or combinations of 
polymers. 
Highly cross linked polymers lack crystallinity and so nucleation of crystals using P IHn 
by the epitaxial mechanism is unlikely.26 It is thought that the PIHn mechanism depends on the 
accessibility of the functional groups present in the polymers which affect interfacial interactions 
between the polymer surface and the compound in solution, directing the nucleation of 
different crystal forms with preferred orientations.26 The strength of polymer-solute 
interactions27 and the addition of tailor made polymers28 have been shown to affect nucleation 
kinetics, yet little is known about how polymer surfaces direct the formation of different 
polymorphs and polymers have not been designed or used to target specific forms. Therefore, 
large libraries of polymers with a broad variety of surfaces have to be investigated to increase 
the likelihood that all possible forms have been found.  
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Carbamazepine (CBZ) forms I-III are prepared readily. CBZ form I is obtained by heating 
forms II or III to 160 °C and 182 °C respectively.29 CBZ form II is obtained from supersaturated 
ethanol solution held at 5 °C and CBZ form III is obtained from supersaturated ethanol solution 
held at 25 °C.29 The previously unobserved fourth form of CBZ was obtained by crystallisation in 
the presence of four different polymers from a whole library of polymers wi th differing 
functional groups.30 CBZ was used as an example compound to test the effectiveness of PIHn 
without consideration of the lattice or surface chemistry of potential polymorphs. The results 
indicated that the use of polymers is an effective way of obtaining new polymorphs.  
The use of PIHn as an effective technique of screening for polymorphs i s also evident 
in the case with FFA where the use of a polymer library enabled eight polymorphs, six of them 
new, to be isolated.31 Three new forms of tolfenamic acid (TA) were also obtained using PIHn 
making TA a pentamorph.32 
 
1.2.2.3 Self-assembled Monolayers 
Self-assembled monolayers (SAMs) have also been used to isolate different 
polymorphic forms of compounds. SAMs are molecular assemblies of organic molecules that 
form on a surface by adsorption in regular arrays (Figure 3). Organic synthesis can be used to 
tailor the surface functionality by changing the terminal functional group of the organic 
interphase. Additionally, the metallic substrate surfaces can be etched (forming islands) giving 
the surface nanoscale geometrical variations.33 A screen using SAMs can be performed by 
varying the size of the islands, the rate of evaporation, the concentration of the API solution and 
the type of SAM used.34 
 
 
 
Figure 3. Schematic diagram of an ideal, single-crystalline SAM with a metal-sulfur interface. The 
anatomy and characteristics of the SAM are highlighted.33  
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Functionalised metallic islands have been used to template the crystal growth of many 
compounds including MA.35, 36 Upon altering the size of the metallic islands, the wetting 
properties and the droplet dimensions of the MA solution on the islands were altered and two 
different polymorphic forms of MA (forms I and II) were obtained.35 In some cases, the two forms 
of MA nucleated simultaneously (concomitant polymorphism) on the SAMs. The presence of the 
two polymorphs of MA on the SAMs highlights the interplay between kinetic and 
thermodynamic factors that can affect polymorphism. The use of SAMs also shows the use of 
another surface that can be used to template the growth of different polymorphic forms. 
 
1.2.2.4 Epitaxy 
Epitaxy is the two dimensional growth of a crystalline material on a crystal substrate 
(seed) from either the vapour or liquid phase and can either be onto a substrate of the same 
compound (homoepitaxy) or onto a related, or different, compound (heteroepitaxy).  
Epitaxial growth has been observed during sublimation experiments when a crystalline 
substrate is present. Investigations into the epitaxial growth of sublimed MA on both FFA form 
I and FFA form III substrates indicate that although the same form of MA (form I) was obtained 
from both, the growth rates and orientation of the MA crystals on the FFA substrate differed 
depending on the polymorphic form.37 Concurrent computational investigations into the 
epitaxial growth of MA on FFA showed that lattice matching as well as molecular conformation 
influenced the orientation and nucleation rate of MA form I crystals.  
Similarly, sublimation of 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile 
(named ROY due to its red, orange and yellow polymorphs) onto a pimelic acid substrate 
displayed selective epitaxial growth in one orientation of only one polymorph of ROY whereas, 
sublimation of ROY onto a succinic acid surface produced two different polymorphs in multiple 
orientations.38  
The examples mentioned above show that it is possible for different polymorphic 
forms to be obtained upon changing the substrate or surfaces present during crystallisation. 
Therefore, in a solid form screen, it is important to consider and investigate both structurally 
related substrates and surfaces that bear little relation to the studied compound as well as 
potential additives to ensure that the extent of polymorphism is investigated as fully as 
possible.19 
 
1.2.3 Automated Screening 
As the number of potential methods for finding solid forms and polymorphs of a 
particular compound increases, there is an increasing need to find a more comprehensive 
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approach to screening. Therefore, automated robotic systems are frequently used in 
experimental screening to carry out multiple simultaneous crystallisations. These high-
throughput (HT) crystallisation systems use a combinatorial approach to solid form screening 
where a large range of conditions, combinations and compositions are processed in parallel 
using minimal solute.12 For example, a HT system, CrystalMax, developed by TransFrom 
Pharmaceuticals can screen up to 18,000 crystallisation conditions in parallel.39 
HT technologies consist of both hardware and software components that drive the 
experiments as well as track, analyse and store the results.12 Analysis of automated HT systems 
is regularly carried out in situ with Raman spectroscopy often being the preferred method of 
characterisation due to the short acquisition time in comparison to other techniques (such as 
powder X-ray diffraction).39-41  
The results of HT experiments can indicate that a compound is polymorphic or show 
that there is evidence of hydrates and solvates that should also be considered when developing 
the relevant pharmaceutical. Using fully automated systems can save time and labour in the 
pharmaceutical industry, but they cannot cover a fully comprehensive list of controllable 
variables that can affect the solid form of an API such as thermal variables, length of time for 
crystallisations, high pressure and the de-solvation of solvates.11, 41 Therefore, if the solid form 
landscape of an API needed to be fully characterised, HT methods should be cons idered 
alongside other experimental techniques. 
 
1.2.4 Solid Forms 
Different polymorphs of a pure compound have different physicochemical properties 
and so choosing to develop one polymorph over another will allow some control over the 
properties of an API. Another way of altering or manipulating the properties of an API is by 
creating multi-component crystals that can be in the form of solvates, hydrates, salts or 
cocrystals.  
 
1.2.4.1 Solvates and Hydrates 
During crystallisation, it is possible for solvent molecules to be incorporated into 
crystal structures of the parent compound to form solvates, and where the solvent is water, 
form hydrates. The incorporation of such molecules into the crystal lattice is thought to occur 
readily as two components can often pack together more easily than a single component.3 It has 
been estimated that up to one third of pharmaceutically relevant molecules are capable of 
forming hydrates.3, 42 It is important to note that solvates themselves can also exhibit 
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polymorphism if the arrangement of the molecules in each crystal lattice is different yet the 
stoichiometric ratio of the components is the same.43 
Hydrates and solvates are of interest when developing APIs due to the different 
properties that they possess in comparison to the parent API. Knowledge of the solid state 
chemistry of the API is important during the development of the drug molecule as hydration, 
dehydration, solvation or desolvation of a pharmaceutical solid can have effects on the physical, 
chemical and/or biological properties of the API as well as its long term stability.43 
 
1.2.4.2 Cocrystals 
Crystalline cocrystals are materials formed with two (or more) neutral molecular 
components, in a stoichiometric ratio, in the unit cell. It has been shown that cocrystals of drug 
compounds can have enhanced physical properties compared to the API alone44, 53. For example, 
the dissolution and stability of adefovir dipivoxil is improved by cocrystallisation with 
saccharin,54 and the physical stability of both caffeine55 and theophylline,56 with respect to 
humidity, is improved by cocrystallisation of each molecule with oxalic acid. 
In theory, all molecules should be able to form cocrystals if the correct coformer is 
chosen, in comparison to salt formation which is only relevant to ionisable molecules. 
Additionally, a salt screen will typically only consider a small number of counter i ons for 
toxicological reasons whereas there are many more potential molecules that can be used in the 
formation of cocrystals that have been “generally recognised as safe” (GRAS) by the U.S. Food 
and Drug Administration (FDA).44 Furthermore, cocrystals are not limited to binary mixtures as 
tertiary and quarternary mixtures are also possibilities45 and cocrystals also provide the 
opportunity for more than one API to be administered simultaneously to the patient if two or 
more APIs can crystallise together.  
As there are thousands of possible GRAS coformers that could be considered in 
cocrystallisation experiments, recent attention has been focused on developing methods and 
knowledge that will help determine whether a cocrystal (or salt) is likely to form, potentially 
reducing the amount of experimental work required. Such approaches consider the 
intermolecular interactions between coformers46 using informatics tools such as hydrogen bond 
propensity calculations (HBPC) that statistically analyse the likelihood of hydrogen bonds 
forming based on relevant structures in the CSD.44 This approach allows coformers to be pre-
screened and has been used to analyse synthon competition in theophylline (a bronchodilator) 
cocrystals47 as well in determining the salts or cocrystals formed between pyrimethamine (an 
anti-malarial) and a number of acids and benzene derivatives48 as well as between 
pyrimethamine and various other APIs and GRAS molecules.49 
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As the interest in cocrystals and salts as alternative solid forms of APIs has increased, 
so too has interest in experimental methods and screening processes that can identify and 
characterise potential cocrystals, salts and other solid forms of APIs. There is a broad range of 
experimental techniques used to target salt and cocrystal formation, including more traditional 
solution based crystallisation methods as well as mechanosynthesis such as solid-state and 
solvent-drop grinding. Many of the methods used for traditional polymorph screening, 
mentioned in Table 1, can also be used to screen for cocrystals and salts if the starting materials 
include potential coformers. High-throughput methods50-52 can also target cocrystal and salt 
formation saving time in obtaining the optimal solid state form of an API. 
 
1.2.4.3 Salts 
In cases where the API is ionisable, the formation of a crystalline salt is often the easiest 
way to improve the solubility and bioavailability as well as alter other desirable properties. When 
a salt is formed, a counter ion is chosen from the GRAS list and the choice is often based on the 
difference between the pKa values of the API and the coformer.  
The pKa rule of thumb has been developed over a number of years within the 
pharmaceutical industry and has more recently been verified by a statistical study on 6465 
crystalline compounds found on the CSD.57 It states that if ΔpKa > 4 then a salt will exclusively be 
formed, however, if ΔpKa < -1 then a cocrystal will be formed. A linear relationship exists 
between the probability of salt formation and ΔpKa when the values of ΔpKa fall in the region of 
-1 and 4 (zone 2, Figure 4).57 Figure 4 shows the relationship between ΔpKa and the occurrence 
of structures on the CSD; zone 1 (ΔpKa < -1), zone 2 (-1 < ΔpKa < 4) and zone 3 (ΔpKa > 4). 
 
 
Figure 4. Relative occurrences of AB cocrystal (grey) and A−B+ salt (orange) as a function of the calculated 
ΔpKa from the study of 6465 crystalline structures by Cruz-Cabeza.57 ΔpKa is the difference in pKa 
between coformers A and B. Zone 2 is defined, −1 ≤ ΔpKa ≤ 4, zone 1 (ΔpKa < -1), zone 3 (ΔpKa > 4).  
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Salts and cocrystals can form similar crystal structures and as such, the protons have 
to be located by crystallography to definitively say whether a structure is a salt or a cocrystal. 
Therefore, when analysing crystal structures from the CSD or literature, it is important to note 
the difficulty in finding the position of protons by crystallography. Did the crystallographer care 
about the position of the proton? Was the diffraction data good enough to experimentally locate 
the proton? These are questions that should be considered before too much information is 
derived from CSD data on salts and cocrystals.  
An experimental investigation into the crystal structures formed from the 
cocrystallisation of a series of five carboxylic acids with pyridine and 4-dimethylaminopyridine 
highlighted the problems of predicting multicomponent systems as salts, cocrystals or 
disordered solid forms.58 Furthermore, periodic electronic structure calculations showed there 
was a significant energy penalty in moving the proton from salt formation to cocrystal and vice 
versa, yet this energy penalty was reduced for disordered structures.58 The importance of the 
positon of the proton was also highlighted in a further investigation into carboxylic acid – 
pyridine crystals that showed the relative stability of the complexes changed significantly when 
the proton was moved away from its observed position in the experimental crystal structure. 59 
Cocrystals and salts can also exist in different polymorphic forms and, similar to pure 
compound screening, the most comprehensive method of identifying as many solid forms as 
possible is by considering a large range of different crystallisation techniques. An example of 
how multiple experimental methods can simultaneously be used to screen the solid state 
landscape of a multicomponent system is observed in the study of the phenazine-mesaconic 
acid, 1:1 cocrystal system. Table 2 shows that multiple experimental approaches produced three 
polymorphs of the 1:1 cocrystal, a monohydrate and a DMSO solvate.60 Table 2 also shows that 
more than one method of crystallisation can be used to obtain forms I and II of the 1:1 cocrystal.  
 
Table 2. Summary of the results from polymorph screening with the 1:1 phenazine-mesaconic acid 
cocrystal by Eddleston.60 
 
Cocrystal form Cocrystallisation methods which have yielded this form 
Form I 
Solution crystallisation, dry grinding, l iquid assisted grinding, sublimation, 
thermal methods, desolvation of the monohydrate 
Form II 
Cocrystall isation at the interface between two saturated solutions, l iquid 
assisted grinding, desolvation of the DMSO solvate 
Form III 
Thermal methods (crystall isation from the melt of a physical mixture of both 
components and from heating form I in the DSC) 
Monohydrate 
Cocrystall isation at the interface between two saturated solutions  (phenazine in 
xylene and mesaconic acid in water) 
acid in water 
DMSO solvate Liquid assisted grinding 
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The multiple experimental screening approach requires a lot of time and resources yet 
will hopefully produce all the potential solid forms of a given multi component system including 
polymorphs, solvates, hydrates and even cocrystals of salts. However, it can never be proven 
that all the solid forms have been found. 
 
1.2.4.4 Solid Solutions 
An alternative outcome of a cocrystallisation experiment could be  the formation of a 
solid solution which can occur between two or more compounds if their molecular structure is 
similar and they have almost the same type, size and position of atoms (molecular 
isostructurality). This means that the different molecular components can occupy equivalent 
crystallographic sites and thus the crystal structure of the parent (major) component can be 
retained with the minor component incorporated within the crystal lattice substitutionally. 
Other solid solutions exist where the minor component is found interstitially in crystallographic 
sites that would normally be vacant.61 
Much of the original work on organic molecular solid solutions, or mixed crystals, was 
carried out by Kitaigorodsky62, 63 who suggested that in order for a solid solution to exist, the 
components had to be molecularly isostructural  and the individual components had to have 
similar crystal structures that were either isomorphous (same space group and unit cell 
dimensions) or isostructural (same packing arrangement, but not the same unit cell dimensions). 
Crystal isostructurality is limited to substituent pairs whose members can replace each other 
without altering the existing packing of the crystal. Chloro and methyl substituents  have very 
similar van der Waals volumes and thus permit isostrucurality.64 
There are a number of descriptors of crystal isostructurality including terms used by 
Kálmán et al. such as the unit-cell similarity index (Equation 1)64 the isostructurality index 
(Equation 2)64 and the volumetric isostructurality index (Equation 3).65 
 
Equation 1   𝛱 =
(𝑎+𝑏+𝑐)
(𝑎′+𝑏′+𝑐′)
− 1 
 
Equation 2   𝐼𝑖(𝑛) =  |√
∑(Δ𝑅𝑖)2
𝑛
− 1| × 100 
 
Equation 3   𝐼𝑣 =
2𝑉∩
𝑉1+𝑉2
 × 100 % 
 
The unit cell similarity index, 𝛱, compares the orthogonalised cell parameters (𝑎, 𝑏, 𝑐  
and 𝑎′, 𝑏′, 𝑐′) of the related structures and has a value of zero for identical cells. The 
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isostructurality index, 𝐼𝑖(𝑛), can also be calculated where 𝑛 is the number of differences in 
distance (Δ𝑅𝑖) between crystal coordinates of identical non-hydrogen atoms.
64 The volumetric 
isostructurality index, 𝐼𝑣, takes into account the volumes occupied in the unit cells of related 
structures where 𝑉1  and 𝑉2 are the volumes of the compared molecules and 𝑉∩ is the 
intersection of these volumes, the volume that is the same in both molecules.65 
Isostructural crystal structures or structures with a high degree of structural similarity 
can also be identified using a number of computational programs such as XPac66 and 
COMPACK.67 XPac is useful for identifying pairs of structures that have one-dimensional (chains 
of molecules in common), two-dimensional (sheets of molecules in common) or three-
dimensional structural similarity. COMPACK analyses the packing environments of two crystal 
structures using interatomic distances and the default coordination sphere considers the closest 
15 molecules. Similarities are quantified by rmsdn values which are the root-mean-square 
deviations of the distances between the non-hydrogen matched atoms of the two molecular 
structures that are being compared for n molecules overlain within the specified tolerances (20 
% and 20 ° for distances and angles respectively).  
The similarity comparisons of fenamate molecules can be carried out for molecules 
with different functional groups by allowing for molecular differences and matching only the 
similar atoms. To generalise the results, if n = 2 it suggests that the hydrogen bonding dimer is 
readily retained, if n = 6 it suggests that there are similarities in the planes of the two structures 
and if n = 15, it suggests that the compared structures are isostructural, differing only at the 
second nearest neighbour level. 
If the crystal structures of two compounds are isostructural, Kitaigorodsky suggested 
that it would be possible to form a solid solution of these compounds. Such crystals consist of a 
single lattice where the lattice sites are occupied at random by two or more species with the 
overall populations equal to the bulk composition of the material.68 As the stoichiometry of the 
different molecular constituents in the solid solution crystals is not limited to integer values, the 
structural and physical properties of the material can be tailored, often in a continuous linear 
fashion, by varying the relative compositions of the two compounds within experimental 
constraints.69 Furthermore, if a solid solution of two or more APIs can be formed then solid 
solutions can have advantages over cocrystals as the ratio of the APIs can be varied for use in 
combination therapy. Solid solutions of cocrystals also exist.68 
 
1.2.5 Computational Screening 
Recent advances in computational methods of crystal structure prediction (CSP) have 
provided researchers with a complimentary approach70 with which to investigate the 
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phenomenon of polymorphism. Advances in computational power and programs have allowed 
thermodynamically feasible crystal structures to be generated for molecules of increasing 
complexity. Originally, the computational CSP methods were only applicable to rigid molecules, 
but the recent successes of CSP methods for highly flexible, pharmaceutically relevant, 
molecules under blind test conditions highlight the advancements made in the field of CSP.  71, 72 
(See chapter 6 for more information on the blind tests.) 
CSP methods produce thermodynamically feasible crystal structures of a given 
compound. CSP can be used to compliment experimental screening to give a more thorough 
understanding of the polymorphic behaviour of a particular compound. In principle, a 
comparison of the structures generated by CSP methods with experimental forms can give 
reassurance that the low energy thermodynamically feasible forms have been found 
experimentally.73 Furthermore, powder X-ray diffraction (PXRD) patterns of predicted structures 
to can be simulated for comparison with PXRD patterns from experimental screening which can 
help identify unknown polymorphs if a single crystal cannot be grown.74  
At present, there is no routine CSP method for polymorph screening and CSP 
approaches are continually adapted in line with the studied compound or API and the purpose 
of the polymorph screen. However, the use of CSP methods in polymorph screening is becoming 
increasingly apparent with CSP programs like Neumann’s GRACE (the Generation, Ranking and 
Characterisation Engine) being commercially available.75 CSP methods have also recently been 
used in collaboration with industrial-style solid form screening processes76-78 and have been 
shown to help direct experimental methods (through solvent choice etc.) so that new 
polymorphs79, 80 and additional metastable forms are obtained.78  
CSP methods often predict more low energy, thermodynamically feasible, structures 
than are observed experimentally. This is because kinetic parameters that are involved in the 
crystallisation process such as cluster nucleation, formation, phase transformation and crystal 
growth are beyond the scope of the calculations.15 Low energy structures generated using CSP 
methods are the result of the compromises between favourable intermolecular interactions 
such as close packing, hydrogen bonds and π-π interactions as well as conformational 
preferences/flexibility81 of the molecules within crystal lattices. 
The set of structures generated by CSP methods that have the lowest lattice energies 
are usually summarised on a crystal energy landscape82 (see Figure 5 for examples) that plots 
the densities (or packing coefficients) against the lattice energies. Crystal energy landscapes are 
a visual summary of the thermodynamically feasible structures that are produced from CSP 
methods with each point representing a structure. These crystal energy landscapes can help 
indicate whether a certain compound is expected to be monomorphic, polymorphic or will tend 
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towards disorder (Figure 5). The structures with the lowest lattice energies on the crystal energy 
landscape are expected to be the most thermodynamically stable.  
 
 
 
Figure 5. Price’s idealized types of crystal energy landscape and examples of molecules that exhibit this 
behaviour.81  
 
Figure 5 shows the idealised types of crystal energy landscapes, as summarised by 
Price,81 alongside some examples of molecules that fall within each type. Figure 5a shows a 
typical monomorphic system where the large energy gap (ΔE) between the energy of the lowest 
predicted structure and the energy of other structures indicates that one structure is 
significantly the most stable and likely to be the only form obtained. Figure 5b shows an idealised 
predictive system that indicates the presence of two polymorphs as there are two structures 
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that are both low in energy, but that differ in their crystal packing as shown by different shaped 
points on the crystal energy landscape, a square and a triangle. Figure 5c shows a crystal energy 
landscape that indicates disorder could be expected as there are numerous structures that are 
similar in both energy and packing. If these structures are related, but differ in the stacking of 
the same sheet of molecules, then it is feasible that stacking errors could occur and disorder is 
likely. 
The information that different crystal energy landscapes provide is obvious in the 
example of the related molecules caffeine and isocaffeine. Isocaffeine appears to be 
monomorphic with an energy gap of 6.05 kJ mol -1 between the global minimum and the next 
most stable crystal structure, in line with experimental observations where only one form of 
isocaffeine has been obtained. In comparison, the crystal energy landscape of caffeine is 
significantly different and helps explain the observed disorder in caffeine form II. 83 
Alongside the successes of CSP methods under blind test conditions,71 CSP methods 
have also managed to predict a new polymorph of carbamazepine (form V)84 that was 
subsequently found after extensive further experimental investigation. The isolation of CBZ form 
V was the first time computational calculations directly influenced the development of the 
experimental procedure that was used to specifically target the predicted form. 84 CSP studies of 
CBZ indicated that there was a thermodynamically feasible form with a catermeric structure that 
was competitive in lattice energy with the previously known forms that all containe d the amide 
hydrogen bond dimer.73, 85, 86 Even though CBZ had previously undergone extensive experimental 
screening, CBZ form V remained elusive until CSP techniques showed the structural similarity 
between CBZ form V and dihydrocarbamazepine (DHC) form II. Experimental procedures were 
subsequently developed which first obtained a solid solution of CBZ and DHC87 and then targeted 
the crystallisation of CBZ form V by sublimation of CBZ onto a template crystal of DHC form II 
(Figure 6).84 Both the solid solution and CBZ form V are isostructural with the predicted 
catermeric CBZ structure and DHC form II. Interestingly, the CBZ form V crystals are formed on 
the smallest edge faces of the crystal and not directly on a large crystal face (Figure 6). This 
suggests that it is not just the isomorphous nature of the seed crystal that is a factor in the 
growth of CBZ form V as this would lead to growth over much of the seed crystal . 
CSP methods had previously been used to tailor experimental procedures to target 
specific packing motifs by choosing specific solvents with relevant hydrogen bond donor or 
acceptor groups to try and produce crystal structures with the desired hydrogen bonding 
motifs.79, 80 In comparison, the results of the investigations into CBZ highlight the potential 
applications of CSP methods in developing templating experiments where a specific surface is 
chosen to target a specific form. If experimentally known forms of related molecules are 
isomorphous or isostructural to predicted, thermodynamically feasible polymorphs, then there 
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exists the possibility that templating experiments could be used to enable the isolation of 
predicted forms.  
 
 
CBZ 
 
DHC 
 
 
Figure 6. DHC II seed crystal with thin plates of CBZ V (i–iii) emerging from the edge faces.84  
 
During the course of this thesis, further experimental investigations have been carried 
out templating CBZ form V using DHC form II seed crystals by sublimation. The latest set of 
experiments used polycrystalline DHC form II as a template surface rather than a single crystal 
which increases the surface area and orientations of different crystal faces that are available for 
vapour deposition of CBZ.88 A separate surface of ordered single crystals of DHC was also 
prepared and both the ordered surface and the polycrystalline surface templated the nucleation 
of CBZ form V. In comparison to the previous templating experiments (Figure 6),84 the latest 
results showed no evidence of face selectivity. 
To further examine the usefulness of the templating experiments, the same 
polycrystalline and single crystal surfaces of DHC form II were used in experiments with another 
related molecule, cyheptamide (CYH). CSP methods had predicted a thermodynamically feasible 
crystal structure of CYH was competitive in energy with known polymorphs and was 
isostructural to DHC II and CBZ V.88 The DHC form II surface successfully templated the growth 
of the predicted isostructural polymorph of CYH, CYH form III, for the first time.  
The results of the experiments concerning the isostructural polymorphs of CBZ form 
V, DHC form II and CYH form III show that targeted crystallisation with isomorphous template 
surfaces can be used to nucleate novel polymorphs that are not found in conventional screening 
methods. 
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1.3 Thesis Aims and Outline 
Sections 1.1 and 1.2 give an overview of the reasons why full characterisation of the 
solid form landscape of an API is important and introduce many experimental techniques that 
are used to investigate the solid form diversity of a compound. This thesis investigates the 
polymorphism displayed by mefenamic acid (MA) and tolfenamic acid (TA) and explores the 
consequences of chloro-methyl replacement in the crystal structures of MA and TA using a joint 
computational and experimental approach.  
 
1.3.1 Research Approach 
Chapter 2 introduces the compounds MA and TA and their known polymorphs. The 
crystal structure similarities and differences between known forms of MA and TA are described 
and chloro-methyl replacement within the crystal structures is discussed.  
Chapter 3 conducts a CSP study on MA by adapting the methodology already used in 
the CSP study on TA.89 The calculated crystal energy landscape of MA was then analysed to 
identify any potential polymorphs that are competitive in energy with the known forms of MA. 
Isostructural relationships between MA and other fenamates, in particular TA, were also 
analysed. 
Alongside the computational work, the use of isostructural heteroseed surface 
templates was explored experimentally, targeting the nucleation of existing forms by new routes 
as well as the nucleation of new forms of MA and TA. The isostructural relationships of MA and 
TA were investigated using solution based crystallisation techniques (chapter 4) as well as 
sublimation techniques (chapter 5). The sublimation techniques were guided by the successes 
of the methods used to nucleate CBZ form V and CYH form III on DHC form II seed templates.84 
Chapter 6 tests the validity of the CSP methodology used in this thesis by participation 
in the 6th blind test held by the CCDC.  
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2 Crystal Structures of Fenamate Molecules 
Chapter 1 introduced the concept of polymorphism, highlighted the importance of 
fully characterising the solid form landscape of a given API and presented some of the various 
experimental methods that are utilised to find novel forms.  
This thesis investigates the polymorphism of mefenamic acid (MA) and tolfenamic acid 
(TA). MA and TA are molecularly isostructural and have the same skeleton of bonds, but differ 
in the replacement of a methyl group on MA with a chloro group on TA (Figure 7). Investigations 
into the polymorphism of MA and TA will provide insights into the possibility of chloro-methyl 
replacement in the crystal structures of MA and TA.  
 
 
 
 
(a) (b) 
 
Figure 7. Diagrams of (a) mefenamic acid and (b) tolfenamic acid. The diagrams shows the molecular  
similarity of the two molecules that differ in the replacement of a CH3 group on MA with Cl on TA. 
 
MA and TA belong to the fenamate group of molecules which are non-steroidal anti-
inflammatory drugs (NSAIDs) that have been used in the pharmaceutical industry since the 
1960s.90 NSAIDs have been used to treat pain from a variety of causes including migraines, 
musculoskeletal/joint disorders and menstrual cramps.91-94 The fenamate group of molecules 
are highly polymorphic with each fenamate exhibiting conformational polymorphism and MA 
having three known polymorphs, TA having five known polymorphs and flufenamic acid (FFA), 
having nine polymorphs, of which eight are fully characterised by X-ray diffraction.31 FFA 
previously held the record for the molecule with the highest number of known crystal structures, 
but this was recently beaten by aripiprazole which has twelve reported anhydrous forms, nine 
of which are characterised crytallographically.95 
The decision to investigate the fenamate group of molecules was influenced by the 
results of a previous CSP study on two fenamates, fenamic acid (FA) and TA. Comparisons of the 
structures of FA and TA, including experimental forms and their most stable hypothetical 
structures, with known crystal structures of other fenamates found in the CSD, suggests that 
there is a high degree of structural similarity between the fenamates (Table 3). The hypothetical 
crystal structure entries in Table 3 are indicated with a #. 
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The structural similarity comparisons were carried out using the Crystal Packing 
Similarity67 module in the program Mercury96, 97 (produced by the CCDC) which considers the 
similarity of the coordination environments of the molecules.  
 
Table 3. The crystal packing similarity of the experimental structures of FA, TA (with three ordered 
models for disordered form V of TA) and their most stable hypothetical crystal structures with the 
known crystal structures of other fenamates in the CSD (denoted by their refcodes). The similarity is 
given in the form n(rmsdn), with the overlays of six or more molecules highlighted as bold. The column 
for MA (the focus of this research alongside TA) is highlighted in grey. The table was copied and 
reformatted from previous work by Uzoh.89  
  
n(rmsdn/Å) MA 
 FPAMCA FPAMC
A11 
LAHLOW PEFMET PEFNAQ SURMEY SURMOI XYANAC 
 
       
FA         
QQQBTY02 2(0.71) 4(1.33) 7(0.84) 3(1.28) 6(0.62) 3(0.50) 3(1.20) 4(0.49) 
#1FA_22 2(0.41) 5(1.91) 6(1.31) 2(0.13) 11(0.96) 4(0.98) 4(1.08) 3(1.80) 
#2FA_2 2(0.43) 3(0.56) 7(1.01) 2(0.10) 11(0.51) 3(1.07) 7(0.98) 3(0.86) 
TA         
II 1(0.89) 2(0.15) 2(0.59) 2(0.11) 1(0.61) 2(0.12) 12(1.87) 2(0.29) 
I 2(0.59) 2(0.48) 3(0.61) 1(0.70) 13(0.38) 6(1.78) 4(1.20) 2(0.62) 
III 1(0.81) 7(0.75) 2(0.48) 13(0.33) 2(0.55) 13(0.61) 3(0.41) 13(0.45) 
IV 2(0.87) 6(0.71) 3(1.09) 11(0.49) 2(0.46) 13(0.84) 3(0.56) 15(0.30) 
V_a 2(0.57) 2(0.46) 5(0.42) 1(0.68) 3(0.39) 2(0.22) 2(0.18) 2(0.57) 
V_b 2(0.75) 3(0.32) 7(0.64) 2(0.47) 4(1.10) 5(0.41) 4(1.19) 5(0.72) 
V_c 2(0.95) 2(0.84) 5(0.41) 1(0.42) 4(1.10) 4(0.51) 2(0.29) 3(0.46) 
#2TA_15 2(0.52) 2(0.53) 3(0.91) 1(0.77) 14(0.4) 4(0.82) 4(1.22) 2(0.70) 
#3TA_876 1(0.93) 4(1.56) 7(1.42) 3(0.43) 1(0.66) 3(0.71) 4(0.47) 2(0.37) 
#4TA_6243 2(0.54) 3(1.15) 3(1.76) 1(0.69) 4(0.16) 4(1.49) 2(0.17) 3(0.91) 
#6TA_82 1(0.92) 2(0.17) 2(0.61) 2(0.12) 2(0.64) 2(0.08) 15(0.28) 2(0.28) 
 
Table 3 shows that there is a high level of crystal structure similarity between MA form 
I (CSD refcode: XYANAC) and TA forms III (CSD refcode: KAXXAI02) and IV (CSD refcode: 
KAXXAI03). This thesis addresses the structural similarities of the MA and TA crystal lattices 
further and investigates the effect of chloro-methyl substitution in the fenamates.  
Previous investigations on the fenamate group of molecules have been mentioned in 
the previous chapter (chapter 1) including the role of heteronucleation in obtaining different 
polymorphs. For example, FFA as an additive can lead to the isolation of metastable MA form 
II,22 use of polymers have led to new forms of FFA31 and TA32 and SAMs have led to the 
observation of concomitant polymorphism of MA.35, 36 
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2.1 Mefenamic Acid 
There are currently three known polymorphs of MA, form I,98 a disordered form II22 
and a recently discovered, metastable form III.99 All three polymorphs belong to the P-1 space 
group, have just one molecule in the asymmetric unit (Z’ = 1) and consist of hydrogen bonded 
dimers (Figure 8). The MA molecules in all three polymorphs have an internal hydrogen bond 
(Figure 8). The two most widely reported polymorphs of MA; forms I and II, are enantiotropically 
related,35, 99 with form I being the most stable at room temperature and form II the most stable 
at elevated temperatures or 170 °C.36 DSC has been reported to show that MA form I transforms 
to form II at 170 °C100 and in the temperature range of 178 – 180 °C.99 Additionally, MA form II 
has been obtained by holding MA form I at 160 °C for a week.35 
 
 
Figure 8. Hydrogen bonded dimers of MA. Inter and intra molecular hydrogen bonds are shown in 
purple.  
 
MA form I has been reported to crystallise from a variety of solvents.101-103 MA form II can 
be obtained by crystallisation from chloroform,99 from a solution of N,N-dimethylformamide,101 
by heating form I to around 150 °C – 160 °C35, 101, 102, 104, 105 or by heteronucleation using SAMs.35, 
36 Form III was obtained serendipitously from a cocrystallisation experiment of MA with adenine 
in a 1:1 DMF/methanol mixture followed by slow evaporation of the solvent  at room 
temperature.99  
Studies on MA show that the infrared spectra of MA forms I and II are different, 
therefore infrared spectroscopy can be a useful technique in determining the polymorphic form. 
It has been reported that upon transformation from form I to form II, the N-H stretching band 
in the infrared shifts from 3313 cm-1 to 3347 cm-1.104 The change in the position of the N-H 
stretching peak was originally attributed to a conformational difference in the polymorphs 
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involving 180 ° rotation of the carboxyl group.101, 104 This meant that the N-H bond would be 
stronger in form II as the internal hydrogen bond is weaker (C-O···H versus C=O···H hydrogen 
bonding), thus resulting in the increase in wavenumber of the peak for the N-H stretch in the 
infrared spectrum. However, a more recent computational study has shown that differences in 
the IR spectra can be explained by rotation about the N-C bond106 and the difference in the 
torsion angle ξ1 (Table 4). This latter explanation was confirmed by the crystallographic data 
when a single crystal of MA form II was isolated for the first time. 22 The ξ1 torsion angle is 
different in the three polymorphs of MA (Table 4). 
As well as infrared spectroscopy, Raman spectroscopy has been used to differentiate 
between polymorphs of MA with three distinct vibrational band differences between MA form 
I and MA form II.35 Low wavenumber Raman spectroscopy can also be used.105 
 
Table 4 The ξ1 torsion angle (C2-N1-C8-C9) in the different polymorphs of MA. The ξ1 torsion angle is shown 
by the blue bonds in the diagram. ξ1 for forms I and II are taken from single crystal data in this research. 
MA form II is disordered in the ratio (a) 0.654 and (b) 0.346. 
 
Polymorph I II III99 
  (a) (b)  
ξ1 torsion angle (°) 
 
119.38 69.72 -78.97 80.82 
 
2.1.1 Redeterminations of MA form I and MA form II 
2.1.1.1 Methods 
Materials. MA was purchased from Sigma Aldrich and was used without further 
purification. A large range of reagent grade solvents were used. 
Preparation of Single Crystals. Single crystals of MA form I were obtained by room 
temperature solvent evaporation to dryness of MA from a number of solvents including ethanol, 
1-butanol, acetonitrile and 1,2-dichloroethane. 
Single crystals of MA form II were obtained by sublimation onto a glass surface under 
a static vacuum (1.0 x 10-5 Pa) for 48 hours. See chapter 5 for further experimental details on the 
sublimation setup. 
Single Crystal X-ray Diffraction. Single crystals of MA forms I and II were chosen using 
a microscope equipped with a rotatable polarising stage. Crystallographic data were collected 
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at 150 K using an Agilent SuperNova diffractometer, equipped with an Oxford Instruments 
cryostat and Cu-Kα radiation (λ = 1.54184 Å). Using Olex2107, structures were solved with the 
SHELXS108 structure solution program using direct methods and were refined using SHELXL109 
using least squares minimisation. In form I the data quality was such that the hydrogen atoms 
were located and subsequently refined in the final difference map. In form II the hydrogen atoms 
were included with a riding model. 
Infrared Spectroscopy. Crystals were analysed using solid state infrared spectroscopy. 
Infrared spectra were obtained using a Perkin-Elmer Spectrum One FTIR fitted with a diamond 
ATR accessory. Spectra were collected over the range 4000−650 cm−1 at a resolution of 4 cm−1 
and analysed using the ACD/Spectrus Processor software.110 
Thermal Analysis. Differential Scanning Calorimetry (DSC) measurements were 
performed on a TA Q2000 (TA Instruments, LLC, USA) that was calibrated at heating rate of 10 
°C min-1 for a temperature range of 0 – 250 °C using an Indium melting point standard. Nitrogen 
(50 mL min-1) was used as a purge gas. Sample sizes were between 0.88 mg and 1.75 mg. Tzero 
non-hermetic aluminium pans and lids were used. The data analysis was carried out using the 
Universal Analysis 2000 software.111 
 
2.1.1.2 Results 
The crystallographic data for MA forms I and II are reported in Table 5 alongside the 
crystallographic data for MA form III as reported by SeethLekshmi et al.99 The thermal ellipsoid 
plot, set at 50 % probability, for MA form I is shown in Figure 9 and for MA form II is shown in 
Figure 12. 
 
Figure 9. Thermal ellipsoid plot, set at 50 % probability, of MA form I. 
 
The infrared spectra collected for MA forms I and II are shown in Figure 10. The spectra 
are in agreement with previous literature and show that forms I and II of MA can be 
distinguished by the position of the N-H stretching peak.104 The N-H stretching peak appears at 
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3308 cm-1 for MA form I and at 3342 cm-1 for form II. The infrared spectrum for MA form III has 
not been found in current literature. 
 
 
Figure 10. The infrared spectra of MA form I (red) and MA form II (blue). 
 
MA forms I and II were analysed by DSC in the temperature range 0 – 250 °C at a 
heating rate of 10 °C min-1 and the scans are shown in Figure 11. Figure 11 shows that there is a 
single melting endotherm for MA form II at 231.4 °C. The DSC scan for MA form I shows an 
endothermic phase transition at 168.5 °C followed by a melting endotherm at 230.7 °C. The 
results from the DSC scans are in agreement with previous literature which show that MA form 
I transforms to MA form II upon heating to 170 °C.100 
 
 
Figure 11. DSC scan of MA form I (blue) and MA form II (black). The scans were carried out at a heating 
rate of 10 °C min-1.  
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Table 5. The crystallographic data of MA polymorphs.  
  
Ithis work IIthis work III99 
Unit Cell Diagram 
   
Crystal System triclinic triclinic triclinic 
Space Group P-1 P-1 P-1 
Temperature (K) 150 150 298(2) 
a (Å) 6.7887(3) 7.7300(3) 7.723(2) 
b (Å) 7.3613(2) 9.1275(4) 7.9340(10) 
c (Å) 14.0330(4) 9.4027(3) 11.2320(10) 
α (°) 76.868(3) 107.112(4) 83.590(10) 
β (°) 79.857(3) 91.604(3) 80.940(10) 
γ (°) 64.863(3) 101.683(3) 67.510(10) 
Cell Volume (Å3) 615.74(4) 618.19(4) 626.96(19) 
Z 2 2 2 
Z’ 1 1 1 
Unique reflections 2170 2436 2287 
Refined parameters 223 205 169 
GOF 1.037 1.053 1.037 
R1 (I > 2σ(I)) 0.0317 0.0454 0.042 
wR2 (all) 0.0841 0.1248 0.109 
R1 (all) 0.0326 0.0525  
 
MA form II is disordered with two different conformations of MA in the unit cell with 
a population distribution of 65:35. The two conformations differ most in the rotation of the 
alkylated phenyl ring (the ξ1 torsion angle as shown in Table 4) and the position of the amino 
bridging group relative to the phenyl ring with the carboxyl group. The disorder exists at low 
temperature (150 K) which suggests it could be of static nature or is kinetically trapped.  
The disorder of MA form II is summarised in Figure 12 with the major component 
shown by solid black bonds and the minor component shown by dashed bonds ( Figure 12a). The 
disorder in the single crystal of MA form II collected in this study was 0.654:0.346, but the 
disorder reported for other determinations on the CSD are 0.705:0.295 (at 150 K) 22 and 
0.555:0.445 (at 298 K).99 Data on the disorder for the crystal structure on the CSD with the 
refcode XYANAC0536 cannot be located. The different occupancies that are reported for the 
disorder observed in MA form II suggest that the disorder is affected by the method o f 
nucleation or could also vary from crystal to crystal. 
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(a) 
  
(b) (c) 
 
Figure 12. The disorder in MA form II. (a) thermal ellipsoid plot of 50 % probability showing both 
components of the disorder, (b) the unit cell of the major component with 0.654 occupancy and (c) the 
unit cell of the minor component with 0.346 occupancy. 
 
Two ordered models of MA form II have been created by separating the two 
components of disorder present in the redetermination of MA form II in this thesis (Figure 12b 
and Figure 12c). The MA molecule in each ordered model is found in just one conformation. 
These ordered models will enable crystal packing similarity calculations to be carried out with 
ease later in this thesis. 
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2.2 Tolfenamic Acid 
TA has five known polymorphs that are found on the CSD. TA form I can be obtained 
by recrystallisation from absolute ethanol and form II can be obtained from rapid cooling of 
boiling ethanol (96 %) in an ice bath.112-114 Experimental and computational investigations have 
also suggested that the form of TA obtained from ethanol can be affected by the starting 
concentration of TA with form II being favoured at low supersaturation and form I being 
obtained at high supersaturation.114, 115 TA forms I and II are often referred to as the white and 
yellow form respectively due to the colour of the crystals.113 TA forms III,IV and V were isolated 
from an ethanol solution in the presence of nonpolar aromatic polymers, by PIHn.32  
As in MA, the five polymorphs of TA all contain the R2
2
(8) carboxylic acid dimers, but 
differ in conformation as shown by the values of the ξ 1 torsion angles for each polymorph 
reported in Table 6. Where all the polymorphs of MA were Z’ = 1, only TA forms I, II and V are Z’ 
= 1. TA form III is Z’ = 2 and TA form IV is Z’ = 3. TA form V is disordered with two conformations 
of TA in the unit cell and was identified to be isostructural with MA form II from PXRD data.116 
 
Table 6. The ξ1 torsion angle (C2-N1-C8-C9) in the different polymorphs of TA. The ξ1 torsion angle is shown 
by the blue bonds in the diagram. 
 
Polymorph I113 II113 III32 IV32 V32 
ξ1 torsion angle (°) 
 
 
 
 
 
74.95 
 
 
 
 
142.63 
 
 
 
 
126.78 
138.37 
 
 
 
 
115.85 
125.92 
134.14 
 
 
 
 
71.36 
-91.63 
 
The different polymorphs of TA can be distinguished using Raman spectroscopy. 32, 105 
Infrared spectroscopy can also be used to differentiate between polymorphs I and II of TA. 
Polymorphs I and II of TA are reported to have different N-H stretching peak positions. Gilpin et 
al. report peaks at 3340 – 3341 cm-1 and 3324 – 3325 cm-1 for forms I and II respectively117 whilst 
Jabeen et al. report peak positions of 3342 cm-1 and 3315 cm-1 respectively.106  
Table 7 shows the crystallographic data of the five known polymorphs of TA taken from 
the CSD. Comparison of the unit cell data of TA form V with MA form II shows that the unit cells 
are isomorphous. 
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Table 7. Crystallographic data for the five known polymorphs of TA taken from the CSD. 
 
Polymorph I113 II113 III32 IV32 V32 
 
   
  
Crystal System monoclinic monoclinic monoclinic triclinic triclinic 
Space Group P21/c P21/n P21/c P-1 P-1 
Temperature (K) 110 110 85(2) 85(2) 85(2) 
a (Å) 4.826(2) 3.836(2) 7.6356(15) 7.5237(8) 7.6488(13) 
b (Å) 32.128(1) 21.997(5) 11.305(2) 14.3308(16) 9.0160(15) 
c (Å) 8.041(4) 14.205(7) 28.065(6) 17.592(2) 9.4184(15) 
α (°) 90 90 90 103.680(2) 107.385(3) 
β (°) 104.88(3) 94.11(4) 93.03(3) 98.253(2) 92.062(3) 
γ (°) 90 90 90 93.038(2) 101.662(3) 
Z 4 4 8 6 2 
Z’ 1 1 2 3 1 
Cell Volume (Å3) 1204.95 1195.54 2419.2 1816.41 603.806 
R-Factor 0.052 0.029 0.0448 0.0723 0.0658 
 
2.2.1 Obtaining TA form I and TA form II 
2.2.1.1 Methods  
Materials. TA was purchased from LKT Laboratories Inc. and was used without further 
purification.  
Preparation of Single Crystals of TA form I. Single crystals of TA form I were obtained 
from recrystallisation from ethanol by room temperature solvent evaporation to dryness. Single 
crystals of TA form I were also obtained by sublimation onto a glass surface under a static 
vacuum (3.0 x 10-2 Pa) for 48 hours. See chapter 5 for further experimental details on the 
sublimation experiment. 
Preparation of TA form II. TA form II was obtained by cooling a solution of TA in boiling 
ethanol using an ice bath, following directions in the literature.112-114 
Single Crystal X-ray Diffraction. See section 2.1.1.1. Unit cell data was collected for 
crystals of TA obtained from ethanol solution and by sublimation. The crystals were confirmed 
to be TA form I by the unit cell data. 
Infrared Spectroscopy. See section 2.1.1.1. 
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2.2.1.2 Results 
The unit cell data collected by SCXRD showed that both recrystallisation from room 
temperature ethanol solution and sublimation onto a glass surface produce TA form I.  
In comparison, rapid cooling of TA in boiling ethanol produced TA form II which was 
confirmed by infrared spectroscopy. The infrared spectra of TA form I (obtained by 
recrystallisation from room temperature ethanol solution) is shown in Figure 13 alongside the 
spectra of TA form II (obtained by rapid cooling of TA in boiling ethanol). The different positions 
of the N-H stretching peaks in Figure 13 indicate the polymorphic form with a peak at 3339 cm-
1 for TA form I and a peak at 3323 cm-1 for TA form II. 
 
 
 
Figure 13. The infrared spectra of TA form I and TA form II. 
 
2.3 Chloro-Methyl Replacement within MA and TA Crystal Structures 
Although the molecules MA and TA are molecularly isostructural, with the same 
skeleton of bonds, current literature on their respective polymorphs shows that there are both 
similarities as well as numerous differences in the way that the two compounds crystallise.  
Table 3 shows the crystal structure similarities between the polymorphs of TA and MA 
form I as calculated by Uzoh.89 The work by Uzoh shows that TA form IV and MA form I are 
isostructural with a 15 molecule overlay, rmsd15 = 0.30 Å, and that TA form III and MA form I are 
structurally similar with a 13 molecule overlay, rmsd13 = 0.45 Å. López-Mejías et al. identified 
MA form II and TA form V as isostructural from PXRD data.116 
TA I 
TA II 
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Crystal structure similarities have been carried out between all the known polymorphs 
of TA and MA using the crystallographic data from this work. The isostructural pairs of crystal 
structures presented in Figure 14 show that MA form I is isostructural to TA form IV and MA 
form II is isostructural to TA form V. No isostructural relationships exist between known 
polymorphs of MA and TA for MA form III or TA forms I, II and III.  
The existence of isostructural polymorphs of MA and TA is likely to be due to the fact 
that MA and TA differ only in the replacement of a methyl group on MA with a chloro group on 
TA (see Figure 7). As mentioned previously in section 1.2.2.1, methyl and chloro groups have 
similar van der Waals volumes and as such can be interchangeable within crystal lattices 24, 25 
following the Kitaigorodsky principle of close packing.62 
Although it is widely agreed that methyl and chloro groups have similar van der Waals 
volumes, there is much disagreement in the literature as to which substituent is larger. In 1986, 
Desiraju and Sarma stated that the chloro group was smaller than the methyl group with a van 
der Waals volume of 19 Å3 compared to 24 Å3 for the methyl.24 The van der Waals volumes of Cl 
and CH3 groups have also been reported to be 20 Å3 and 24 Å3, respectively.118-120 However, most 
recent literature states that the methyl group is the smaller substituent with a van der Waals 
volume of 19 Å3 compared to 21 Å3 for the chloro group.21, 25, 121 Whichever substituent (methyl 
or chloro) is larger, the van der Waals volumes are similar enough in size to facilitate 
isostructurality between two pairs of known polymorphs of MA and TA ( Figure 14).  
The occurrence of isostructural crystal pairs that result from a chloro-methyl 
interchange has previously been investigated by analysing the extensive number of structures 
on the CSD.119, 122 Results suggest that only approximately 25 % of molecularly isostructural 
compounds, that differ by chloro-methyl interchange, are crystallographically isostructural.119, 
122 Furthermore, only 2 out of 22 isostructural crystal structure pairs that have just a singular 
chloro-methyl group interchange, have Cl···Cl distances less than 4.0 Å.25 This information would 
tend to suggest that isostructural crystal structures would be less likely to be observed if there 
are short Me···Me or Cl···Cl interactions and the facile interchange of methyl and chloro 
substituents may not take place.24 The Me···Me distance in MA form I is 3.63 Å and is as short as 
3.09 Å in MA form II depending on the components of disorder. Similarly, the Cl···Cl distances in 
TA form IV are 3.44 Å on average and are 3.51 Å on average in TA form V depending on the 
disordered components. These Me···Me and Cl···Cl distances do not support suggestions from 
the literature. It is possible that in the case of MA and TA, isostructurality is retained because 
the chloro group occupies a space filling role123 and does not have a structure directing role. 
There are differences in the way that the isostructural pairs (MA form I - TA form IV 
and MA form II – TA form V) crystallise as well as differences in the number of known polymorphs 
of MA and TA. PIHn was used to obtained all forms of TA, including forms III, IV and V for the 
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first time, alongside the previously known forms I and II.32 In comparison, the use of PIHn with 
MA only produced forms I and II and was not successful in obtaining form III or any additional 
polymorphs.116 This information suggests that molecular differences between MA and TA 
influence the nucleation of different forms.  
Additionally, sublimation experiments carried out in this thesis (see chapter 5 for more 
details) show that under the same conditions, MA and TA behave differently. For example, as 
has already been reported in sections 2.1.1.2 and 2.2.1.2, subliming MA onto glass obtains MA 
form II, but subliming TA onto glass under the same conditions obtains TA form I which is not 
isostructural to MA form II. 
 
 
rmsd15 = 0.332 Å 
(a) 
  
rmsd15 = 0.164 Å rmsd15 = 0.172 Å 
(b) 
 
Figure 14. Crystal packing similarities of isostructural crystal structures of TA and MA. (a) MA form I 
(coloured by element) and TA form IV (coloured by orange carbons), rmsd15 = 0.332 Å (b) MA form II 
(coloured by element) and TA form V (coloured by blue and pink carbons) – showing the overlays of 
ordered componenets of the disordered structure, rmsd15 = 0.164 Å, 0.172 Å. The crystal structures for 
MA used in the similarity calculations are the redeterminations in this work. 
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3 Crystal Structure Prediction of Mefenamic Acid 
The polymorphic landscape of a compound is most frequently investigated 
experimentally, but the ability to predict the polymorphs can reduce product development time 
scales and add confidence to the fact that all potential polymorphs have been identified 
experimentally. Therefore, CSP methods are continually being developed and tested for 
increasingly difficult systems including large, pharmaceutically relevant, flexible molecules,72, 77, 
78, 124 cocrystals,125-127 salts59 and hydrates.128, 129 
3.1 Introduction 
CSP methods find the range of different packings of molecules in a system that are 
thermodynamically feasible crystal structures. A common assumption is that the most stable 
packings correspond to observed crystal structures and that the most stable polymorphs will be 
found as minima on the crystal energy landscape if entropic effects are ignored.  
In this chapter, the crystal energy landscape of MA is computed. The predicted 
structures were analysed and were compared to known polymorphs of MA. Additionally, the 
generated structures of MA were compared to known polymorphs of other known fenamates.  
3.2 Computational Methodology 
The computational methodology employed in this study on MA was adapted from that 
used to calculate the crystal energy landscapes for two other fenamates, FA and TA, 89 which was 
in turn adapted from that used for the successful crystal structure prediction of a flex ible, 
pharmaceutically relevant, molecule in the fifth blind test.71, 72 The methodology follows a 
multistep process involving conformational analysis, a global search of the possible crystal 
packings and then energy minimisation using quantum-mechanical calculations to evaluate the 
lattice energies, Elatt, of the generated structures.  
As the lattice energies at each step in the methodology are evaluated with greater 
accuracy, the cost of the computational calculation increases. Therefore, as the model for Elatt 
improves, the number of unique structures that are considered is reduced. However, care must 
be taken to ensure that enough structures are considered at each stage to allow for the possible 
re-ranking of the relative stabilities of the crystal structures  
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3.2.1 Overview 
The success of CSP methods does not solely depend on the generation of all the 
possible crystal structures for a particular crystal system, but also on the accurate ranking of 
lattice energies. The lattice energy, Elatt, is the energy of the static crystal relative to infinitely 
separated molecules in their lowest energy conformation, the gas phase minimum.70 The crystal 
energy is approximated as the lattice energy, Elatt, which is the energy at 0 K and 0 Pa ignoring 
the zero-point energy and thus is related to the thermodynamic stability of the system. The CSP 
calculations ignore kinetic factors that affect nucleation. 
 
3.2.1.1 Conformational Analysis and Selection of Degrees of Freedom 
The lattice energy, Elatt, can be broken into two components, the intermolecular 
interactions between two molecules, Uinter, and the molecular energy penalty associated with 
distorting the molecule from its gas phase conformation, ΔEintra, 
 
Equation 4   𝐸latt =  𝑈inter +  ∆𝐸intra 
 
Early CSP calculations on rigid molecules could ignore the ΔEintra term. However, as CSP 
studies have developed and flexible molecules are now considered, there exists the possibility 
that the conformation of the molecule may change. Conformational changes incur a ΔEintra 
energy penalty, but may allow for improvements in the hydrogen bonding or close packing of 
molecules in the crystal structures. As such, the division of Elatt into the two components, Uinter 
and ΔEintra, is used in many current CSP methodologies. 
In general, a molecule will generally adopt a low energy conformation in crystal 
structures, however, small changes in the conformation of a molecule can greatl y improve the 
stability of a crystal structure by permitting more favourable intermolecular interactions. 70 In 
such cases, the conformational energy penalty paid, ΔEintra, is generally quite small. In other 
more exceptional cases, a molecule might change conformation and break an internal hydrogen 
bond, resulting in a large ΔEintra energy penalty, but this conformation change allows the 
molecule to form more favourable intermolecular hydrogen bonds, thus adopting a stable 
crystal structure.78 
Small conformational changes (such as methyl group rotation or minor changes in 
torsion angles) that significantly affect the crystal stability can be considered later on in the CSP 
methodology when optimising the crystal structures. Initial conformational analysis helps 
identify the flexible degrees of freedom that require consideration in the global search so that a 
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balance is reached between reliable modelling of the effect of conformational changes and the 
computational costs. 
 
3.2.1.2 Choice of Computational Model.  
The next step in the CSP process involves identifying an appropriate model that 
accurately represents both the intra- and intermolecular interactions in the crystal structures. 
This involves deciding upon the level of theory and basis set for quantum-mechanical 
calculations on the isolated molecule which are used to calculate the intramolecular energy and 
electrostatic intermolecular interactions.130 Additionally, an appropriate potential function 
needs to be decided upon to be used for the description of repulsion/dispers ion intermolecular 
interactions. The choice of computational model is most often aided by testing the ability of the 
model to reproduce crystal structures of existing polymorphs or related molecules.  
 
3.2.1.3 Global Search.  
The extent of the crystallographic space involved in the search is influenced by the 
number of independent molecules in the asymmetric unit. Most searches consider just one 
molecule in the asymmetric unit (Z’ = 1) to minimise computational costs . The search space 
increases with more molecules in the asymmetric unit (for example cocrystals and salts) as the 
number of variables required to describe the positions of the molecules relative to each other 
increases. 
The global search must also take into consideration the range of possible space groups 
of the crystal system. Most organic molecules crystallise in a small range of the 230 space 
groups. It is common for the global search to only consider the 59 most populated space 
groups131 on the CSD as a compromise between computational costs and the completeness of 
the search. 
The global searches in this thesis are performed using the CrystalPredictor algorithm 
for flexible molecules,132, 133 but there are a number of other computational search methods 
such as GRACE75 and MOLPAK134 that can also be used to generate crystal structures. 
CrystalPredictor generates a large number of crystal structures that vary in the selected 
conformational degrees of freedom of the molecule and in all the lattice variables for the chosen 
space groups such as unit-cell dimensions and angles and the relative positions and orientations 
of the molecules. 
CrystalPredictor optimises the lattice energy of the generated crystal structures using 
pre-calculated atomic charges and intramolecular energies (ΔEintra) for the isolated molecule in 
the range of conformations covered by the search. The atomic charges are used to model the 
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electrostatic interactions and an appropriate potential function is used to describe the 
repulsion/dispersion interactions that contribute to Uinter. 
The search space is considered complete when the lowest energy structures have been 
found numerous times by the search algorithm. The generated structures are clustered together 
if they are deemed to be similar from comparisons of simulated PXRD patterns and molecular 
coordination spheres. Therefore, the number of unique structures found in a search will be less 
than the number of structures generated. 
 
3.2.1.4 Accurate Lattice Energy Minimisation.  
The lowest energy structures produced by the search are then used as starting points 
for local lattice energy minimisation with improved models for Elatt. Local lattice energy 
minimisation is often a multistep process.  
 
3.2.1.4.1 CrystalOptimizer 
Generated structures are re-minimised using the CrystalOptimizer135, 136 algorithm 
which significantly improves the modelling of the lattice energy. Lattice energy minimisation can 
be considered a two-level problem which CrystalOptimizer solves by firstly optimising the 
conformation of the molecule and then using this fixed conformation as the input for rigid body 
calculations that optimise the lattice geometry of the crystal structure  and minimise the lattice 
energy, Elatt. 
CrystalOptimizer more accurately calculates Elatt than in previous steps because it 
allows minor conformation changes and molecular flexibility (such as small torsion angle 
changes and methyl group rotations) to be considered in energy minimisations. CrystalOptimizer 
uses GAUSSIAN137, 138 to calculate the intramolecular energy and the wavefunction of the 
molecule. DMACRYS139, 140 then minimises the lattice energy using extracted multipoles to 
evaluate the electrostatic interactions alongside an appropriate potential function for the 
repulsion/dispersion interactions. 
CrystalOptimizer finds the optimum balance between intra- and intermolecular 
energies as the conformation of the molecule varies. This could be computationally demanding 
as new quantum mechanical calculations would have to be performed for each new 
conformation for each of the crystal structures being optimised. To overcome this, 
CrystalOptimizer uses local approximate models (LAMs) to reduce the computational costs of 
calculations. LAMs model the intramolecular energy and multipole representation of the charge 
density with reference to a particular conformation stored in a database. If the conformation of 
the molecule differs by more than the tolerance of accuracy of the LAMs approximation, from 
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any conformation in the database, then a new quantum mechanical calculation will be 
performed and added to the database. Hence, the CrystalOptimizer calculations become 
progressively faster as more crystal structures are optimised.  
 
3.2.1.4.1.1 Distributed Multipole Moments 
Previous steps in the computational methodology use point charges to represent the 
electrostatic interactions between molecules. However, due to the anisotropic nature of charge 
density at short range, a more accurate representation is achieved when the  electrostatic 
potential of a molecule is represented by a multipole expansion (charge, dipole, quadrupole, 
octupole and hexadecapole) around a number of centres. Distributed multipole analysis 
(DMA)141, 142 assigns multipole moments to each atom (or other sites defined in the molecule). 
Distributed multipoles need to be recalculated for changes in conformation of the molecules. 
The computational DMA approach derives the charge distribution from the ab initio 
wavefunction of a molecule calculated using GAUSSIAN and describes it using distributed 
multipoles extracted using the Gaussian Distributed Multipole Analysis (GDMA)143 program. 
 
3.2.1.4.1.2 Repulsion-Dispersion Potential 
The dispersion and repulsion terms are modelled with an empirical exp-6 atom–atom 
potential. The exponential term represents the repulsive contributions that are present at short 
distances while the negative 𝑅−6 term models the long range dispersion contributions. 
 
Equation 5.  𝑈𝑟𝑒𝑝𝑢𝑙−𝑑𝑖𝑠𝑝 =  ∑ 𝐴𝜄𝜅exp (−𝐵𝜄𝜅𝑅𝑖𝑘𝑖,𝑘 ) − 𝐶𝜄𝜅𝑅𝑖𝑘
−6 
 
where the interactions are between atom 𝑖 of type 𝜄 in molecule 1 and atom 𝑘 of type 
𝜅 in molecule 2. Equation 5 assumes that the interactions between molecules or ions can be 
approximated by the interactions of their constituent atoms. It is also assumed that the atom-
atom parameters 𝐴𝜄𝜅, 𝐵𝜄𝜅 and 𝐶𝜄𝜅 are transferrable between different molecules. The 
parameters 𝐴𝜄𝜅, 𝐵𝜄𝜅 and 𝐶𝜄𝜅 are specific to the pair of interacting non-bonded atoms and 
determine the strength of the repulsion-dispersion forces as a function of the intermolecular 
separation, 𝑅𝑖𝑘. The repulsion-dispersion potential has been derived by empirically fitting the 
parameters to known crystal structures.144, 145 
 
3.2.1.4.2 Polarisable Continuum Model  
It has been noted that the CrystalOptimizer calculated lattice energies that combine 
density functional theory (DFT) intramolecular energies with atom-atom potentials for 
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intermolecular interactions do not always accurately distinguish the observed crystal structures 
from other low energy generated alternatives when the electrostatic contribution to the lattice 
energy is derived from isolated molecule calculations.146 This is because the effect that the bulk 
crystalline environment has on distorting the molecular charge distribution is not considered. 
Therefore, another refinement to the lattice energy can be made by considering a 
model for the bulk crystalline environment and the polarisation of the molecular charge 
distribution of molecules. The polarisable continuum model (PCM)147 can be applied to the most 
stable crystal structures following CrystalOptimizer by calculating the intramolecular energy and 
wavefunction of the molecule using GAUSSIAN with a dielectric of Ɛ = 3.0, shown to be typical 
of organic crystals.146  
The PCM has been used in many CSP studies78, 89, 124, 128, 148 and is routinely used as a 
method of refining the lattice energies of organic crystals.70  
 
3.2.1.4.3 Sensitivity of Lattice Energy to Computational Model 
The sensitivity of the calculated lattice energies to the choice of computational model 
is often evaluated to estimate any uncertainties in the relative energy estimates of the 
thermodynamically plausible crystal structures. A number of different computational models 
are applied to the putative structures and any stability re-ranking due to a change in method of 
calculation is analysed to confirm that the relative stabilities of the generated structures are not 
just an artefact of the choice of computational model.  
Often the use of the PCM is an initial test to see how sensitive the lattice energies are 
to a change in computational model. The Helmholtz free energy at 298 K149 can also be estimated 
and different potentials, such as the Williams W99150 or custom potentials are often tested. 
Periodic electronic structure calculations have also been used to estimate lattice energies.88, 148 
In principle, the effect of temperature could be estimated to give a free energy.  
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3.2.2 Application of Methodology to Mefenamic Acid 
This section describes the how the computational methodology outlined in section 
3.2.1 is implemented in the CSP study on MA. 
 
3.2.2.1 Conformational Analysis 
The conformational flexibility of MA was initially analysed by comparing the molecular 
conformations of the known polymorphs of MA (Figure 15a) noting that a comparison of the 
different conformations of MA in MA form II was mentioned previously in section 2.1.1.2. Figure 
15a shows that the conformations of MA differ most in the rotation of the alkylated phenyl ring 
and the position of the amino bridging group relative to the phenyl ring with the carboxyl group. 
These conformational differences are mirrored in the molecular overlays of TA which are shown 
in Figure 15b. 
 
 
(a) (b) 
Figure 15. Molecular overlays of (a) MA and (b) TA showing the conformations of the molecules as found 
in the known polymorphs of each compound on the CSD. 
 
The conformational overlays of MA and TA in Figure 15 indicate that the major degree 
of freedom that needs to be considered is the ξ1 torsion angle (defined previously in Table 4). 
This was the only degree of freedom investigated in the initial conformation scans which is 
justified by the presence of the internal hydrogen bond which keeps the carboxyl group, the 
adjacent ring and the bridging amino group planar (see Figure 8). 
Quantum mechanical, ab initio calculations were carried out on the isolated molecule 
using GAUSSIAN03137 at the PBE0/6-31+G(d) level of theory to provide a relaxed conformational 
scan of the ξ1 torsion angle. The conformational energy of MA was scanned in the range -180 ° 
to 0 ° in 10 ° steps. The aim of the torsion angle scan was to observe how the relative 
conformational energy of MA changes as a function of ξ1. This indicates the range of 
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conformations (that are the lowest in energy) that should to be considered when performing a 
search using CrystalPredictor which uses an approximate conformational energy surface in the 
initial stage in the search for feasible crystal structures. 
The decision to only analyse the effect of changing the ξ1 torsion angle on the 
conformational energy of MA echoes the choice made by Uzoh in the calculation of the crystal 
energy landscape of TA.89 The potential energy surface of isolated MA was calculated at the 
PBE0/6-31+G(d) level of theory as this was the level of theory used by Uzoh. This CSP study on 
MA mirrors many of the decisions made by Uzoh in order to compute a crystal energy landscape 
of MA that will be comparable to that of TA. 
 
3.2.2.2 Choice of Computational Model 
The choice of computational model for the final lattice energy minimisation was 
verified for MA by testing the accuracy of reproduction of the known forms of MA at the PBE0/6-
31+G(d) level of theory using the FIT potential, an exp-6 atom-atom repulsion-dispersion 
potential with empirically fitted parameters.145 
  
3.2.2.3 Global Search 
Before the crystal structures were generated in the global search, GAMESS151 was used 
to produce an approximate conformational energy surface to be used in the input for 
CrystalPredictor. The most recent versions of CrystalPredictor allow the use of GAUSSIAN at this 
stage, but this CSP study was conducted using CrystalPredictor 1.6 which was only compatible 
with GAMESS. Therefore, as GAMESS cannot carry out calculations at the PBE0/6-31+G(d) level 
of theory, the molecule was first optimised at the B3LYP/6-31G(d,p) level of theory and then the 
atomic charges and single point energies were also calculated at the B3LYP/6-31G(d,p) level of 
theory. The conformational energy surface produced by GAMESS as a function of the ξ1 torsion 
angle closely follows the conformational energy surface produced in section 3.2.2.1 and is an 
adequate representation of the conformational energy surface of MA. A comparison of the 
conformational energy scans carried out by GAMESS at the B3LYP/6-31G(d,p) level of theory and 
GAUSSIAN at the PBE0/6-31+G(d) level of theory can be found in Appendix 1 on page 196. 
Crystal structures were generated with one molecule in the asymmetric unit (Z’ = 1) 
over the low conformational energy region of MA, determined following the conformational 
analysis, varying the torsion angle, ξ1, from 40° to 180°. The structures were generated using 
CrystalPredictor in the following 59 space groups: P1, P-1, P21, P21/c, P21212, P212121, Pna21, 
Pca21, Pbca, Pbcn, C2/c, Cc, C2, Pc, Cm, P21/m, C2/m, P2/c, C2221, Pmn21, Cmc21, Aba2, Fdd2, 
Iba2, Pnna, Pccn, Pbcm, Pnnm, Pmmn, Pnma, Cmcm, Cmca, Fddd, Ibam, P41, P43, I-4, P4/n, P42/n, 
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I4/m, I41/a, P41212, P43212, P-421c, I-42d, P31, P32, R3, P-3, R-3, P3121, P3221, R3c, R-3c, P61, P63, 
P63/m, P213, Pa-3. The intermolecular contributions to the energy of the lattice of the generated 
structures were calculated from the atomic charges and the FIT potential . 
 
3.2.2.4 Accurate Lattice Energy Minimisation 
Following the CrystalPredictor search, DMAflex-Quick152 was used to improve the 
description of electrostatic interactions by including multipoles in calculating the lattice energy 
for the unique crystal structures following CrystalPredictor. The DMAflex-Quick code uses 
multipoles from the lowest energy conformation and analytically rotates them to minimise the 
lattice energy using DMACRYS. DMACRYS calculated the lattice energy, Uinter, using the PBE0/6-
31+G(d) distributed multipoles and the FIT potential.  
Following DMAflex-Quick, the unique crystal structures lying within 30 kJ mol -1 of the 
global minimum were reminimised using CrystalOptimizer. CrystalOptimizer optimised the 
structures to minimise the lattice energy Elatt, by allowing the conformational degrees of 
freedom shown in Figure 16 to change as well as the geometry of the crystal structure. The 
intramolecular energy, ΔEintra, was calculated using distributed multipoles at the PBE0/6-31+G(d) 
level of theory which were extracted from GAUSSIAN calculations using GDMA.  
 
 
Figure 16. The degrees of freedom optimized by CrystalOptimizer for crystal structures of MA (ξ1 ≡ C2-
N1-C8-C9, ξ2 ≡ C1-C2-N1-C8, ξ3 ≡ O1-C7-C1-C2, ξ4 ≡ H15-O1-C7-C1, ξ5 ≡ H8-C14-C9-C8, ξ6 ≡ H11-C15-C10-C9, θ1 ≡ H14-
N1-C8, θ2 ≡ H15-O1-C7). The diagram shows the dihedral angle, ξ1, which was the only flexible angle in the 
CrystalPredictor search. The molecule is symmetric about the dihedral angle, ξ1, thus + ξ1 = - ξ1. The 
diagram also shows the numbering of the atoms used in all calculations. 
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The flexible degrees of freedom that were considered in the CrystalOptimizer 
calculations for MA mirror the degrees of freedom that were considered in CrystalOptimizer 
calculations on TA. However, MA requires consideration of an additional degree of freedom to 
TA, the ξ6 torsion angle (Figure 16), due to the replacement of the chloro group on TA with the 
methyl group on MA which will rotate. 
In order to estimate the effect of the crystal environment, the PCM was applied to the 
unique crystal structures following CrystalOptimizer calculations. The bulk crystalline 
environment was modelled using GAUSSIAN03 to calculate the wave function of the molecular 
structure in a dielectric of 𝜀 = 3.0, shown to be typical of organic crystals. GDMA was then used 
to extract the distributed multipoles and the crystal structures were re-minimised, keeping the 
molecule rigid, using DMACRYS. The resulting Uinter was combined with ΔEintra (the intramolecular 
energy penalty with respect to the lowest intramolecular energy of the set of predicted crystal 
structures) to evaluate the final lattice energies. The resulting structures from CSP methods 
were labelled #yMA_x where x is the energy ordering after CrystalPredictor and y is the energy 
ordering following the PCM calculations. Labelling in this way will allow for immediate 
identification of the extent of the re-ranking of structures due to improved models for the lattice 
energy. 
For comparison with the generated structures, analogous CrystalOptimizer 
calculations were also carried out using the experimental structures of the MA polymorphs as 
the input structures. This enabled the CSP methods to be analysed to see how rigorous the CSP 
methods were to verify that the known experimental forms were found in the search and that 
the search was extensive enough. 
 
3.2.2.4.1 Sensitivity of Lattice Energy to Computational Model 
To test the sensitivity of the calculated lattice energies of a se lected number of 
structures of interest, the lattice energies were re-evaluated using different computational 
models. Initially, the Williams W99 potential was tested with CrystalOptimizer and the PCM. 
Alternative estimates of the lattice energy were also obtained by Rui Guo who carried out 
periodic electronic structure calculations, a plane wave DFT+D approach using the CASTEP 153 
code with the PBE functional and the Tkatchenko-Scheffler (TS)154 dispersion correction. Rui Guo 
carried out the periodic DFT+D calculations on the UK National High Performance Computing 
Facility, ARCHER. 
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3.3 Results and Discussion 
3.3.1 Conformational Energy Surface 
The conformational potential energy surface of the isolated MA molecule is shown in 
Figure 17a. Outside of the low energy conformational region (- 180 ° to - 40 °), the energy penalty 
for conformational change, ΔEintra, is greater than what is expected to be observed in crystal 
structures. For these reasons, the approximate conformational energy surface that was used in 
the CrystalPredictor search only considered conformations where the ξ 1 torsion angle was 
between - 40 ° and - 180 °. The high energy conformational region corresponds to the presence 
of steric hindrance due the bulky methyl groups approaching the benzene ring.  
The conformational scan of MA shows that the global energy minimum is around -140° 
and there is another shallow, local, energy minimum around -70 °. The experimental ξ1 torsion 
angle value for MA form I is -119.42 ° which is located in the same well as the global minimum. 
The ξ1 torsion angle values for MA form II and MA III correspond closely to the local energy 
minimum. The range of conformations that MA adopts in the known polymorphs shows the 
importance of considering the whole low energy region in the global search.  
These results are in agreement with the results of the previous study on fenamic acid 
(FA) and TA carried out by Uzoh (Figure 17b).89 In the case of FA, the energy penalty for 
conformational change is less than 6 kJ mol -1 over all possible conformations.44 This is due to the 
fact that there is less steric hindrance than is observed in MA and TA as there are no substituent 
groups on the benzene ring that rotates as the ξ1 torsion angle changes. In comparison, as TA is 
molecularly similar to MA with bulky substituents, the conformational energy scan also displays 
a high energy conformational region.  
The conformational energy scans of MA, FA and TA are also in agreement with an 
earlier study on TA that was carried out by Mattei and Li 155 who computed the conformational 
energy of TA as a function of the same ξ1 torsion angle in the gas phase as well as in ethanol and 
tetrachloromethane solvent media. The calculations by Mattei and Li were carried out using 
GAUSSIAN03 and the B3LYP functional with the basis sets 6-311G(d,p) and 6-311++G(d,p). They 
report a global minimum at -142 ° and a local minimum at -75 ° for the isolated molecule of TA.  
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(a) 
 
 
 
(b)89 
 
 
 
 
Figure 17. Relaxed scan of the relative conformational energy as a function of the ξ1 torsion angle  
calculated at the PBE0/6-31+G(d) level of theory, including the experimental values of ξ1 for (a) MA. (b) 
shows the conformational energy scans of fenamic acid and TA as calculated by Uzoh.89 The symmetry 
equivalent FA conformations are denoted by open black squares and an inset diagram shows the steric 
hinderance for TA in the high-energy region. The conformational scans in Figure 17 can be compared 
because the difference in the ξ1 –axis corresponds to the difference in how ξ1 was defined for MA and 
TA. For MA the torsion angle was defined as C2-N1-C8-C9, but in TA it was defined as C2-N1-C8-C13 using 
the numbering system for MA in Figure 16. 
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3.3.2 Validation of the Computational Model 
The chosen computational method was able to satisfactorily reproduce the ordered 
structures of MA form I, MA form III and the major component of disordered form II as 
minimums in the lattice energy following CrystalOptimizer and PCM calculations (Table 8). The 
minor component of MA form II overlays nine molecules with the Z = 2 model for the 
experimental minor component, rmsd9 = 0.851 Å. 
 
Table 8. Comparison of the experimental structuresof the polymorphs of MA taken from the CSD (forms 
I, II and III) and this work (redetermination of MA form I) with the computationally modelled structures 
(Comp) following CrystalOptimizer and PCM calculations. 
 
  Elatt  
(kJ mol -1) 
a  
(Å) 
b  
(Å) 
c  
(Å) 
α  
(°) 
β  
(°) 
γ  
(°) 
rmsd15 
(Å) 
MA I 
XYANAC  14.556 6.811 7.657 119.57 103.93 91.30 0.240 
This work  6.7887 7.3613 14.0330 76.868 79.857 64.863 0.166 
Comp -149.1612 14.2140 6.9602 7.6574 118.8731 103.0429 93.8582  
MA II 
(major) 
XYANAC02  7.6969 9.1234 9.4535 107.113 91.791 101.481 0.464 
Comp -148.7365 7.9760 8.7303 9.8305 109.5327 95.6673 97.7283  
MA III 
XYANAC03  7.723 7.9340 11.2320 83.590 80.940 67.510 0.569 
Comp -146.4427 7.8068 8.2872 11.1171 77.1428 81.0798 62.3338  
 
 
 
 
rmsd15 = 0.240 Å 
 
rmsd15 = 0.166 Å 
(a) (b) 
Figure 18. Crystal packing similarity of the computational model of MA form I (coloured by element) 
with (a) MA form I from the CSD, XYANAC, (pink) and (b) MA form I from the redetermination in this 
work (orange). 
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The computational model has a better 15 molecule overlay with MA form I from this 
work than with XYANAC from the CSD with an rmsd15 value of 0.166 Å compared to 0.240 Å. This 
would be expected from the lower temperature redetermination; as SCXRD data was collected 
at 150 K in this work and at room temperature for XYANAC. 
The range of lattice energies of the MA polymorphs is less than 3 kJ mol-1 which is 
consistent with the small energy range expected for such polymorphs. The order of stability of 
the polymorphs from the lattice energy minimisations is I > II > III (if we only consider the ordered 
model of the major component for MA form II) which is in agreement with experimental 
observations of the stability at ambient temperatures.99  
 
3.3.3 Crystal Energy Landscape 
The CrystalPredictor search produced 440,086 structures of which 17,591 were unique 
and 9102 were within 30 kJ mol -1 of the global minimum. DMAflex-Quick calculations were 
carried out on the 9102 structures. The number of unique structures was reduced to a total of 
7312 after the minima determined by the DMAflex-Quick calculations were clustered.  
Clustering carried out crystal packing similarity calculations by comparing the 
simulated PXRD patterns of the generated structures and then using 20 molecule clusters to 
determine equivalent structures. Structures were deemed to be equivalent if they had a PXRD 
similarity greater than 0.97 and a rmsd20 value below 0.1 Å.  
CrystalOptimizer calculations were then carried out on the 1859 unique structures 
within 20 kJ mol-1 of the global minimum after DMAflex-Quick. Finally, PCM calculations were 
carried out on the 1260 structures that were determined to be unique lattice minima. Clustering 
occurred between each stage to eliminate duplicate structures. 
Figure 19 shows the calculated crystal energy landscape of the structures that are 
within 10 kJ mol-1 of the most stable structure. A cut-off of 10 kJ mol-1 was used following a 
statistical study2 that showed 23 % of conformational polymorphs differ in lattice energy by 6 to 
10 kJ mol-1. All the crystal structures in Figure 19 contain the same, approximately planar, R2
2
(8) 
carboxylic acid dimers. However, the structures differ in packing because the orientations of the 
phenyl ring with the methyl substituents changes due to differing values of the ξ1 torsion angle. 
Appendix 2 on page 197 details the ξ1 torsion angles for the most stable 23 structures which take 
values from 60.66 ° to 157.07 ° and the distribution of ξ1 torsion angles is shown in Appendix 3 
on page 198. The majority of the generated structures have ξ1 torsion angle values between 135 
° and 140 ° that correspond to the global minimum conformational energy for MA as described 
in section 3.3.1. However, as will be discussed and as is shown in Figure 20, the two lowest 
energy structures are both isostructural to MA form I, but differ in the ξ1 torsion angle by 17 °. 
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Figure 19. The lowest 10 kJ mol-1 of the crystal energy landscape of MA where each symbol represents 
a crystal structure of the specified space group which is a minimum in the lattice energy (calculated 
within the polarizable continuum). In total, 1260 lattice energy minimisations were carried out. 
Appendix 2 on page 197 details the lattice energy minima and unit cell dimensions of the 23 structures 
of MA that lie lowest in energy following the PCM calculations. The structure similarity of generated 
structures with known polymorphs of TA is discussed in section 3.3.4. The two structures around the 
global minimum are both isostructural with MA form I. The lattice energy minima starting from the three 
observed polymorphs of MA using the same computational model (Table 8) are also shown. The packing 
coefficient is the proportion of the cell volume156 occupied by the molecule calculated using a grid 
spacing of 0.02 Å. 
 
The energy ranking of the structures following CrystalPredictor was markedly different 
to the final energy ranking following PCM calculations. This is because the lattice energies of the 
generated structures are sensitive to the quality of method used which was increased at each 
stage of the calculations. The labels of the structures (list of 23 most stable in Appendix 2, page 
197) on the crystal energy landscape show how the energy ranking of each structure changed 
as the method improved from using fixed point charges at the B3LPY/6-31G(d,p) level of theory 
in CrystalPredictor to using the PCM and distributed multipoles at the PBE0/6-31+G(d) level of 
theory. For example, structure #19MA_5643 was 5643rd lowest in energy after CrystalPredictor 
but 19th lowest in energy following the PCM calculations.  
The energy rankings changed less after the introduction of the distributed multipole 
electrostatic model, but was still significant (see Appendix 4 on page 199 for a comparison of 
the crystal energy landscapes after (a) DMAflex-Quick, (b) CrystalOptimizer and (c) PCM 
calculations). In particular, the application of the PCM model made #1MA_128 0.569 kJ mol-1 
more stable than #2MA_978, whereas these two approximations to MA form I were almost 
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isoenergetic after CrystalOptimizer (at which stage the global minimum structure was 
#2MA_978 which was only 0.055 kJ mol -1 lower in energy than the next structure, #1MA_128). 
 
Table 9. Comparison of the experimental structures of the three polymorphs of MA with the closest  
matching structures generated in the search. The PXRD similarity was calculated using Mercury. 
 
Polymorph Similar 
structure 
from search 
PXRD 
similarity 
rmsd1 
(Å) 
rmsd15 
(Å) 
I  #1MA_128 0.988 
0.0412 
 
0.158 
II - major #4MA_889 0.934 
0.1167 0.438 
II - minor #23MA_497 0.894 
0.1200 
 
0.609 
III  #7MA_1666 0.941 
0.1534 0.584 
 
The global minimum structure on the crystal energy landscape, #1MA_128 (Z’=1, space 
group P-1), matches the single crystal X-ray result for MA form I, reproducing both the 15 
molecule coordination sphere, rmsd15 = 0.229 Å, and the molecular conformation, rmsd1 = 
0.0516 Å (Table 9).  
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The other two experimental forms of MA were also found in the search (Table 9). MA 
form III is structurally similar to #7MA_1666, the ordered model of the major component of 
disordered form II was found to be structurally similar to #4MA_889 and an ordered model of 
the minor component of the disordered form II was found to be structurally similar to 
#23MA_497. Although the ordered models of MA form II have the same unit cells (by definition), 
the two structures that were found in the search, #4MA_889 and #23MA_497, did not have 
identical unit cells and had a large difference (5.275 kJ mol -1) in lattice energy. This energy gap 
is too large for a configurational entropy term to account for the disorder. 70 This is consistent 
with the structural difference between the two components, meaning that the disorder in MA 
form II is kinetically trapped as rearrangement to an ordered form would involve rotating the 
phenyl rings of one component of disorder by ~ 180 ° in the solid. 
The energy ordering for the generated structures in the search suggests that the order 
of stability for the three polymorphs of MA would be I > II > III (#1MA_128 > #4MA_889 > 
#7MA_1666). This is in agreement with the previous calculations using the experimental crystal 
structures as starting points for lattice minimisation as well observations of the stabilities at 
ambient temperatures,99 giving us reasonable belief in the relative energies of the generated 
structures as a whole. 
 
 
(a) (b) 
Figure 20. (a) Conformational overlay of one molecule of experimental MA form I (coloured by element) 
with generated structures #1MA_128 (green) and #2MA_978 (pink). The main difference in 
conformation is the ξ1 torsion angle which is 119.40° (experimental), 117.15° (#1MA_128) and 134.19° 
(#2MA_978). There is also a noticeable difference in the orientation of a methyl group on #2MA_978  
compared to the other two structures. (b) 15 molecule overlay of #1MA_128 and #2MA_978 with rmsd15 
= 0.448 Å. 
 
Structure #2MA_978 is the second lowest structure on the crystal energy landscape 
and like the global minimum structure, has a 15 molecule overlay with the experimental MA 
form I, but a significantly worse rmsd15 = 0.419 Å. The generated structures #1MA_128 and 
#2MA_978 are not significantly different considering the likely amplitude of thermal motion, 
differing by a ‘tilt’ in the orientation of the phenyl ring with methyl substituents (Figure 20). 
Hence, it is not expected that #2MA_978 would be observed experimentally as a distinct 
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polymorph. Therefore, MA form I (optimised from XYANAC), #1MA_128 and #2MA_978 are 
grouped together on the crystal energy landscape in Figure 19 by the dashed light blue circle.  
MA form III is the 7th most stable structure on the crystal energy landscape. There are 
three generated crystal structures that are competitive in lattice energy with the observed forms 
of MA; #3MA_237, #5MA_510 and #6MA_288. As indicated by the space group symbols in 
Figure 19, structures #3MA_237 and #6MA_288 belong to the P21/c and C2/c space groups 
respectively. These space groups are different to the space groups of the known polymorphs of 
MA, which are all P-1. Therefore, unsurprisingly, there is no signi ficant similarity between 
#3MA_237 and #6MA_288 and any of the known MA structures. Structure #5MA_510 belongs 
to the P-1 space group, but is not crystallographically similar to any of the known forms of MA.  
Table 10 shows the unit cell diagrams of the ten most stable, unique crystal structures 
on the crystal energy landscape after duplicates that were not clustered together were removed 
manually. 
 
Table 10. Unit cell diagrams of 10 unique most stable crystal structures on the crystal energy landscape  
following manual clustering to eliminate similar structures. 
 
#1MA_128 
 
 #6MA_288 
 
#2MA_978 
 
 #7MA_1666 
 
#3MA_237 
 
 #8MA_2853 
 
#4MA_889 
 
 #11MA_1069 
 
#5MA_510 
 
 #14MA_318 
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3.3.4 Structure Similarity of Generated Structures with Known Fenamates 
The next stage of analysis involved comparing the computationally generated 
structures of MA with the structures of known forms of other fenamate molecules. The crystal 
structure similarity of the known fenamates with the low energy putative structures gave an 
indication as to whether fenamate crystals could possibly be used as templates surfaces in the 
search for predicted forms of MA following a similar approach to that used to nucleate CBZ form 
V for the first time using DHC form II.84  
The crystal structure comparisons were carried out pairwise comparing the 57 
generated structures that were within 10 kJ mol -1 of the global minimum with the known 
fenamates structures taken from the CSD. Full results of the comparisons are detailed in 
Appendix 5 on page 201, but pairings that had the highest level of similarity (15 molecules in the 
coordination sphere) are highlighted in Table 11. The fenamate structure that had the highest 
level of similarity with any of the generated structures of MA was SURMOI (Figure 21a) which 
was similar to #48MA_480 (rmsd15 = 0.1907 Å). The other fenamates with high levels of similarity 
to the generated structures are KAXXAI# (tolfenamic acid) and PEFNAQ (Figure 21b).  
 
Table 11. Summary of the generated structures of MA with the highest level of similarity to other 
fenamate structures from the CSD. 
 
Reference 
structure 
Comparison structure  
(CSD refcode) 
rmsd15 (Å) PXRD similarity 
#48MA_480 SURMOI 0.1907 0.9812 
#6MA_288 KAXXAI02 0.3431 0.9629 
#1MA_128 KAXXAI03 0.3950 0.9528 
#19MA_5643 KAXXAI01 0.4203 0.9434 
#4MA_889 KAXXAI04-major 0.4218 0.9510 
#23MA_497 KAXXAI04-minor 0.5851 0.9515 
#5MA_510 PEFNAQ 0.6346 0.9285 
 
 
 
 
 
(a) (b) 
Figure 21. Structural diagrams of the fenamate molecules with CSD refcodes (a) SURMOI and (b) 
PEFNAQ. 
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It is not surprising that the generated structures of MA are similar to those of TA due 
to the similar packings of the structures that are possible because of chloro-methyl replacement. 
Table 11 highlights again the similarity of TA form IV and TA form V with MA form I (#1MA_128) 
and MA form II (#4MA_889 and #23MA_497) respectively. Table 11 also indicates that 
generated structures #6MA_288 and #19MA_5643 are similar to TA form III and TA form I 
respectively. The isostructural relationships between MA and TA are summarised in Table 12. 
 
Table 12. Summary of the isostructural relationships that exist between MA and TA. MA form II and TA 
form V are disordered. 
 
Pairing Crystallisation details Crystal Packing Similarity overlay 
MA I 
Recrystall isation from 
variety of solvents 
 
rmsd15 = 0.332 Å 
TA IV PIHn 
MA II 
Sublimation under 
static vacuum onto 
glass 
 
rmsd15 = 0.164 Å 
 
rmsd15 = 0.172 Å 
TA V PIHn 
#6MA_288 Predicted structure 
 
rmsd15 = 0.361 Å 
TA III PIHn 
#19MA_5643 Predicted structure 
 
rmsd15 = 0.418 Å 
TA I 
Recrystall isation from 
absolute ethanol  
 
The key output of this analysis, is that computer generated MA structures which are 
similar to with form III and form I of TA are predicted to be competitive in energy with observed 
metastable forms. Hence structures #6MA_288 and #19MA_5643 have been highlighted on the 
crystal energy landscape of MA in Figure 19 due to their crystal structure similarity with form III 
and form I of TA respectively which is shown in Table 12. The unit cell similarities are shown in 
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Appendix 6 on page 203. The calculated lattice energy of #19MA_5643 indicates that it is around 
5 kJ mol-1 less stable than the global minimum structure (MA form I) and could therefore be too 
high in energy to be considered a potential polymorph. In comparison, structure #6MA_288, is 
shown to be competitive in energy as it is more stable than MA form III and therefore could be 
a possible target polymorph for experimental investigations.  
 
3.3.5 Relative Stability of Structures Using Different Computational Models 
Following the identification of isostructural relationships between MA and TA, the 
relative stabilities of the structures of interest were investigated further by calculating the lattice 
energies using different computational models so that the sensitivity of the structures to the 
method of calculation could be evaluated. 
The lattice energies of MA forms I, II (ordered models) and III were compared alongside 
the lattice energies of generated structures #1MA_128, #6MA_288 and #19MA_5643. The 
lattice energies were calculated using CASTEP (for the periodic electronic structure calculations) 
as well as CrystalOptimizer and the PCM with both the FIT and Williams potential.  
The sensitivity analysis results are depicted in Figure 22 which shows that there is some 
degree of re-ranking of stabilities of the structures depending on the computational model. 
#1MA_128 and MA form I minimise to have the same lattice energy when the Williams potential 
is used in place of the FIT potential as well as in the DFT+D (TS) calculations. 
The DFT+D (TS) calculations estimate MA form III to be more stable than MA form I by 
about 1 kJ mol -1 which is not in line with any experimental observations.99 For all other 
computational models, the relative stability of the known polymorphs of MA calculated at 0 K is 
in agreement with experimental observations at ambient temperature. 
The relative stability of the two generated structures of MA that are isostructural to 
TA polymorphs (#6MA_288 and #19MA_5643) changes depending upon the computational 
model. The CrystOpt+PCM (Williams potential) and DFT+D (TS) calculations estimate that 
#6MA_288 is less stable than MA form III which casts doubt upon the possibility that it could be 
found experimentally using TA form III as a template surface. 
The results of the sensitivity analysis show that the crystal structures of MA are 
sensitive to the computational model used to evaluate the lattice energy, in particular to the 
choice of dispersion/repulsion potential. The differences arise because the hydrogen bonding 
motifs are the same throughout the structures, but the ξ1 torsion angles differ significantly which 
affects the packing of the molecules in the unit cell and the close contacts.  
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Figure 22. Energies of MA crystal structures relative to the most stable polymorph at ambient 
temperature (MA form I), calculated by different methods: CrystalOptimizer (CrystOpt) with the FIT 
potential; CrystOpt+PCM with the FIT potential; CrystOpt and the Williams potential; CrystOpt+PCM 
with the Williams potential; DFT, periodic PBE density functional calculations with the TS (Tkatchenko -
Scheffler) dispersion correction. Squares represent known forms of MA, triangles represent generated 
structures of MA.  
 
3.4 Conclusion 
Computation of the crystal energy landscape of MA has shown that there are a number 
of thermodynamically feasible crystal structures that are competitive in energy with the three 
known polymorphs. In particular, using CrystalOptimizer, the PCM and the  FIT potential, there 
are three distinct structures that are more stable than MA form III and another 12 that are lower 
in energy than the ordered model for the minor component of disordered form II. Such results 
suggest that should the right experiment be performed, the predicted low energy polymorphs 
could be nucleated for the first time.  
The search for predicted forms by identification of an isostructural heteroseed or 
template surface has previously been exploited in the nucleation of CBZ form V and CYH form III 
using DHC form II seeds.84, 88 Comparisons of the predicted structures of MA with known 
fenamate structures from the CSD, in particular TA, have been carried out in this work to identify 
any isostructural relationships that could be exploited in the search for new polymorphs of MA.  
The difference between MA and TA is the replacement of a methyl group with a chloro 
group. As methyl and chloro groups have similar van der Waals volumes, they can be expected 
to occupy the same space in a crystal lattice and are therefore interchangeable, following the 
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Kitaigorodsky principle of close packing.62 Therefore, it is not surprising that four isostructural 
pairings have been observed (Table 12) between known forms of TA and two known forms of 
MA as well as two low energy predicted structures of MA. 
Experimental work in this thesis that follows these calculations focuses on the 
identified isostructural pairs of structures of MA and TA to investigate the consequences of 
chloro-methyl replacement on the crystal structures. It was hoped at this point that TA form III 
and/or TA form I could be used as heteroseeds in the nucleation of new, predicted, forms of MA. 
However, the calculations using different computational models (Figure 22) have cast doubt 
over the relative stability of these two predicted forms, in particular #6MA_288 which was 
initially thought to be more stable that MA form III following CrystalOptimizer and PCM 
calculations with the FIT potential. Additionally, there is the added issue of obtaining TA form III 
which has only been reported to have nucleated using PIHn methods.  
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4 Solid Solution Series and Solution Seeding of Mefenamic Acid 
and Tolfenamic Acid 
4.1 Introduction 
The previous chapters have introduced the molecular similarity of MA and TA that 
differ with the replacement of one methyl group on MA with a chloro group on TA. 
Computational comparisons carried out in the previous chapter have shown that there is a high 
degree of crystal structure similarity between known polymorphs of MA and TA and also 
between the known polymorphs and computationally generated structures from CSP methods.  
This chapter experimentally investigates the possibility of chloro-methyl replacement 
in the crystal structures of MA and TA polymorphs using solution based crystallisation methods. 
 
4.1.1 Crystal Similarity of Mefenamic Acid form I and Tolfenamic Acid form IV 
This chapter examines the crystallographic similarities between MA form I and TA form 
IV as highlighted in the previous chapter. This relationship was picked due to the ease of 
producing MA form I crystals from a number of solvents (see chapter 2). There is a high degree 
of similarity between MA form I and TA form IV crystal structures which are isostructural (they 
have a good 15 molecule overlay with rmsd15 = 0.332 Å, Figure 23), but not isomorphous (Table 
13). MA form I and TA form IV crystallise under very different conditions with MA form I 
crystallising from a variety of solvents101-103 whereas TA form IV is only obtained using polymer-
induced heteronucleation (PIHn).32 
 
 
Figure 23. Crystal packing similarity of MA form I (coloured by element) with TA form IV (purple) showing 
a 15 molecule overlay, rmsd15 = 0.332 Å.  
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Table 13. Crystallographic data of MA form I and TA form IV. 
  
MA form Ithis work TA form IV32 
 
 
 
Crystal System triclinic triclinic 
Space Group P-1 P-1 
a (Å) 6.7887(3) 7.5237(8) 
b (Å) 7.3613(2) 14.3308(16) 
c (Å) 14.0330(4) 17.592(2) 
α (°) 76.868(3) 103.680(2) 
β (°) 79.857(3) 98.253(2) 
γ (°) 64.863(3) 93.038(2) 
Cell Volume (Å3) 615.74(4) 1816.41 
Z 2 6 
Z’ 1 3 
Crystallisation 
Method 
Crystall ises from room temperature 
solvent evaporation of a variety of 
solvents 
Polymer-induced heteronucleation  
(PIHn) 
 
 
The first section of this chapter investigates the possibility of producing a solid solution 
of MA and TA by cocrystallisation from different solvents. Solid solutions can occur between 
compounds, with almost the same type and position of atoms, that have crystal structures that 
are either isomorphous (same space group and unit cell dimensions) or isostructural (same 
packing motifs, but not the same unit cell dimensions). Thus we might hope a solid solution to 
form between MA and TA where the lattice sites are randomly occupied by either MA or TA 
molecules with the relative populations of MA and TA equal to the bulk composition and the 
input molar ratio. Results show that a solid solution can be formed between MA and TA with the 
same unit cell as MA form I.  
The second section of this chapter further investigates the relationship between MA 
and TA using MA form I as hetero-seeds to try and nucleate TA form IV via an alternative route 
to PIHn. Results show that hetero-seeds of MA form I produced crystals of TA that although 
similar to TA form IV, are in fact a new form of TA that is isostructural to MA form I.  
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4.2 Solid Solution Series in the Same Unit Cell as Mefenamic Acid Form I 
4.2.1 Methods  
Materials. MA was purchased from Sigma Aldrich as form I while TA form I was 
purchased from LKT Laboratories Inc. Both compounds were used without further purification.  
Preparation of the Solid Solution. Preliminary cocrystallisation experiments of MA 
with TA from ethanol produced single crystals that had the same unit cell as MA form I, but 
detailed crystallographic analysis showed both MA and TA were present. The thermal ellipsoid 
plot for this preliminary cocrystal structure is shown in Figure 24 and crystallographic data can 
be found in the first column of Table 14. 
 
Figure 24. Thermal ellipsoid plot, set at 50 % probability, of the crystal structure resulting from the 
preliminary cocrystallisation experiment of MA and TA. SCXRD analysis shows that both MA and TA are 
present  
 
Subsequently, further cocrystallisation experiments were carried out by room 
temperature solvent evaporation to dryness from ethanol, di -ethyl ether and acetonitrile. The 
molar ratios of TA:MA were 50:50, 60:40, 70:30, 80:20 and 90:10 (mole fraction of TA = 0.5, 0.6, 
0.7, 0.8, 0.9) in each solvent.  
Colourless block crystals were obtained after a few days and had crystal morphologies 
that were similar to that of MA form I. A series of solid solution crystals from ethanol were 
analysed using single crystal X-ray diffraction (SCXRD) and 1H NMR spectroscopy in order to 
determine the crystal structure and the relative composition of TA and MA in the single crystals. 
The crystals were then further analysed by DSC and Raman spectroscopy to determine that they 
were a single phase.  
Single Crystal X-ray Diffraction. Single crystals from the ethanol series were chosen 
using a microscope equipped with a rotatable polarising stage. Crystallographic data were 
collected at 150 K using an Agilent SuperNova diffractometer, equipped with an Oxford 
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Instruments cryostat and Cu-Kα radiation (λ = 1.54184 Å). Using Olex2107, structures were solved 
with the SHELXS108 structure solution program using Direct Methods and were refined using 
SHELXL109 using Least Squares minimisation. The relative TA:MA ratio in the experimental solid 
solution crystals was determined by refining the site occupancy of the CH3 and Cl groups in the 
least squares minimisation cycles using appropriate entries on the FVAR card (and sometimes 
EADP) commands in SHELXL. All non-hydrogen atoms were refined anisotropically and where 
possible, hydrogen atoms were located in the final difference maps and refined with a riding 
model. 
1H NMR Spectroscopy. A number of crystals from the solid solution vials were 
transferred to NMR tubes and dissolved in duetero-chloroform. Commercial MA and TA were 
also dissolved in CDCl3 in NMR tubes. The 1H NMR spectra were collected on a Bruker Avance 
300 MHz NMR spectrometer operating at room temperature. Data was analysed using the 
ACD/NMR Processor Academic Edition software.157 
Thermal Analysis. Differential Scanning Calorimetry (DSC) measurements were 
performed on a TA Q2000 (TA Instruments, LLC, USA) that was calibrated at a heating rate of 10 
°C min-1 in a temperature range of 0 – 250 °C using an Indium melting point standard. Nitrogen 
(50 mL min-1) was used as a purge gas. Sample sizes were between 0.88 mg and 1.75 mg. Tzero 
non-hermetic aluminium pans and lids were used. The data analysis was carried out using the 
Universal Analysis 2000 software.111 
Infrared Spectroscopy. Crystals were analysed using solid state infrared spectroscopy. 
Infrared spectra were obtained using a Perkin-Elmer Spectrum One FTIR fitted with a diamond 
ATR accessory. Spectra were collected over the range 4000−650 cm−1 at a resolution of 4 cm−1 
and analysed using the ACD/Spectrus Processor software.110  
Raman Spectroscopy. Multiple crystals from the 0.5 mole fraction vial were analysed 
using Raman spectroscopy. The crystals were mounted on a glass microscope slide and focused 
upon using a x50 objective mounted on a Renishaw InVia Raman microscope. Spectra were 
collected using a laser wavelength of 514 nm in the range of 3200-100 cm-1 and analysed using 
the WiRE software package.158 
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4.2.2 Results 
The cocrystallisations of TA:MA, of varying compositions, in ethanol produced a solid 
solution series that was analysed and identified using SCXRD, 1H NMR spectroscopy, DSC, 
infrared spectroscopy and Raman spectroscopy.  
 
4.2.2.1 SCXRD Refinement 
Single crystals from the vials containing mole fractions of TA = 0.5, 0.6, 0.7 and 0.8 in 
ethanol solution were analysed using SCXRD. No suitable crystals were obtained from the 0.9 
mole fraction of TA vials. Inspection by eye suggests that the 0.9 TA crystals had a needle like 
morphology (Table 14), more similar to the morphology of TA form I, than MA form I which 
forms blocks. 
Unit cell determination from SCXRD showed that all the chosen solid solution crystals 
from the ethanol series had a unit cell indistinguishable from MA form I. Further analysis showed 
that the unit cells contained molecules of both MA and TA identified by refining the occupancies 
of the chloro and methyl groups that are interchangeable within the crystal lattice. 123 The 
stoichiometry of the two compounds in the solid solutions was not limited to integer values69 
and the mole fraction of TA calculated from the SCXRD refinement approximately reflected the 
target mole fraction of TA indicating the existence of a solid solution series.  
The single crystals of the 0.7 mole fraction sample were very small and gave poorer 
quality data than the other samples studied. A weakly diffracting crystal gave the cell and mole 
fraction reported in Table 14, but full data on this sample is not reported. 
Table 14 reports crystallographic data for the crystals in the MA-TA solid solution series 
from ethanol (CIF files for the series can be found on CD). All the crystals have the same unit cell, 
which does not show any systematic change in volume with the inclusion of more TA in the 
crystal structure.  
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Table 14. The morphologies and crystallographic data of the crystals in the MA-TA solid solution series. Data in the first column relates to the crystal structure from the preliminary 
cocrystallisation experiment.  
 
Target mole 
fraction of TA 
Preliminary 
cocrystallisation 
experiment 
0.5 0.6 0.7 0.8 0.9 
 
- 
     
a (Å) 6.7452(4) 6.7312(9) 6.7336(4) 6.7295(16) 6.7241(8) - 
b (Å) 7.3151(4) 7.2896(10) 7.2720(4) 7.2619(15) 7.2432(8) - 
c (Å) 14.1796(8) 14.2268(15) 14.2713(10) 14.269(4) 14.3139(15) - 
α (°) 77.092(5) 77.197(10) 77.150(5) 77.25(2) 77.181(9) - 
β (°) 79.765(5) 79.624(10) 79.547(6) 79.59(2) 79.411(10) - 
γ (°) 65.318(5) 65.533(13) 65.678(6) 65.74(2) 65.937(11) - 
Cell Volume (Å3) 616.85(7) 616.52(15) 617.66(7) 616.9(3) 617.27(13) - 
R1 (I > 2σ(I)) 0.0507 0.0737 0.0609 0.0937 0.0710 - 
R factor (all) 0.0547 0.0981 0.0690 0.2355 0.0832 - 
Mole fraction of 
TA by SCXRD 
refinement 
0.37(1) 0.43(1) 0.58(1) 0.64(1) 0.78(1) - 
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Table 15. The thermal ellipsoid plots, set at 50 % probability, of the MA-TA solid solution crystal 
structures. The mole fraction of TA reported in this table is calculated from the relative occupancy of Cl 
in the structures from refinement of the SCXRD data. Ellipsoids are shown for both the CH3 and Cl 
components of the solid solution. 
 
Mole fraction of TA 
by SCXRD refinment 
Thermal Ellipsoid Plot 
0.43 
 
0.58 
 
0.78 
 
 
 
Table 15 shows the thermal ellipsoid plots, set at 50 % probability, of the MA-TA solid 
solution crystal structures. The thermal ellipsoid plots show the positions of both the chloro and 
methyl groups that interchange within the solid solution series. As the mole fraction of TA 
increases and more TA is included in the solid solution crystal, the thermal ellipsoids of the 
chloro and methyl interchangeable groups generally increase in size as do the thermal ellipsoids 
on some neighbouring carbons atoms, consistent with slight, but unresolved, differences in 
phenyl carbon atom placement.  
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(a) (b) 
 
Figure 25. (a) The R𝟐
𝟐
(8) carboxylic acid dimer observed in all the MA-TA solid solution crystals as well as 
MA form I, shown here between two TA molecules. (b) The structure diagram of MA/TA (X = Cl on TA, X 
= CH3 on MA) showing the ξ1 torsion angle with the relevant bonds coloured blue. The ξ1 torsion angle is 
the torsion angle that varies the most amongst polymorphs of MA and TA (see section 3.2.2.1). 
 
 
As observed in MA form I, the crystal structures of the MA-TA solid solution series all 
form R2
2
(8) carboxylic acid dimers (Figure 25a). The ξ1 torsion angle (shown in Figure 25b) is the 
torsion angle that varies the most amongst polymorphs of MA and TA as shown in section 
3.2.2.1. Table 16 shows that as more TA is incorporated into the solid solution crystal, the ξ1 
torsion angle deviates away from its value in pure MA form I (119.99 ° in XYANAC98 and 119.39 
° from the redetermination of MA form I earlier in this thesis). Table 16 also reports the Cl···Cl 
interaction distances which tend to increase as the torsion angle increases with the exception 
of the 0.78 mole fraction. However, the thermal ellipsoids for the Cl group in this crystal 
structure (Table 15) are larger than in the other mole fractions and this could affect the Cl···Cl 
distance reported by Mercury. 
 
Table 16. The ξ1 torsion angle and Cl···Cl distances in the MA-TA solid solutions. 
 
Mole Fraction of TA from 
SCXRD 
0.37 0.43 0.58 0.78 
Torsion Angle ξ1 (°) 121.79 122.66 123.86 124.89 
Cl···Cl distance (Å) 3.369 3.374 3.381 3.366 
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4.2.2.2 1H NMR Spectroscopy 
1H NMR spectra were collected for the MA-TA solid solution series, as well as for 
commercial MA and commercial TA. Integration of the 1H NMR spectra was used to determine 
the mole fraction of TA present in the bulk solid solution crystals to support the SCXRD data.  
 
(a) 
 
(b) 
 
(c) 
 
 
Figure 26. NMR spectra of (a) commerical MA, (b) commercial TA and (c) a MA-TA solid solution (target 
mole fraction of TA is 0.6). 
 
Figure 26a shows the 1H NMR spectra for commercial MA which has two peaks, of 
equal integral, at 2.34 ppm and 2.18 ppm arising from the presence of two methyl groups on 
the MA molecule. In comparison, Figure 26b shows the 1H NMR spectra of commercial TA which 
has only one peak at 2.34 ppm as the TA molecule has only one methyl group. Figure 26c shows 
the 1H NMR spectra for the target 0.6 mole fraction of TA which has two peaks that differ in 
integral, at 2.34 ppm and 2.18 ppm. The content of TA in each solid solution crystal can be 
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determined by integration of the peaks at 2.34 ppm and 2.18ppm, noting that the 2.18 ppm 
peak is only present due to MA in the solid solution crystals. The 1H NMR spectra for the other 
solid solutions can be found in Appendix 7 on page 204. 
The mole fractions of TA from integration of the 1H NMR data are reported in Table 17 
alongside the results from the SCXRD data. The mole fraction of TA from the two different 
methods of analysis are in good agreement considering the experimental error.  The 
experimental mole fractions of TA in the solid solutions from SCXRD and 1H NMR data are also 
in relatively good agreement with the target mole fractions. 
 
Table 17. The mole fractions of TA present in the MA-TA solid solution series as determined from SCXRD 
and 1H NMR spectroscopy. 
 
Target mole fraction of TA 0.5 0.6 0.7 0.8 
Mole fraction of TA from 
SCXRD refinement 
0.43(1) 0.58(1) 0.64(1) 0.78(1) 
Mole fraction of TA from 
integration of  1H NMR spectra 
0.43 0.60 0.69 0.76 
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4.2.2.3 DSC Data 
Each of the solid solutions were investigated by DSC in the temperature range 0 – 250 
°C at a heating rate of 10 °C min-1. The DSC scans in Figure 27 show melting endotherms for each 
of the MA-TA solid solution crystals and show that the melt is from a single phase as the slope 
of the onset is smooth. The melting points show that there is an approximately linear 
relationship between the amount of TA incorporated into the solid solution crystal and the 
melting point.68, 69 As the content of TA in the MA-TA solid solution increases, the melting point 
decreases which is to be expected as MA form I has a higher melting point (onset temperature 
of 229 °C and melting point of 230 °C)99, 159, 160 than TA (forms I – V have melting points between 
206.78 °C and 215.17 °C).32 
 
 
 
Figure 27. DSC scans for the MA-TA solid solutions labeled with the target mole fraction of TA. The scans 
were carried out at a heating rate of 10 °C min-1. 
 
  
0.5 
0.8 
0.7 
0.6 
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4.2.2.4 Infrared Spectroscopy 
The infrared spectra in Figure 28 show the N-H stretching peak of the spectra of 
commercial MA with a peak at 3307 cm-1 and commercial TA with a peak at 3339 cm-1. Figure 28 
also shows the infrared spectra of the MA-TA solid solution crystals. The infrared spectra for the 
target mole fractions of TA = 0.5, 0.6, 0.7 and 0.8 could indicate that both MA and TA are present 
in the solid solution crystals. This conclusion is reached because of the presence of a broad peak 
that encompasses a main peak due to MA (around 3307 cm -1) and a shoulder peak due to TA 
(around 3339 cm-1). As the target mole fraction of TA increases, the infrared spectra show 
evidence that more TA is present in the MA-TA solid solution crystals as the relative heights of 
the two peaks change with composition. 
 
 
Figure 28. Infrared spectra of the N-H stretching peak of commercial MA, the solid solutions of MA-TA 
(labelled with the target mole fraction of TA) and commercial TA. 
 
However, it should be noted that the different polymorphs of TA also have different 
peak positions. Gilpin et al. report that TA forms I and II have peaks at 3340 – 3341 cm-1 and 
3324 – 3325 cm-1 respectively117 and Thybo et al. additionally report that TA form I has an 
additional component in the spectrum at 3310 – 3312 cm-1.161 Similarly, Jabeen et al. report that 
TA polymorphs I and II have peaks at 3342 cm-1 and 3315 cm-1 respectively.106 Jabeen et al. also 
calculated the vibrational spectra for TA and MA for different conformations of the molecules 
using DFT methods. The conformations of TA and MA used in their calculations varied by 
0.5 
0.6 
0.7 
0.8 
0.9 
TA 
MA 
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changing the ξ1 torsion angle (Figure 25b). The results of the DFT calculations indicated that for 
both MA and TA, the conformation of the molecule can affect the position of the N -H stretching 
peak. For example, in TA, if the ξ1 torsion angle is 142.08 ° the N-H stretching peak would appear 
at 3301 cm-1, however, if the ξ1 torsion angle is 70.43 ° the N-H stretching peak would appear at 
3315 cm-1. The infrared spectra for TA forms III – V have not been reported. 
The infrared spectrum of the 0.9 target mole fraction of TA does not show any clear 
evidence that MA is present as there is just one strong peak observed in the same position as 
commercial TA. This infrared spectrum for TA = 0.9 suggests that the crystals chosen for analysis 
by infrared spectroscopy are pure TA. This result is in line with the observation that the crystal 
habit of the TA = 0.9 crystals are more similar to TA form I than MA form I (Table 14), although 
the presence of a small amount of MA cannot be completely ruled out.  
 
4.2.2.5 Raman Spectroscopy 
Raman spectra were collected for five different crystals from the vial containing the 
0.5 target mole fraction of TA. The Raman spectra taken at points on the five chosen crystals are 
shown in Figure 29 and images of the different morphologies of the five different crystals are 
shown in Table 18. There are no significant differences in the Raman spectra of the five different 
crystals which suggests that the crystallographic structure is the same throughout the sample 
even if the crystal habit is not consistent across all five samples.   
 
 
Figure 29. Raman spectra for five different crystals of the 50:50, MA-TA solid solution.   
89 
 
Table 18. Optical images of the different morphologies of the 0.5 target mole fraction of TA solid solution 
crystals from which Raman spectra were collected.  
 
 Magnification x5 
crystal 1 
 
crystal 2 
 
crystal 3 
 
crystal 4 
 
crystal 5 
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4.2.3 Discussion 
The results presented in section 4.2.2 confirm that MA and TA can cocrystallise from 
ethanol solution to form solid solution crystals that are isomorphous with MA form I. The MA 
and TA molecules occupy the same sites in the crystal lattice at random with the overall 
populations equal to the bulk composition. The experimentally determined composition of the 
MA-TA solid solution series reflects the target mole fraction and the input ratios of the MA and 
TA compounds before crystallisation by solvent evaporation to dryness. The results show that 
TA is soluble in MA up to around 80 %.  
As MA form I and TA form IV are isostructural, the fact that the MA-TA solid solution 
is isomorphous with MA form I was not unexpected. However, it is important to note that other 
outcomes were also possible. For example, TA form I crystallises from ethanol and has an 
isostructural crystal structure of MA, #19MA_5643, that was predicted in the CSP study in 
chapter 3. However, as discussed in chapter 3, the relative stability of #19MA_5643 is dependent 
on the computational model and may be too high in energy to be observed experimentally. 
Additionally, MA is reported to be less soluble than TA162-164 therefore nucleation rates of MA 
and TA would be different and it’s possible that MA would nucleate more readily.  
The DSC scans of the MA-TA solid solutions reported in section 4.2.2 show the 
existence of single phase crystals as shown by the single melting endotherms. These DSC results 
are complemented by the Raman spectra which is the same at different sampled positions on 
different crystals. This indicates that the solid solution crystals are homogeneous.  
The similarities between the target and the experimental mole fractions of TA are 
important discussion points concerning the MA-TA solid solution series. In general, as reported 
in Table 17, there is good agreement between the target mole fraction of TA and the 
experimental mole fraction of TA. The mole fractions of the solid solutions determined from the 
two experimental methods (SCXRD and 1H NMR) are in good agreement with each other, giving 
the same mole fraction for TA = 0.5 and differing by just 2 % for TA = 0.6 and 0.8. However, the 
two methods of calculation of the mole fraction for TA = 0.7 differ by 5 % which is most likely to 
be due to the comparison of a single crystal with bulk analysis by 1H NMR. It is likely that the 
bulk ratio would more representative of the target mole fraction than a single crystal as the mole 
fraction of individual single crystals might vary slightly depending on which crystal was picked 
for analysis. Furthermore, it is important to note the size and quality of the crystal used for 
SCXRD for TA = 0.7. The X-ray data for the TA = 0.7 crystal is less reliable, than for the other solid 
solution crystals, due to the poor crystal quality.  
In general, there is also a good agreement between the target mole fraction of TA and 
the mole fraction calculated from the 1H NMR spectra with all reported values differing by no 
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more than 4 %. However, the mole fraction by SCXRD and 1H NMR of the solid solution for TA = 
0.5, does not match the target molar fraction of TA. This suggests that excess TA would be 
present and that this might be observed in bulk analysis measurements. If there had been excess 
(pure) TA crystals present then the 1H NMR data should demonstrate this. Additionally, the DSC 
data would show two melting endotherms, one relating to pure TA, and another for the MA -TA 
solid solution at a higher temperature. The DSC data shown in Figure 27 shows no evidence of 
pure TA.  
Another useful method of bulk analysis, that could have indicated the presence of pure 
TA crystals amongst the solid solution crystals, is powder X-ray diffraction (PXRD). If excess TA 
had been present in the sample, the PXRD pattern could have shown peaks, that correspond to 
TA form I (obtained from ethanol in the absence of MA) in addition to peaks that correspond to 
the solid solution crystal that is isomorphous to MA form I. PXRD was not collected for the MA -
TA solid solution series as there was insufficient sample.  
The MA-TA solid solution exists because the chloro and methyl groups are similar in 
size which allows them to be interchangeable within crystal lattices, following the Kitaigorodsky 
principle of close packing.62 Replacing a methyl group with a chlorine, or vice versa, does not 
significantly alter the size or shape of the molecule as methyl and chloro groups have similar van 
der Waals volumes with the smaller substituent being about 79 – 91 % of the size of the larger 
depending on the literature source (see section 2.3, page 50, for additional information). 
Kitaigorodsky suggested that replacing larger molecules with smaller ones in a solid 
solution happens more readily than the reverse. In comparison to other isostructural systems 
such as caffeine and theophylline165 which involved replacing a methyl group with a hydrogen, 
the difference in the van der Waals volumes of the chloro and methyl groups is not significant 
and as such it would be difficult to predict which substituent would most easily be replaced.  
Examples of chloro-methyl interchange in solid solutions and isostructural systems 
from literature20, 21, 25, 119, 120, 166 suggests that as more methyl substituents are introduced into 
the unit cell, the unit cell volume increases. For example, the isomorphous unit cells of fuchsone 
derivatives (Figure 30)123 show an increase in volume when two chloro and two methyl 
substituents in dichlorodimethylfuchsone are changed for four methyl groups in 
tetramethylfuchsone.123 The unit cell of pure tetramethylfuchsone is 1741 Å3 and the unit cells 
of pure dichlorodimethylfuchsone crystal structures are 1719 – 1727 Å3. The solid solutions of 
the fuchsone derivatives with varying ratios of chloro and methyl substituents have unit cell 
volumes of 1731 – 1737 Å3, between the values of the pure compounds.  
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(a) (b) (c) 
Figure 30. Structure diagrams of the fuchsones studied by Nath et al. (a) tetramethylfuchsone, (b) and 
(c) dichlorodimethylfuchsones. 
 
The inclusion of 2,6-dimethyl N-phenylformamide (Figure 31)167 molecules into the 
crystal structure of 2,6-dichloro N-phenylformamide to form a solid solution also shows an 
increase in unit cell volume.167 Likewise a unit cell volume increase is also observed in binary 
cocrystals of 1,4-diazabicyclo[2.2.2]octane with 4-X-phenols (X = Cl, CH3) as more of the methyl 
substituted molecule is included in the crystal structures.120 
  
(a) (b) 
Figure 31. Structure diagrams of (a) 2,6-dimethyl N-phenylformamide and (b) 2,6-dichloro N-
phenylformamide. 
 
Although there is some disagreement in the literature about which substituent is 
larger, the isomorphous crystal structures just mentioned suggest that the unit cell volume 
increases as chloro groups are replaced with methyl groups. This would suggest that the unit cell 
volume of the MA-TA solid solution series found in this work would decrease with increasing 
replacement of methyl groups with chloro groups, as more TA is included. However, the unit cell 
volumes reported in Table 14 do not show this trend.  
Table 14 shows that as more Cl substituted molecules are included in the solid solution 
crystal, there is a small increase in unit cell volume. The cell volume is 615.74(4) Å3 for MA form 
I, 616.52(15) Å3 for the 0.5 mole fraction and 617.27(13) Å3 for the 0.8 mole fraction. The unit 
cell volume of MA form I and the MA-TA solid solution series could be influenced by the 
conformation of the molecules in the unit cell. As Table 16 shows, the ξ1 torsion angle increases 
as more TA molecules are incorporated in the solid solution crystals which could affect the unit 
cell volume. It is interesting to note the differences in unit cell volumes for MA form I and the 
MA-TA solid solution series, but it is important not to place too much emphasis on this variation. 
Small unit cell volume variations can arise due to differing crystal quality as well as how well 
centred the sample is in the X-ray beam.   
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4.3 Seeding of Tolfenamic Acid in Ethanol with Mefenamic Acid Form I 
Following on from the results of the solid solution series, hetero-seeding experiments 
were attempted that used MA form I crystals to seed a solution of TA in ethanol. It was hoped 
that hetero-seeding a solution of TA with MA form I would provide a new route to nucleating TA 
form IV which is only reported to be obtainable by PIHn.32 
 
4.3.1 Methods 
Materials. As in section 4.2.1.  
Hetero-seeding. MA form I seeds were obtained by recrystallization of MA from 
acetonitrile by room temperature solvent evaporation to dryness. Several small MA form I seeds 
were transferred to a saturated solution of TA in ethanol. After room temperature evaporation 
of the TA ethanol solution to dryness, clusters of single crystals were observed and were 
separated and analysed by SCXRD. 
Single Crystal X-ray Diffraction. As in section 4.2.1. All non-hydrogen atoms were 
refined anisotropically and hydrogen atoms were refined with a riding model.  Disorder in the 
phenyl ring was modelled by using PARTS and the AFIX 66 constraint. 
Raman Spectroscopy. As in section 4.2.1. 
Thermal Analysis. As in section 4.2.1, but the TA Q2000 (TA Instruments, LLC, USA) 
was calibrated at heating rate of 100 °C min-1 for a temperature range of 0 – 250 °C.  
Infrared Spectroscopy. As in section 4.2.1. 
 
4.3.2 Results – New Polymorph of Tolfenamic Acid (form VI) 
Seeding of TA in ethanol solution with MA form I crystals produces crystals with a 
different habit from that of TA form I which is routinely obtained by recrystallisation from 
ethanol. TA form I forms needle crystals from ethanol whereas the crystals obtained when the 
solution is seeded with MA show clusters of block crystals (Figure 32).  
 
  
(a) (b) 
Figure 32. The crystal morphologies of (a) TA form I and (b) TA form VI. 
2 mm 2 mm 
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4.3.2.1 SCXRD Refinement 
SCXRD data collected from TA seeded with MA show that a new form of TA is produced 
with a unit cell isomorphous to the MA form I heteroseed and the MA-TA solid solution series 
reported in section 4.2 (Table 19).  
The crystallographic refinement of the new form of TA (herein referred to as TA form 
VI) showed that TA is disordered and adopts two different conformations within the crystal 
lattice. Two data sets were obtained for two different crystals of TA VI which are labelled TA VIa 
and TA VIb, both of which had essentially the same unit cell dimensions as MA form I (Table 19). 
 
Table 19. Crystallographic data for isomorphous crystals of MA form I and TA form VI. The table shows 
crystallographic data for two different crystals of TA fom VI (TA VIa and TA VIb). 
  
MA form I TA form VIa TA form VIb 
Unit Cell Diagram 
   
Crystal System triclinic triclinic triclinic 
Space Group P-1 P-1 P-1 
Temperature (K) 150 150 150 
a (Å) 6.7887(3) 6.7482(4) 6.7233(3) 
b (Å) 7.3613(2) 7.2034(5) 7.2430(4) 
c (Å) 14.0330(4) 14.3406(9) 14.3109(9) 
α (°) 76.868(3) 77.497(6) 77.245(5) 
β (°) 79.857(3) 78.947(5) 79.405(5) 
γ (°) 64.863(3) 65.963(7) 65.867(6) 
Cell Volume (Å3) 615.74(4) 617.34(8) 616.85(7) 
Z 2 2 2 
Z’ 1 1 1 
Unique reflections 2170 2427 2390 
Refined parameters 223 227 227 
GOF 1.037 1.063 1.064 
R1 (I > 2σ(I)) 0.0317 0.0503 0.0614 
wR2 (all) 0.0841 0.1538 0.1839 
R1 (all) 0.0326 0.0624 0.0667 
Ratio of disorder - 48:52 55:45 
 
The differences in unit cell volume upon the replacement of a methyl group with a 
chloro group has already been discussed in section 4.2.3. Investigations into the extent of chloro-
methyl interchange in structures found on the CSD have provided additional isostructural pairs 
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of crystal structures to compare.119, 122 Brief analysis of these structures from the CSD, 
concentrating on the unit cell volumes, suggests that the unit cell volume decreases when 
methyl groups are replaced by chloro groups. This trend is also retained in the unit cell volumes 
of known polymorphs of MA and TA (Table 20). Table 20 shows that on average, the unit cell 
volume per molecule of MA in its different polymorphs is greater than the unit cell volume per 
molecule of the TA polymorphs.  
 
Table 20. The unit cell volumes, Z and Z’ values of the known polymorphs of MA and TA. 
 
 Polymorph Unit Cell Volume (Å3) Z Z’ 
Unit cell volume per 
molecule to nearest whole 
number (Å3) 
MA 
Ithis work 615.74(4) 2 1 308 
IIthis work 618.19(4) 2 1 309 
III99 626.96(19) 2 1 313 
TA32 
I 1205(2) 4 1 301 
II 1196(2) 4 1 299 
III 2419.1(8) 8 2 302 
IV 1816.41 6 3 303 
V 603.81(17) 2 1 302 
 
However, the SCXRD data shows that the unit cell volume of TA VI is similar in size to 
that of MA form I (Table 21). This is contrary to the literature and could be due to the fact that 
the packing is poorer in the presence of disorder. 
The two different conformations of TA (labelled conformations A and B) can be seen 
in the thermal ellipsoid plot in Figure 33 and in the molecular overlay diagram in Figure 34c and 
Figure 34d. The two conformations that TA adopts in TA VI arise due to variations in the ξ1 torsion 
angle, shown previously in Figure 25b. The values of the ξ1 torsion angle in TA VIa are 124.35 ° 
for conformation A and 128.10 ° for conformation B. The two disorder components are present 
in the ratio 48:52. The ξ1 torsion angle values for TA VIb are 121.68 ° for conformation A and 
127.43 ° for conformation B. The two disorder components are present in the ratio 55:45. As the 
ξ1 torsion angle for MA form I is 119.38 °, conformation A has a much better conformational 
overlay with MA form I, with a rmsd1 value of 0.0398 Å compared to 0.1360 Å for conformation 
B in TA VIa (Figure 34c).  
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Figure 33. Thermal ellipsoid plot, at 50 % probability, of TA VIa. Conformation A is shown by the solid black bonds and conformation B is shown by the dashed bonds.
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The two conformations of TA in TA form VI can be considered individually as two 
ordered Z’ = 1 structures. The crystal structure of MA form I can be separately overlaid with each 
component of TA form VI as shown in Figure 34. The 15 molecule overlays with MA form I are 
better for conformation A than conformation B, shown by the rmsd15 values in Table 21.  
The crystal structure of TA form IV has also been separately overlaid with each 
component of TA form VI.  There is only a 14 molecule overlay,  between TA form IV and TA form 
VI (Table 21). TA form VI is similar to TA form IV, but has a different unit cell. TA form IV is Z’ = 3 
whereas TA form VI is Z’ = 1, but is disordered with two different conformations of TA in the unit 
cell. The coordination sphere and unit cell data of TA IV and TA VI are different and as such TA 
form VI can be considered a quite different polymorph. 
 
  
(a) 
 
 
(b) 
  
(c) (d) 
 
Figure 34. Overlays of MA form I with two ordered components of disordered TA VIa. The disorder of TA 
form VI exists because the TA molecule adopts two different conformations, A (pink) and B (orange). (a) 
15 molecule overlay of MA form I with an ordered componenet of TA form VIa using conformation A, 
rmsd15 = 0.218 Å, (b) 15 molecule overlay of MA form I with an ordered componenet of TA form VIa using 
conformation B, rmsd15 = 0.234 Å (c) molecular overlay of MA form I with conformation A, rmsd1 = 
0.0398 Å and (d) molecular overlay of MA form I with conformation B, rmsd1 = 0.136 Å. 
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Table 21. Crystal structure similarities of TA VIa and TA VIb with MA form I and TA form IV. The results 
are given as n(rmsdn) values where n is the number of molecules matched in the coordination sphere.  
 
  ξ1 torsion angle 
(°) 
n(rmsdn / Å) 
  MA I TA IV 
TA VIa 
Conf. A 124.35 15(0.218) 14(0.311) 
Conf. B 128.10 15(0.234) 14(0.372) 
TA VIb 
Conf. A 121.68 15(0.175) 14(0.304) 
Conf. B 127.43 15(0.203) 14(0.373) 
 
The simulated PXRD patterns of TA form IV and TA form VI have been generated from 
single crystal data and are shown in Figure 35. The simulated PXRD patterns show that the crystal 
structures of TA form IV and TA form VI are generally similar. However, there are also differences 
visible in the pattern as some peaks visible in TA form IV are not visible in the TA form VI pattern 
and vice versa. For example one of the most prominent differences in the PXRD pattens include 
a peak for TA VI at 15.9 ° compared to a peak at 16.16 ° for TA IV, more peaks for TA IV than TA 
VI in the region 17.5 – 20 °, a difference in the peaks around 20.4 ° and an extra peak for TA VI 
at 30.5 °. The differences in the simulated PXRD patterns confirm that the two forms are distinct.  
 
 
Figure 35. The simulated PXRD patterns of TA form IV (red) and TA VI (blue) generated from single crystal 
data. 
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4.3.2.2 Raman Spectroscopy 
The Raman spectrum collected for TA form VI is shown alongside the Raman spectra 
for MA form I and the MA-TA solid solution 0.5 mole fraction in Figure 36. The Raman spectra of 
three different TA form VI crystals are shown in Appendix 8, page 208, alongside a peak list. The 
Raman spectrum for TA form VI is different to both the spectra of MA form I and also the MA -
TA solid solution. The Raman spectrum for TA form VI has also been compared to the Raman 
spectra collected by López-Mejías et al. for the other five polymorphs of TA (found in the 
supporting information)32. The spectrum for TA VI is similar to that of TA IV which is to be 
expected due to the crystal structure similarity, however, there are some notable differences. 
TA form VI has a peak at 658 cm-1 which is not reported for TA form IV. Similarly, TA form IV has 
peaks at 683 cm-1, 959 cm-1, 1235 cm-1, 1965 cm-1, and 2566 cm-1 which are not visible in the 
spectra for TA form VI.  
 
 
Figure 36. Raman spectra for TA form VI, MA form I and the 0.5 mole fraction MA-TA solid solution. 
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4.3.2.3 DSC Data 
The DSC scan for TA form VI (sample size of 1.055 mg) was carried out at a heating rate 
of 100 °C min-1 in the range of 0 – 250 °C (Figure 37). TA form VI has the highest melting 
endotherm (Tm) of all the TA polymorphs showing a melting endotherm at 218.11 °C (Table 22). 
Even though the DSC scans for TA forms I – V were carried out at a heating rate of 20 °C min-1, 
the melting points can still be compared because melting is a thermodynamic process and 
therefore is not affected by the heating rate.168 
In addition to the data in Table 22, Tybo et al. note a melting endotherm for TA at 
around 216 °C for the starting material, but do not explicitly state which polymorph of TA this 
is.161 
It is interesting to note that the melting points of TA form IV and TA form VI are 
significantly different even though the crystal structures are very similar.  
 
Table 22. The DSC data for TA forms I-V, taken from the supplementary information provided by López-
Mejías et al.32 and for TA form VI in this thesis. 
 
TA polymorph Tm (°C) 
I 213.10 
II 213.52 
III 214.09 
IV 206.78 
V 215.17 
VI 218.11 
 
 
 
Figure 37. The DSC scan for TA form VI carried out at a heating rate of 100 °C min-1.  
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4.3.3 Discussion  
A new form of TA (form VI) can be obtained by seeding a supersaturated solution of 
TA in ethanol with MA form I seeds. The MA form I heteroseeds facilitate the first nucleation of  
TA form VI which is isomorphous to MA form I. SCXRD refinements have been carried out on 
two separate single crystals of TA form VI and show that the structure is disordered with the TA 
molecules adopting two different conformations within the unit cell. The conformations of TA 
in TA form VI are similar to the conformation of MA in MA form I.  
The unit cell data, simulated PXRD patterns and DSC data show that TA form VI is 
distinct from all other forms of TA yet in its three dimensional packing of molecules it is 
crystallographically similar to TA form IV, with a rmsd14 value around 0.3 Å. 
Given that the Cl···Cl distances in TA form VI are as short as 3.352 Å, it is somewhat 
surprising in light of the literature and statistical studies,25 that the relationship between MA 
form I and TA form VI has shown that the chloro and methyl groups are interchangeable in the 
crystal lattice with the same unit cell as MA form I. It is possible that in the case of MA form I 
and TA form VI, isostructurality is retained because the chloro group occupies a space filling 
role123 and does not have a structure directing role.  
 
4.4 Review of Previous Crystal Structure Prediction Study of Tolfenamic Acid – 
What have we learnt from finding this new polymorph and the solid solution 
series? 
Kitaigorodsky suggested that for a solid solution to exist between two (or more) 
compounds, the compounds needed to be molecularly isostructural as well as able to crystallise 
as isostructural solid forms.63 This chapter began by highlighting the crystal structure similarity 
of MA form I and TA form IV which appeared to be isostructural as there was a good 15 molecule 
overlay of the coordination spheres of both structures with an rmsd15 value of 0.332 Å. Thus, 
MA form I and TA form IV appeared to satisfy the conditions stated by Kitaigorodsky.  
The results of the investigation into the possible chloro-methyl interchange between 
MA and TA has shown that (a) TA can cocrystallise with MA forming a solid solution and (b) TA 
can crystallise as a new polymorph when seeded with MA form I heteroseeds. Both the MA -TA 
solid solution series and the new polymorph of TA have essentially the same unit cell as MA form 
I.  
TA had previously been studied using CSP methods by Uzoh89 who produced the crystal 
energy landscape in Figure 38. The crystal energy landscape shows a number of predicted 
structures that are competitive in energy with the previously known polymorphs of TA, yet the 
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polymorph of TA found in this study (form VI) was not found on the original crystal energy 
landscape. The identification of two isomorphous crystal structures on the two separate crystal 
energy landscapes of MA and TA was suggested as a criteria for the prediction of a solid solution 
form by Habgood et al.169 Therefore, had the new polymorph of TA been predicted by Uzoh, it 
would have allowed a more confident prediction of the existence of the solid solution in the 
same unit cell as MA form I. It would also have pointed towards the use of MA form I heteroseeds 
as possible route to nucleate a new polymorph of TA. 
 
 
Figure 38. Taken from the previous CSP study on TA by Uzoh.89 The crystal energy landscape of TA where 
each symbol represents a crystal structure of the specified space group, which is a minimum in the lattice 
energy (calculated within the polarizable continuum). The open symbols correspond to the minima 
starting from the experimental polymorphs. The packing coefficient is the proportion of the cell 
volume156 occupied by the molecule calculated using a grid spacing of 0.1 Å. 
 
 
The discovery of the new form of TA (form VI) with the same unit cell as MA form I led 
Uzoh to revisit his CSP work on TA to investigate why the observed structure was not on the final 
crystal energy landscape even though it was a Z’ = 1 structure. However, upon re-examination 
of Uzoh’s CSP study, it was found that one component of TA form VI (conformation A) with the 
same unit cell as MA form I, had been generated albeit high in energy. In order to minimise 
computational costs, the number of structures evaluated at each level of theory was reduced 
and in the final stage of lattice energy minimisation of TA, Uzoh only minimised 100 structures. 
The structure that matched conformation A of TA form VI was too high in energy and above the 
cut off (ranked 137) to be minimised in the last step before the crystal energy landscape was 
produced. 
After the discovery of TA VI, Uzoh subsequently re-minimised the hypothetical TA form 
VI structure found in his search which was then calculated to have a lattice energy of -144.97 kJ 
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mol-1 and a packing coefficient of 0.7043 making it competitive in energy with the known 
polymorphs of TA.170 This showed that in the last step of the computational methodology, there 
is a significant amount of energy re-ranking of hypothetical crystal structures of TA and Uzoh 
concluded that more minimisations and lattice energy refinements were required on a greater 
number of structures. 
Had CrystalPredictor failed to find TA form VI in the search space this would have 
brought the computational methodology followed in this work into doubt. However, the 
experimental discovery of TA form VI has highlighted the need to minimise as many hypothetical 
crystal structures as possible, within computational and time restrictions, at each stage of 
calculating the crystal lattice energy. The extent of re-ranking of the lattice energies of the 
hypothetical crystal structures in a CSP study should be considered in more detail to ensure that 
all the structures that minimise to be competitive in energy with known polymorphs or the 
global minimum have been refined at the optimum level of theory.  
CSP studies in this thesis have accounted for the possible re -ranking of the lattice 
energies of structures at improved levels of theory by minimising thousands of structures rather 
than hundreds (see chapters 3 and 6) and by looking at the lattice energy difference between 
different computational models.  
 
4.5 Conclusions 
Work in this chapter has shown that MA and TA can cocrystallise from ethanol solution 
to form solid solution crystals that are isomorphous with MA form I. The ratio of MA:TA is 
representative of the target mole fraction and TA is soluble in MA form I up to around 80%. In a 
separate series of experiments, MA form I seed crystals were used to obtain a new polymorph 
of TA, form VI, with the same unit cell as MA form I.  
The unit cell volumes of MA form I, the MA-TA solid solution series and TA form VI do 
not appear to be significantly affected by chloro-methyl replacement. The results in this chapter 
show no clear evidence as to which substituent is larger  
The discovery of TA form VI also raised questions about the computational 
methodology that was followed by Uzoh for TA (and subsequently in this thesis for MA) as TA VI 
was not found on Uzoh’s crystal energy landscape. However, re -examination of Uzoh’s TA crystal 
energy landscape showed that the computational methodology did accurately generate the TA 
VI crystal structure, but that not enough crystal structure minimisations were carried out to 
account for the re-ranking of structures. 
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5 Sublimation of Mefenamic Acid and Tolfenamic Acid 
 
Chapter 4 has shown that MA and TA can cocrystallise from ethanol solution to form 
solid solution crystals and a new form of TA, form VI, can be obtained by seeding a 
supersaturated solution of TA in ethanol with MA form I. Both the solid solution crystals and TA 
form VI are isomorphous with MA form I. These results provide rationale for investigating the 
sublimation behaviour and vapour deposition of MA and TA which aimed to nucleate targeted 
forms of MA and TA as identified by the isostructural pairings shown in Table 12, page 72, by 
introducing template surfaces into the vapour deposition experiments. The sublimation 
techniques were guided by the successes of the methods used to nucleate CBZ form V on 
isostructural DHC form II seed templates.84 The DHC/CBZ sublimation experiments followed the 
identification of a possible new polymorph of CBZ from CSP studies and the cocrystallisation of 
CBZ and DHC which formed a solid solution that was isostructural to DHC form II. 87 
5.1 Introduction 
Two different approaches were taken to investigate the sublimation behaviour of both 
MA and TA. Initially, MA and TA were sublimed in a glass tube under a static vacuum of around 
3.0 x 10-2 mbar, subsequently more sophisticated sublimation experiments were carried out 
using bespoke apparatus and a dynamic vacuum of around 5.0 x 10-6 mbar. The results from 
both approaches showed that MA and TA display different behaviour from one another upon 
sublimation onto different surfaces. The sublimation experime nt under dynamic vacuum 
employed a copper surface which nucleated a new form of TA that was identified by PXRD. No 
new forms of MA were identified, but MA was deposited as form I on the copper surface, but 
form II on glass surfaces. The use of crystal surfaces as templates in the experiments failed to 
nucleate targeted forms of MA and TA that were previously identified as isostructural or 
isomorphous. 
5.2 Sublimation Under Static Vacuum 
The first approach was to investigate the sublimation of pure MA and pure TA under a 
static vacuum. The initial experiments identified the temperatures at which MA and TA sublimed 
using the apparatus shown in Figure 39 as well as the position at which the sublimed material 
recrystallised. This information helped optimise the experimental set up when template crystals 
were introduced to target the nucleation of specific forms of MA and TA by exploiting the 
isostructural relationships.  
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5.2.1 Methods 
Materials. MA was purchased from Sigma Aldrich as form I and TA was purchased from 
LKT Laboratories Inc. as form I. Both compounds were used without further purification.  
Preparation of Sublimed Crystals. MA and TA were sublimed using the apparatus 
shown in the schematic diagram in Figure 39. A sample of MA or TA was loaded into a glass tube 
(length, 300 mm and diameter, 10 mm) followed by a small amount of glass wool which was 
used to stop mass transport of the loaded material. A Schlenk line171, 172 with a two stage vacuum 
pump was used to evacuate the glass tube to a pressure around 3.0 x 10-2 mbar. The glass tube 
was sealed and placed horizontally inside copper piping which was in turn inserted into a tube 
furnace (the heat source) which could be set to the required temperature. The copper piping 
provided a temperature gradient ensuring that the temperature of the glass tube was elevated 
above room temperature. Measurements of the temperature gradient were not taken so 
specific temperatures along the sublimation tube are unknown. 
 
 
Figure 39. Schematic diagram of the apparatus used in the sublimation of MA and TA under a static 
vacuum. 
 
Once the apparatus was set up, the tube furnace was switched on and the temperature 
was gradually increased to observe at what temperature the material under investigation 
sublimed and how far along the glass tube the sublimed product was deposited. Temperatures 
of between 230 – 250 °C were required to sublime MA and temperatures of between 180 – 205 
°C were needed to sublime TA. For both MA and TA, the sublimed material grew as single crystals 
after 48 hours on the glass walls of the tube around 50 - 70 mm along from where the starting 
material was loaded (Figure 40a). The sublimed crystals were scraped off the walls of the glass 
tube for analysis. 
The apparatus was subsequently modified so that a template crystal surface could be 
present during the sublimation experiments. The template crystal was first attached to a wire 
using superglue and then positioned in the middle of the glass tube around 60 mm away from 
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the end of the tube (Figure 40b). After sublimation, the template crystal on the wire was 
carefully removed so that any crystals that had nucleated on the surface of the crystal and the 
wire could be analysed. 
 
 
(a) 
 
(b) 
Figure 40. Images of the glass tube used in the sublimation experiments under static vacuum. (a) 
sublimation of pure MA and the appearance of sublimed crystals on the glass walls and (b) the 
introduction of a template crystal surface before sublimation. Pictures are not to scale and are for 
illustrative purposes only. 
 
Single Crystal X-ray Diffraction. See section 2.1.1.1. Sublimation under static vacuum 
gave high quality single crystals for sublimed MA, in the absence of template crystal surfaces, 
from which a complete data set could be obtained. All non-hydrogen atoms were refined 
anisotropically and due to the disorder, hydrogen atoms were refined using a riding model. For 
sublimed TA and crystals of MA and TA that grew in the presence of a template crystal surface, 
only unit cell data was collected to identify the polymorph. 
Powder X-ray Diffraction. Microcrystalline samples were ground and loaded into a 0.5 
mm capillary tube. The PXRD patterns were recorded at room temperature on a Stoe STADI-P 
powder X-ray capillary diffractometer equipped with Cu-Kα1 radiation (using 40 kV and 30 mA, 
λ = 1.5406 Å). The instrument was operated between initial and final 2θ angles of 2.000 ° and 
45.065 °, in an increment of 0.495 °. Counts were accumulated for 20 seconds at each step. 
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5.2.2 Results 
5.2.2.1 Tolfenamic Acid – Sublimation without Templating 
TA was heated to around 200 °C for 48 hours and colourless needle crystals were 
observed on the glass walls of tube. Multiple crystals were analysed by collecting SCXRD unit cell 
data which identified the sublimed crystals to be TA form I, the most stable form. 
 
5.2.2.2 Mefenamic Acid – Sublimation without Templating 
MA was heated to around 230 °C for 48 hours before colourless crystals were observed 
to nucleate on the walls of the glass tube. The crystals were identified as MA form II from SCXRD 
unit cell data. A complete data set was then collected and refined. The crystallographic data for 
MA form II has already been reported in Table 5 on page 46. At the time of writing, it appears 
that this is the first time a single crystal of MA form II has been obtained using a sublimation 
technique. 
It is not surprising that the sublimed crystals of MA were form II considering that MA 
form II is reported to be the most stable form at elevated temperatures and literature reports 
that MA form II can be obtained by heating form I to above the transition temperature of 150 – 
175 °C depending on the literature.35, 99, 101, 102, 104, 105 During the sublimation experiment, the bulk 
sample of MA was heated above the transition temperature to 230 °C for 48 hours.  
 
Figure 41. PXRD patterns of polymorphs of MA: (a) experimental PXRD pattern of the bulk MA, used in 
the sublimation experiments under static vacuum, after being heated to around 230 °C for 48 hours; (b) 
calculated PXRD pattern of MA form II using single crystal data from this work and (c) calculated PXRD 
pattern of MA form I using single crystal data from this work. 
(a) 
(b) 
(c) 
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After the sublimation experiment, small crystallites were observed in the glass wool as 
well as in the bulk sample of MA that was originally loaded into the glass tube. The bulk sample 
of MA was analysed using PXRD and the PXRD pattern was compared to simulated PXRD patterns 
of MA forms I and II from single crystal data (Figure 41).The experimental data of the bulk MA 
has the same peaks as the calculated PXRD pattern of MA form II. Peaks relating to MA form I 
are absent. These results confirm that the loaded MA sample had transformed from MA form I 
to MA form II during the experiment and that there was no remaining trace of MA form I. The 
experimental PXRD data for the bulk MA was collected at room temperature in whereas the 
single crystal data for MA form II was collected at 150 K. The differences in the temperature of 
data collection gives rise to small differences in the peak positions observed in Figure 41. 
 
5.2.2.3 Experiments Involving the use of Template Surfaces 
In more sophisticated experiments, template crystal surfaces were provided within the 
sublimation apparatus to investigate the nucleation of a targeted form of MA or TA by exploiting 
isostructural relationships that have been discussed in previous chapters.  
 
5.2.2.3.1 Tolfenamic Acid Form I Template Surface 
A single crystal of TA form I was introduced into the sublimation apparatus as a 
template surface. TA form I is isostructural with a predicted form of MA, #19MA_5643. TA form 
I and #19MA_5643 have a good 15 molecule overlay with a rmsd15 value of 0.418 Å (Table 12, 
page 72). However, as was discussed in section 3.2.2.4.1, calculations indicated that the relative 
stability of #19MA_5643 was sensitive to the method of calculation which cast doubt as to 
whether #19MA_5643 would nucleate or grow. 
The sublimation experiment using TA form I as a template surface was explored 
despite concerns that it might not nucleate the predicted form of MA. Commercial MA was 
loaded into the glass tube followed by the glass wool and a TA form I crystal was placed inside 
the tube around 50 mm away from the commercial MA. The commercial MA was heated to 
around 210 °C and the MA was left to sublime over the period of a week. The temperature of 
sublimation in these templating experiments was less than that in the sublimation of pure MA 
onto the glass walls to try and encourage slower nucleation and growth. 
Figure 42 shows the TA form I on the wire (a) before the sublimation and (b) after the 
sublimation where the TA form I template crystal has decreased in size, indicating it may have 
partially sublimed.  
Figure 42b shows that following the sublimation, small crystals of MA have grown on 
both the wire and the remains of the TA form I template crystal. Crystals were gently removed 
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from both the wire and the template crystal and SCXRD unit cell data was collected. The unit cell 
data indicated that all crystals were MA form I. Under the current experimental conditions, TA 
form I template failed to nucleate or grow an isostructural form of MA. It is possible that the 
nucleation of MA form I on the wire was occurring before any other form was able to nucleate. 
Therefore, it is possible that MA form I growing over the TA form I template crystal inhibited the 
formation of other potential forms. Lowering the sublimation temperature and moving the 
template crystal further away from the heat source did not alter the observations.  
 
  
 (a) (b) 
Figure 42. Optical image of the TA form I template surface as attached to metal wire (a) before and (b) 
after sublimation of MA. 
 
5.2.2.3.2 Mefenamic Acid Form I Template Surface 
The isomorphous relationship between MA form I and TA form VI, that has already 
been investigated using solution based crystallisation techniques in chapter 4, was examined. 
The MA form I template crystal used in these experiments was large enough that it could be cut 
and one surface crushed in order to increase the number of different crystallographic faces that 
would be exposed to the sublimed TA. Different crystallographic faces are of interest when 
designing crystalline surfaces that control the nucleation of specific forms by hete roepitaxy. It 
has been shown that as well as the chemical functionality of the exposed surface, the 
geometrical lattice similarity can also affect nucleation and polymorph selectivity.38, 173  
The template crystal was aligned so that the crushed surface of MA faced the bulk 
commercial TA that was loaded into the glass tube. Figure 43 shows the MA form I crystal after 
TA had been sublimed at 200 °C for a week. The sublimed TA crystals grew as needles all over 
the template crystal in multiple, random orientations. Often there was just one nucleation point 
for several needle crystals that grew at different angles from the surface. The exposed crushed 
surface did not appear to favour or promote the nucleation of TA crystals.  
Multiple crystals of sublimed TA were analysed by collecting SCXRD unit cell data. All 
crystals that nucleated on the surface of the MA form I template were TA form I, the most stable 
polymorph, not the isomorphous TA form VI. 
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Figure 43. Optical images of the MA form I seed template covered in crystals after sublimation of TA. 
Some of the nucleation points of multiple crystals that grow at different angles are indicated by the 
dashed red rings. The MA form I seed was roughly 2 mm x 1 mm x 1 mm in size. 
 
5.2.3 Discussion 
The results of the sublimation experiments that have been carried out under a static 
vacuum of around 3.0 x 10-2 mbar using the apparatus in Figure 39 have indicated differences in 
the behaviour of MA and TA.  
Sublimed MA grows as form II on a heated glass surface. This observation was initially 
thought to be due to the fact that the glass walls of the sublimation tube were held at a 
temperature above the transition temperature of MA form I to MA form II (due to the 
temperature gradient provided by the copper piping). However, when the metallic wire and the 
TA form I crystal surfaces were introduced into the sublimation tube, and held at temperatures 
above the transition temperature, MA crystallises as form I. These additional results suggest that 
the surface and not just the temperature is affecting the nucleation and polymorphic selectivity 
of MA, however, the specific role of the surface cannot be quantified. 
In comparison, TA crystallises as form I both on the heated glass walls of the 
sublimation tube as well as on the surface of MA form I template crystals and the metal wire. 
Thus, the surface does not appear to be affecting the nucleation and growth, or polymorphic 
form, of sublimed TA. 
The introduction of TA form I and MA form I templates into the sublimation apparatus 
did not nucleate the targeted forms of MA or TA. However, as the template and target crystals 
are isomorphous, epitaxial growth might be expected to give rise to a uniform layer of the target 
crystal structure covering the template seed.88 Such an observation would be hard to confirm as 
the layers of epitaxial growth would be too thin to observe on the time scale of the experiment. 
The results of the sublimation of TA onto the MA form I template (Figure 43) show crystals of TA 
form I growing on, and out from, the template crystal. These observations do not disprove the 
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theory that a uniform layer epitaxially grows on the surface of the template as it is possible that 
the nucleation of TA form I occurs at small defects on the surface of the template crystal. The 
defects on the surface could promote nucleation of TA form I in multiple directions with a growth 
rate significantly higher than that of any uniform epitaxial layers. 
 
5.3 Sublimation Under Dynamic Vacuum 
This section describes the experimental apparatus, the methodology used and the 
results obtained from more sophisticated sublimation experiments. These experiments made 
use of bespoke sublimation apparatus that was previously used to study amorphous solid 
water174, 175 and can reach pressures of around 5.0 x 10-6 mbar using a dynamic vacuum. The 
experimental procedure in this section is notably different to those described in section 5.2 and 
the main differences are summarised in Table 23. Details of the two types of sublimation 
apparatus are described in the respective Methods sections 5.2.1 and 5.3.1. 
 
Table 23. Summary of the main differences between the two different sublimation experiments detailed 
in sections 5.2 and 5.3. 
 
 Section 5.2 Section 5.3 
Type of vacuum static dynamic 
Pressure 3.0 x 10-2 mbar 5.0 x 10-6 mbar 
Temperature of target 
surface 
elevated room temperature 
Direction of sublimation 
horizontal (along temperature 
gradient) 
vertical  
Distance travelled by 
sublimed product 
50 mm 250 mm 
Duration  2 – 7 days 3 – 4 hours 
Temperature required to 
heat sample  
180 – 250 °C 100 – 150 °C 
Method of analysis SCXRD PXRD 
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5.3.1 Methods 
Materials. See section 5.2.1. 
Preparation of sublimed product. See section 5.3.1.1. 
Powder X-ray Diffraction. See section 5.2.1. The sublimed product was scraped off the 
respective surface using a nickel spatula and loaded straight into a 0.5 mm capillary tube.  
1H NMR Spectroscopy. See section 4.2.1.The product of sublimed TA and commercial 
TA were analysed using 1H NMR spectroscopy.  
Infrared Spectroscopy. See section 4.2.1. Data was analysed using the ACD/Spectrus 
Processor software.110 
Thermal Analysis. See section 4.2.1. The TA Q2000 (TA Instruments, LLC, USA) DSC was 
calibrated at heating rates of both 10 °C min-1 and 100 °C min-1 in a temperature range of 0 – 
250 °C using an indium melting point standard.  
Raman Spectroscopy. See section 4.2.1. 
Simultaneous DSC-synchrotron X-ray diffraction (DSC-XRD). Simultaneous PXRD and 
DSC data were collected for samples of the sublimed/deposited TA and commercial TA. 
Experiments were performed on Beamline I12 of Diamond Light Source synchrotron. 176 This 
beamline generates a continuous spectrum of X-rays over the energy range from 50 to 150 keV. 
All experiments reported here were conducted with the beam monochromated to an energy of 
ca. 53 keV (λ = 0.2337 Å). DSC measurements were performed with TA Q20 DSC (TA Instruments 
LLC) using Tzero aluminium pans. The DSC furnace was modified to allow the X-ray beam to pass 
through the sample by having two holes drilled in both sides of the DSC cell. The DSC was 
calibrated with indium following the manufacturer’s instructions. A Thales Pixium RF4343 
detector was sited 2.5 m away from the DSC pans. The PXRD patterns were collected every 6 
seconds (4 seconds data collection plus 2 seconds pause). Data was collected at heating rates of 
10 °C min-1 and 2 °C min-1 in the range 40 – 250 °C. Data were analysed using the Fit2D program177 
to convert the 2D data collected on the Pixium to 1D patterns.178 These patterns were 
background-subtracted using in-house routines. The method has previously been described.179, 
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5.3.1.1 Sublimation Apparatus 
The apparatus used was initially developed to study amorphous solid water, 174, 175 but 
was adapted to include an organic evaporation source used to sublime organic compounds such 
as MA and TA. A schematic diagram of the apparatus is shown in Figure 44. More detailed 
diagrams can be found in Jacob Shephard’s thesis titled, ‘Structure-Property Relationships In 
Two-Component Liquids: Hydrophobic Effects and Azeotropy ’, see reference.175 
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The main variables that were investigated by the apparatus were (a) the rate of 
deposition and (b) deposition onto different surfaces (copper and glass). Analysis focused on the 
effect of these variables on the product including the polymorphic form and phase purity.  
 
 
Figure 44. Schematic diagram of the apparatus used in the sublimation of MA and TA using a dynamic 
vacuum at pressures of ca. 5.0 x 10-6 mbar. 
 
5.3.1.1.1 Vacuum Chamber 
The following description is adapted from that given by Shephard.175 The vacuum 
chamber was purpose built (Kurt J. Lesker, Kastings, UK) with internal dimensions of 24 x 12 x 12 
inches. There are several large KF40 and LF100 flanges and a full sized door for easy access with 
a glass viewing window. A base pressure of around 5.0 x 10-6 mbar can reliably achieved using a 
diffusion pump (Diffstack 63, BOC Edwards, Crawley, UK) containing polyphenol ether oil 
(Santovac5, BOC Edwards) backed with a two-stage rotary vane pump (model 12, BOC Edwards). 
A liquid nitrogen baffle, which requires topping up throughout the deposition experiments, is 
positioned above the diffusion pump to trap any oil residues. The pressure within the vacuum 
chamber was measured using a dual Pirani/cold cathode ionisation pressure gauge (Penning Vac 
PTR 90, Oelikon Leybold Vacuum, Cologne, Germany) and recorded using RS232 connections to 
a computer using Labview software. 
The vacuum chamber is equipped with the ability to adjust the height of the copper 
deposition plate (203 mm in diameter, 6 mm thick), but all sublimations in this thesis were 
carried out with the deposition plate set 250 mm above the evaporation source. Although the 
deposition plate can be cooled to liquid nitrogen temperatures, all the depositions in this work 
were carried out with the deposition plate at room temperature. Lower pressures can be 
achieved if the deposition stage is cooled as it acts as a cryopump. 
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5.3.1.1.2 Evaporation Source 
The sublimation of MA and TA was carried out using two different evaporation sources. 
The first evaporation source was the one described by Shephard for the deposition of C60.175 It 
consisted of an aluminium oxide crucible, (EVC1A0, Kurt J. Lesker), tungsten filament, 
(EVB8B3025W+, Kurt J. Lesker), and a high current (20 A, 1.3 mm diameter copper conductors) 
electrical base plate feed-through (264-13Cu1K-2-BP, Allectra, Sussex, UK). A purpose built 
power supply containing transformers (MPI-400-12, SignalTransformer, New York, USA) was 
able to regulate the electric potential across the filament to between 0 and 6 V.  The current 
flowing through the filament was monitored with a current sense resistor by measuring the 
voltage across two 20 mΩ/50 W resistors in parallel (1 A = 10 mV) with a multimeter, (IDM 72, 
ISO-TECH, Gyeonggi-do, Korea). Due to restrictions on the way the current was set and 
monitored when using this evaporation source, it was hard to repeat the experiments with 
exactly the same current. Therefore, measurements of the deposition rate from a quartz crystal 
microbalance (QCM) were integral to the interpretation of the results. 
During the course of this study, modifications were made to the bespoke vacuum 
chamber that enabled the temperature of the crucible to be set and controlled to within ± 0.1 
°C. An OLED Low Temperature Evaporator (LTE10, Kurt J. Lesker) was used which was equipped 
with a thermocouple in contact with the base of the crucible for accurate temperature readings. 
An aluminium oxide crucible (EVCEF−10AO, Kurt J. Lesker) was heated using the low 
temperature evaporator which was connected to a single channel controller ( BM833-01S, Kurt 
J. Lesker) which set the temperature.  
It should be noted that as well as there being significant differences between the 
heating of the two evaporation sources, there were also differences in the size and shape of the 
crucibles that were compatible with each evaporation source (Figure 45). Although the distance 
from the loaded material to the deposition plate was kept constant across all experiments, due 
to significant differences in the geometries of the two crucibles, there were differences in the 
extent to which they were filled, Figure 45.  
 
Figure 45. Schematic diagram of the differences in the two crucibles used with (a) the original  
evaporation source and (b) the more sophisticated evaporation source. 
115 
 
5.3.1.1.3 Monitoring Deposition with a Quartz Crystal Microbalance 
The deposition of MA and TA was monitored using a quartz crystal microbalance 
(QCM) which was attached to the centre of the copper plate (Figure 46). A QCM is a very precise 
balance that uses the piezoelectric effect to monitor mass change. A potential is applied across 
a quartz crystal that has two electrodes attached to the top and the bottom of the crystal which 
is held in a quartz crystal holder and sensor. When the correct frequency of alternating current 
is applied, the crystal will start vibrating at its fundamental frequency. One surface of the quartz 
crystal is exposed and the crystal reacts quickly and precisely to any changes at the surface, in 
this case, the deposition of MA or TA. The resonant frequency of the crystal decreases with 
increasing mass on the surface.  
 
Equation 6   ∆𝑓 =
2𝑓 ∆𝑚0
2
𝐴√𝜌𝑞𝜇𝑞
 
 
Using the Sauerbrey equation (Equation 6), the mass change can be monitored over 
time and the deposition rate can be calculated. Where ∆𝑓 is the change in frequency (Hz), 𝑓0 is 
the resonant frequency (Hz), 𝑚 is the mass (g), 𝐴 is the active electrode area (cm2), 𝜌𝑞  is the 
density of quartz (2.648 g cm-3) and 𝜇𝑞 is the shear modulus of quartz (2.947x10
11 g cm-1 s-2). 
6 MHz, gold plated, AT-cut quartz crystals (Sycon Instruments, USA) were placed inside 
the QCM crystal holder which was connected via a coaxial cable (CCSMA-MM-RG316DS-24, 
Crystek, USA) to a 0.5 – 60 MHz, N2PK vector network analyser. AT cut crystals are cut at an 
angle of 35 ° 15 ‘ to the z axis of the crystal. The T in the cut name marks a temperature 
compensated cut. AT cut crystals were used because they are forgiving of room temperature 
deposition. The deposition rate was monitored by recording the change in Sauerbrey mass over 
time using myVNA and QTZ software. The gradients of graphs of Sauerbrey mass against time 
were compared to identify which deposition experiments were the fastest.  
 
Figure 46. The copper deposition plate used in the sublimation of MA and TA showing the position of 
the QCM crystal holder in the middle alongside other features of the plate.  
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5.3.1.1.4 Incorporating a Glass Surface 
A glass surface was introduced into the sublimation apparatus by attaching microscope 
slides onto the surface of the copper deposition plate (Figure 47). This enabled deposition onto 
both glass and copper surfaces simultaneously. It also meant that one compound could be 
sublimed onto the glass surface and then the other compound could be sublimed on top of it in 
a subsequent deposition experiment. 
 
 
Figure 47. Photograph of the deposition plate following simultaneous deposition onto both the copper 
and glass microscope slide surfaces. The picture shows some product being scraped off and the positions 
of the microscope slides and QCM. 
 
5.3.1.2 Sublimation Procedure 
Preparing the apparatus. The material to be sublimed (around 2 g of MA or TA) was 
loaded into the crucible, secured in place at the base of the vacuum chamber and connected to 
the relevant heat source. The surface of the copper deposition plate was prepared using 
sandpaper (aluminium oxide, 80 μm grit) and ethanol to remove the copper oxide layer. The 
QCM and microscope slides (if required) were then attached to the plate before it was fixed in 
the chamber and the height was adjusted so that it was 250 mm above the evaporation source 
(Figure 45). High vacuum grease was applied to the chamber door before closure and all 
chamber vents were closed. 
Procedure for evacuating the chamber. To evacuate the chamber, the pressure was 
first reduced to between 2 x 10-2 – 4 x 10-2 mbar using the rotary vane pump. A two way tap was 
then used to change from actively evacuating the chamber to begin evacuating the diffusion 
pump. The liquid nitrogen baffle was then filled which reduced the pressure in the chamber to 
around 2 x 10-4 mbar. The pressure in the chamber increased very slightly when the chamber 
was not being actively evacuated. After at least a further 20 minutes, a butterfly valve above the 
diffusion pump was opened and the chamber pressure reduced further to around 5 x 10 -6 mbar. 
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Figure 48 shows how the pressure in the vacuum chamber changes during the evacuation of the 
chamber.  
 
 
Figure 48. Evacuation of the chamber showing how the pressure changes with the different stages of 
the evacuation process over time. 
 
Procedure for starting sublimation. When the chamber reached constant pressure, 
the evaporation source was heated so that the product sublimed and deposition began. The 
procedure was different depending on the evaporation source. Deposi tion of MA and TA from 
the original evaporation source was started by adjusting the transformer to give a desired 
filament current which would heat the crucible. Deposition from the more sophisticated 
evaporation source was started by setting the required temperature and ramp rate on the single 
channel controller. 
Monitoring the deposition. As the material in the crucible was deposited onto the 
copper plate, the deposition was monitored using the QCM. For the original evaporation source, 
the QCM data was used to determine (a) that the filament current was high enough that the 
material was subliming and (b) to compare the relative deposition rates of a series of repeated 
experiments. For the second evaporation source, the QCM was used to confirm that the material 
was subliming at the selected crucible temperature. A screen grab of the QTZ software is shown 
in Appendix 9, page 209, which shows that the resonant frequency of the crystal decreases as 
the Sauerbrey mass increases. 
Figure 49 shows the rate of deposition of MA as a change in Sauerbrey mass over time. 
The data was collected by the QCM that was attached to the copper deposition plate monitoring 
Initial chamber evacuation 
with rotary vane pump 
Liquid nitrogen 
baffle filled 
Diffusion pump evacuated 
Chamber evacuated 
with diffusion pump 
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the deposition of MA from the first evaporation source. The different deposition rates were 
achieved by manually altering the filament current. The steeper the gradient, the faster the 
deposition.  
 
 
Figure 49. Graph showing the deposition rate of MA as a change in Sauerbrey mass over time, measured 
by the QCM. The graph shows three different deposition rates that were altered by manually changing 
the current through the tungsten filament. The steeper the gradient, the faster the deposition. 
 
Deposition was carried out until either all the sample in the crucible had sublimed or 
the deposition was stopped due to time restrictions as the apparatus could not be operated 
overnight. The deposition time in most experiments was 3 – 4 hours. 
Procedure following deposition. After the deposition experiment was stopped, the 
evaporation source was turned off and left to cool. The vacuum chamber was then vented 
before the deposition plate was removed. The sublimed product was scraped off the surface 
(Figure 50) and either loaded immediately into a PXRD capillary or stored in a sample vial for 
analysis. 
 
 
 
Figure 50. Scraping the sublimed product off the deposition plate around the QCM in the centre.  
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5.3.2 Results 
Both MA and TA were studied with the apparatus described in section 5.3.1, with both 
the original evaporation source (temperature unknown) and then with the evaporation source 
where the temperature could be controlled. Results of the deposition experiments show that 
MA and TA behave differently from one another when deposited onto different surfaces at 
different deposition rates. 
 
5.3.2.1 Tolfenamic Acid – New Polymorph (form VII) 
The majority of the work with TA was carried out using the original evaporation source 
where the temperature of the crucible holding the commercial TA to be sublimed was unknown. 
The results show that a new form of TA was obtained. Furthermore, the deposition rate (as 
monitored by the QCM, but not quantified) affected the phase purity of TA deposited onto both 
copper and glass surfaces. Perhaps not unsurprisingly, the slower the deposition, the more 
phase pure the deposited product.  
 
5.3.2.1.1 Powder X-ray Diffraction 
Figure 51 shows the PXRD patterns of both commercial TA and the product from 
vapour deposition under vacuum onto the copper surface. The PXRD pattern of the deposited 
TA is different to the starting material (commercial TA, form I). Figure 52 shows the simulated 
PXRD patterns of the known forms of TA from single crystal data from the CSD (forms I – V) and 
this work (form VI). Comparisons of the PXRD patterns in Figure 51 and Figure 52 suggests that 
a new form of TA has been obtained. 1H NMR spectroscopy confirmed that the TA had not 
decomposed and the sublimed product was pure TA (see section 5.3.2.1.2 on page 124 for 
additional information). 
The PXRD pattern of deposited TA could not be initially indexed which suggested that 
phase impurities may be present in the deposited product. Therefore, the deposition 
experiment was repeated multiple times to try and obtain a phase pure product through slower 
deposition which was monitored by the QCM.  
Figure 53 shows how multiple PXRD patterns were compared in order to differentiate 
between peaks that were due to the deposited TA and peaks that were due to a phase impurity 
in the sample. The relative intensity of some peaks change with variation of the deposition rate 
and other peaks disappear which indicates that they could be due to phase impurity. Diffraction 
peaks that were consistently present were assigned to the new form of TA. The arrows in Figure 
53 indicate the regions in the PXRD spectra that showed the most variation between samples. 
The bottom PXRD pattern in Figure 53 is the most phase pure and the top spectrum is the least 
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phase pure. The highest phase purity of TA VII can be obtained from deposition onto a copper 
surface with a crucible temperature of 100 °C. 
 
 
Figure 51. PXRD patterns in the range 5 – 40 2θ (°) of commercial TA, form I (red) and the product of 
vapour deposition of TA onto a copper surface held at room temperature (blue). 
 
 
 
Figure 52. Simulated PXRD patterns of the five previously known polymorphs of TA from single crystal 
data stored in the CSD as well as TA VI from this work.  
TA I 
TA V 
TA IV 
TA III 
TA II 
TA VI 
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Figure 53. PXRD patterns of multiple depositions of TA onto the copper surface. Some areas of 
discrepancy (suggesting phase impurity) between the spectra are highlighted by the black arrows. The 
phase purity, identified by analysis of the PXRD patterns, decreases from the bottom spectrum to the 
top spectrum. 
 
The PXRD pattern of the most phase pure sample was indexed, by Jeremy Cockcroft 
and Martin Vickers, and gave the crystal structure of the new polymorph of TA, now referred to 
as TA form VII.  
Crystallographic data for TA form VII is reported in Table 24. TA form VII belongs to the 
P-1 space group with one molecule in the symmetric unit. TA form VII consists of the R2
2
(8) 
carboxylic acid dimers that are common amongst the fenamate crystal structures.  
Crystal structure similarity calculations show that TA forms I and VII have a 13 molecule 
coordination sphere overlay with an rmsd13 value of 0.145 Å. Figure 55 depicts the similarity in 
packings of the crystal structures of TA form I and TA form VII which consists of the same double 
layer of molecules of R2
2
(8) carboxylic acid dimers, but differs in the stacking of the double layers. 
The conformations of TA in forms I and VII are similar, rmsd1 = 0.1243 Å (Figure 54). The ξ1 torsion 
angle of TA form VII is 85.91 ° compared to 74.95 ° in TA form I. 
 
Figure 54. Molecular overlay of TA in forms I (coloured by element) and VII (orange), rmsd1 = 0.1243 Å.  
phase pure 
least phase pure 
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Table 24. Crystallographic data of TA form VII (this work) and TA form I. 
 
Polymorph I113 VIIThis work 
Unit Cell Diagram 
 
(Viewed along a-axis) 
 
(Viewed along c-axis) 
Crystal System monoclinic triclinic 
Space Group P21/c P-1 
Temperature (K) 110 298 
a (Å) 4.826(2) 8.00353 
b (Å) 32.128(1) 16.48600 
c (Å) 8.041(4) 4.84067 
α (°) 90 95.720 
β (°) 104.88(3) 105.246 
γ (°) 90 94.754 
Z 4 2 
Z’ 1 1 
Cell Volume (Å3) 1204.95 609.189 
R-Factor 0.052  
 
 
 
 
  
TA form I TA form VII 
 
Figure 55. Diagram showing that TA form I and TA form VII differ in the packing of the same double layer 
of hydrogen bonded dimers.  
  
double 
layer 
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Deposition of TA onto a glass surface was also investigated. PXRD patterns of 
experiments where TA was deposited simultaneously onto both copper and glass surfaces are 
shown in Figure 56. Although Figure 56 shows that the surface does not influence the 
polymorphic form of deposited TA under the current experimental conditions, the results 
suggest that deposition onto a glass surface negatively affects the phase purity of the product.  
 
 
Figure 56. PXRD patterns of TA that has been deposited onto both glass and copper surfaces  
simultaneously. Some areas of discrepancy (suggesting phase impurity) between the spectra are 
highlighted by the black arrows. 
  
copper 
glass 
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5.3.2.1.2 1H NMR Spectroscopy 
To check that the TA had not decomposed upon heating in the crucible, the 1H NMR 
spectra of commercial TA and of the TA form VII from the copper surface were collected. The 1H 
NMR spectra are displayed in Figure 57 which show that the deposited product is the same as 
commercial TA, thus confirming decomposition upon heating had not occurred. In addition, the 
1H NMR spectrum of deposited TA does not indicate that there is evidence of any molecular 
impurities.  
 
 
Figure 57. 1H NMR spectra of (a) commercial TA and (b) TA deposited onto a copper surface. 
  
(a) 
(b) 
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5.3.2.1.3 Infrared Spectroscopy 
Infrared spectra were collected from a number of samples of TA VII from deposition 
onto both copper and glass surfaces. The position of the N-H stretching peak of TA can be used 
to determine the polymorphic form.106, 117 Figure 58 shows the position of the N-H stretching 
peak of TA that was deposited onto both copper and glass alongside the N-H stretching peak of 
TA form I (3339 cm-1) and TA form II (3323 cm-1) collected previously in this work. The N-H 
stretching peak for TA VII appears at 3336 cm-1 which is similar, but different, to that of TA form 
I at 3339 cm-1. As the position of the N-H stretching peak changes depending on the 
conformation of the TA molecule in the different polymorphs,106 the fact that the N-H stretching 
peak for TA form I and TA form VII occur at similar wavenumbers suggests that the conformation 
of TA in the two polymorphs would be similar, in agreement with the observations from the 
PXRD data. The molecular overlays of TA molecules in forms I and VII are shown in Figure 54 
which confirms a high level of conformational similarity. 
The infrared spectra of TA VII appear to have a shoulder peak towards lower 
wavenumbers. The suggestion that the presence of the shoulder peak could be due to TA form 
II can be ruled out from analysis of the PXRD data. The shoulder peak is present in all 
preparations of TA form VII (see Appendix 11 on page 211).  
 
 
Figure 58. Infrared spectra of TA showing the position of the N-H stretching peak of TA form VII that has 
been deposited onto glass and copper surfaces alongside TA form I and TA form II.  
TA VII - glass 
TA VII - copper 
TA I 
TA II 
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5.3.2.1.4 Thermal Analysis 
A series of DSC experiments using heating rates of 10 °C min -1 and 100 °C min-1 in the 
range 0 – 250 °C were carried out on different preparations of TA form VII. DSC scans in the 
region 10 – 210 °C are shown in Figure 59 and Figure 60 for heating rates of 10 °C min-1 and 100 
°C min-1 respectively. The sample of TA VII with the highest phase purity (evaporation source set 
to 100 °C and deposition onto copper) as identified from the PXRD data is indicated in the 
figures.  
Figure 59 shows evidence of an exothermic phase transition around 125 – 133 °C. 
Similarly, Figure 60 shows evidence of an exothermic phase transition around 144 – 157 °C. 
Increasing the heating rate, from 10 °C min-1 to 100 °C min-1, has the effect of raising the onset 
temperature at which the exothermic phase transition of TA VII occurs. The DSC data does not 
provide any further evidence to understand what is occurring during the exothermic phase 
transition. The phase transition is followed by a melting endotherm as shown in Figure 61. 
 
 
Figure 59. DSC scans of multiple preparations of TA VII at a heating rate of 10 °C min-1 in the range 10 – 
210 °C. 
 
Figure 61 shows the DSC scans of four different preparations of TA form VII deposited 
onto copper in the region 120 – 230 °C at a heating rate of 100 °C min-1. Following the exothermic 
phase transition, the most phase pure sample, shown by the green line in Figure 61, has a single 
melting endotherm at 213.65 °C. Although the temperature of this melting endotherm is the 
same as that of TA form I,32 DSC results alone cannot confirm that the deposited TA has 
100 °C – copper – high phase purity 
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transformed to TA form I. However, further analysis of the samples, using simultaneous DSC-
XRD (as discussed in section 5.3.2.1.6) confirms that TA VII transforms to TA form I upon heating 
and that the sample contains pure TA form I before melting at 213 °C. 
 
Figure 60. DSC scans of three preparations of TA VII at a heating rate of 100 °C min-1 in the range 10 – 
210 °C. 
 
 
Figure 61. DSC scans at a heating rate of 100 °C min-1 in the region 120 – 230 °C of four different 
preparations of TA VII on a copper surface including a phase pure sample prepared with a crucible  
temperature of 100 °C (green) and three other preparations where the temperature of the evaporation 
source was unknown. 
100 °C – copper – high phase purity 
100 °C – copper – high phase purity 
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The DSC thermograms of samples of TA form VII containing phase impurities, as 
identified from PXRD data, also indicate that the samples are not phase pure as there are two 
peaks in the melting endotherm (Figure 61). The double peak in the melting endotherm is not 
evident at a heating rate of 10 °C min-1 (Figure 62) suggesting that the whole sample of deposited 
TA has time to transform to the same form at a slower heating rate. The temperature of the 
melting endotherms when the samples is heated at 10 °C min -1 is again consistent with TA form 
I. 
The DSC thermograms confirm that the most phase pure sample of TA VII is produced 
when the evaporation source temperature is 100 °C and the TA is deposited onto the copper 
surface which is shown by the single melting endotherm in Figure 61. The DSC data is consistent 
with the PXRD patterns already discussed in section 5.3.2.1.1 which indicated that the most 
phase pure sample of TA VII was produced with a crucible temperature of 100 °C when deposited 
onto copper. 
 
 
Figure 62. DSC scans at a heating rate of 10 °C min-1 in the region 120 – 230 °C of four different 
preparations of TA deposited onto a copper surface. The temperature of the evaporation source for all 
preparations is unknown. 
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5.3.2.1.5 Raman Spectroscopy 
Raman spectra were collected for a number of preparations of TA VII and compared to 
the spectrum of TA form I. The Raman spectra are shown in Figure 63 which shows that there 
are small variations in the peak positions between TA VII and TA form I. The most noticeable 
differences between the Raman spectra of TA form I and TA form VII are the absence of a peak 
at 480 cm-1 and the appearance of an additional peak at 606 cm-1 in the spectrum of TA form VII.  
 
 
Figure 63. Raman spectra of TA form I (blue) alongside TA form VII (red). 
 
5.3.2.1.6 Simultaneous DSC-Synchrotron X-ray Diffraction 
Simultaneous DSC-synchrotron X-ray diffraction (DSC-XRD) experiments were carried 
out to provide information on the phase transition of TA form VII as identified by DSC in section 
5.3.2.1.4. The DSC-XRD experiments were carried out by Asma Buanz, Alex Clout and Simon 
Gaisford and were performed on Beamline I12 of the Diamond Light Source, U.K.176 Samples of 
TA form VII were heated at rates of 10 °C min-1 and 2 °C min-1 in a DSC and PXRD patterns were 
simultaneously collected.  
The PXRD pattern of TA form I does not change upon heating although Figure 64 shows 
that, as expected, the reflections shift to a lower angle as the unit cell expands with increasing 
temperature. The relative intensity of the peaks increase slightly with temperature and the PXRD 
patterns show small variations as the sample approaches the temperature of the melting 
endotherm which occurs at around 213.5 °C. 
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Figure 64. PXRD patterns of TA I collected in situ as the sample is heated at a rate of 10 °C min-1. 
 
In comparison to TA form I, the 2D graphs in Figure 65 show that the PXRD patterns of 
TA form VII change with increasing temperature (around scan number 80 for 10 °C min -1 and 
around scan number 400 for 2 °C min-1). The change in the PXRD pattern for TA form VII occurs 
at the same temperature at which the DSC thermograms (Figure 66) show an exothermic phase 
transition (132 °C for 10 °C min-1 and 119 °C for 2 °C min-1). 
The changes observed in the diffraction pattern of TA VII upon heating at a rate of 10 
°C min-1 are depicted in Figure 67. The PXRD patterns were collected in situ as the sample was 
heated in the DSC. The corresponding DSC data, as shown by the blue line in Figure 66, indicates 
the presence of an exothermic phase transition at 132 °C which has previously been discussed 
in section 5.3.2.1.4. The diffraction data in Figure 67 indicates that the sample begins to 
transform at around 120 °C and has completed by 135 °C. The main changes in the PXRD patterns 
are the disappearance of diffraction peaks at 1.73, 1.88, 2.32, 2.56, 3.20, 4.00 and 4.16 ° 2θ and 
the appearance/increase in intensity of diffraction peaks at 1.79, 2.15, 2.41, 2.73, 2.99, 3.13, 
3.76, 4.25, 4.30, 4.36 and 4.47 ° 2θ. 
Figure 68 shows the diffraction patterns of TA form VII as the sample is heated at 2 °C 
min-1. The corresponding DSC data, shown by the red line in Figure 66, indicates the phase 
transition occurs at around 119 °C which is confirmed by the PXRD data that indicate that the 
transition begins at around 105 °C and has completed by 130 °C.  
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Figure 65. 2D graphs produced by Alex Clout showing the PXRD patterns of TA VII and TA I as the samples 
are heated. The increasing scan number relates to an increase in temperature. The colours of the lines 
reflect the intensity of the peaks. 
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Figure 66. DSC scans of TA VII from the simultaneous DSC-XRD experiments performed at Diamond with 
heating rates of 10 °C min-1 (blue and green) and 2 °C min-1 (red). The temperatures of the exothermic 
phase transitions, that are dependant on heating rate, are highlighted. 
 
Analysis of the PXRD patterns confirms that TA form VII transforms to TA form I upon 
heating above the exothermic phase transition temperature for the relevant heating rate. The 
subsequent melting endotherm is that of TA form I. Appendix 12 on page 212 depicts the PXRD 
data for a second sample of TA form VII which again shows that the phase transformation begins 
at around 120 °C and has completed by 135 °C. The corresponding DSC data is shown by the 
green line in Figure 66. 
Increasing the heating rate has the effect of raising the temperature of the phase 
transition of TA form VII to TA form I from 119 °C at a heating rate of 2 °C min-1 to 132 - 134 °C 
at a heating rate of 10 °C min-1 (Figure 66). This change in transformation temperature was 
previously identified in section 5.3.2.1.4 in relation to heating rates of 10 °C min-1 and 100 °C 
min-1. The temperature of the melting endotherm of TA form I appears to vary depending on the 
sample and the heating rate. The melting endotherm of the same sample increases from 203.5 
°C at a heating rate of 2 °C min-1 to 210.3 °C at a heating rate of 10 °C min-1.  
The simultaneous DSC-XRD experiments were carried out around six months after the 
preparation of some samples of TA VII. The DSC-XRD experiments confirmed the samples were 
still TA form VII showing that it is stable under ambient storage conditions for up to six months. 
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10 °C min-1 
same 
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Figure 67. PXRD patterns of TA VII collected in situ as the sample is heated at a heating rate of 10 °C min-1. 
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Figure 68. PXRD patterns of TA VII collected in situ as the sample is heated at a heating rate of 2 °C min-1. 
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5.3.2.1.7 Comparison of the Crystal Structure of TA VII with Other Fenamates 
Using the Crystal Structure Similarity67 module in Mercury,181 the crystal structure of 
TA form VII was compared to the known crystal structures of other fenamate molecules and also 
to the CSP generated structures of MA from chapter 3. TA form VII is isostructural with CSP 
generated structure #5MA_510, rmsd15 = 0.505 Å, as shown in Figure 70. TA form VII is also 
isostructural with N-(m-Tolyl)anthranilic acid (CSD refcode: PEFNAQ, Figure 69)182, rmsd15 = 
0.420 Å, which is to be expected as PEFNAQ and #5MA_510 are also isostructural (Table 11 on 
page 71). 
 
 
Figure 69. Structural diagram of N-(m-Tolyl)anthranilic acid, CSD structure PEFNAQ. 
 
As TA form VII is isostructural to #5MA_510 and TA VII can be reliably reproduced, it is 
possible that it could be used as a template surface to target the nucleation of a new form of 
MA. Some deposition experiments, discussed later in section 5.3.2.2, have been attempted 
where TA VII is deposited on a glass slide and then subsequently MA is deposited on top of that 
layer. 
 
Figure 70. 15 molecule overlay of TA VII (coloured by element) with predicted structure #5MA_510 
(purple) from the CSP study on MA, rmsd15 = 0.505 Å. 
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5.3.2.1.8 Summary 
In summary, TA form VII is readily reproduced using the bespoke sublimation/vapour 
deposition apparatus that was described in section 5.3.1.1. TA form VII grows on both copper 
and glass surfaces irrespective of the deposition rate. However, the phase purity of TA VII is a 
function of both the substrate and deposition rate. The use of glass and fast deposition rates 
reduce the phase purity of the sample.  
The phase purity of TA VII can be qualitatively assessed by looking at the PXRD patterns 
and DSC scans. Some diffraction peaks appear to be due to a phase impurity and the absence 
(or a decrease in the relative intensity) of these peaks is consistent with a more phase pure 
sample. Additionally, a single melting endotherm in the DSC scan would suggest that the sample 
is phase pure. The presence of other impurities in the sample have been ruled out following 
analysis of 1H NMR data.  
The comparison of PXRD patterns of multiple preparations of TA form VII enabled the 
identification of peaks which were due to TA form VII and not a phase impurity. This led to the 
determination of the crystal structure from the PXRD pattern. The crystal structure of TA form 
VII is related to the crystal structure of TA form I as the molecules have a similar conformation 
and the same double layer of molecules consisting of R2
2
(8) carboxylic acid dimers. However, TA 
forms I and VII differ in the stacking of the double layers of molecules.  
Comparison of the crystal structure of TA form VII with crystal structures of known 
fenamate molecules as well as CSP generated structures of MA indicated that TA form VII is 
isostructural to both PEFNAQ (from the CSD) as well as #5MA_510 (from the MA CSP study).  
DSC data on TA form VII indicated the presence of an exothermic phase transition 
followed by a melting endotherm which occurred at the same temperature as the melting 
endotherm of TA form I. The behaviour of TA form VII upon heating was investigated further 
using simultaneous DSC-XRD. The PXRD patterns of TA VII (performed on Beamline I12 of 
Diamond Light Source synchrotron) were collected in situ as the sample was heated in a DSC 
pan. Analysis of the DSC-XRD data showed that the PXRD pattern changed as the sample reached 
the transition temperature, from TA form VII to match the PXRD pattern of TA form I.  The DSC-
XRD experiments confirmed that TA form VII transforms to TA form I upon heating and the 
subsequent melting endotherm corresponds to the melting of TA form I. 
Infrared data shows that the N-H stretching peak for TA form VII occurs at 3336 cm-1. 
The N-H stretching peak of TA form I occurs at 3339 cm-1 (this work). The similarity in position 
of the N-H stretching peaks could be due to the fact that the conformation of TA has been shown 
to affect the position of the N-H stretching peak106 and the conformations of TA form I and TA 
form VII are similar.  
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5.3.2.2 Mefenamic Acid  
The majority of the experiments that deposited MA were carried out using the 
improved methodology where the temperature of sublimation was set and monitored. In this 
set of experiments, the effect of the deposition rate and the role of the surface were 
investigated.  
To investigate the effect of deposition rate, the QCM was first used to monitor the rate 
of deposition as the temperature of the evaporation source was slowly increased. A crucible 
temperature of 100 °C was chosen for the majority of deposition experiments as it was the 
slowest deposition rate that yielded enough product for analysis . An increased crucible 
temperature of 120 °C was also studied and deposition of MA was carried out simultaneously 
onto both copper and glass surfaces. Although the crucible temperature is known to affect the 
rate of deposition, with a higher temperature increasing the rate of deposition, this study has 
not quantified the difference in deposition rates. 
The role of the surface was further investigated when MA was simultaneously 
deposited onto three different surfaces: copper, glass and glass covered in microcrystalline TA 
form VII. Microcrystalline TA VII was chosen because, as discussed in section 5.3.2.1.7, TA form 
VII is isostructural with the predicted structure #5MA_510 of MA and therefore could be a 
potential template surface from which to nucleate #5MA_510 for the first time. #MA_510 is 
calculated to be competitive in energy with known polymorphs of MA, see chapter 3.  
Simultaneous deposition onto multiple surfaces was achieved by first depositing TA 
(crucible temperature set to 100 °C) onto two glass microscope slides that were incorporated 
into the sublimation apparatus as shown in Figure 47. The evaporation source was set to 100 °C 
to allow slow deposition of TA as this has been shown to give the highest phase purity of TA 
form VII (see section 5.3.2.1). The microscope slides were then removed and the apparatus was 
cleaned before one microscope slide covered in TA form VII was replaced on the deposition plate 
alongside a clean microscope slide. The TA that was deposited onto the glass microscope slide 
was confirmed to be TA form VII (with a small amount of phase impurity) from PXRD data 
collected on the slide that was removed from the apparatus. MA was then sublimed with the 
evaporation source set to 100 °C. MA was deposited simultaneously onto the copper surface, 
the clean microscope slide and the microscope slide that was covered in microcrystalline TA. 
During the simultaneous deposition of MA onto copper, glass and TA form VII, the deposition 
rate is constant and has not affected the polymorphic form of the product, any differences are 
due to the role of the surface.  
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5.3.2.2.1 Powder X-ray Diffraction 
The effect the deposition rate had on the deposited products of MA onto both copper 
and glass surfaces were analysed using PXRD. Figure 71 shows the PXRD patterns of MA forms I 
and II alongside products of the deposition of MA onto copper (evaporation source set to 120 
°C) and glass at two different deposition rates (evaporation source set to 100 °C and 120 °C). The 
polymorphic form of the deposited MA can be identified by comparison of PXRD patterns with 
the PXRD patterns of the known polymorphs.  
The PXRD data shows that MA grows as form I on the copper surface, but as form II on 
the glass surface if the deposition rate is slow enough. This is in line with the results of the 
previous sublimation experiments in section 5.2 where SCXRD data showed that MA nucleated 
as form II on the glass walls of the sublimation tube, but as form I  on the wire.  
Figure 71 shows that MA grows as form II on the glass surface at a slow deposition rate 
(evaporation source set to 100 °C), however, when the deposition rate is increased (evaporation 
source set to 120 °C), concomitant polymorphism is observed as MA grows as both form I and 
form II. This observation is confirmed by the presence of diffraction peaks that correspond to 
both form I and II in the PXRD pattern of fast deposition of MA onto glass. In comparison, the 
MA that was deposited onto glass at a slower rate of deposition (evaporation source set to 100 
°C) appears to be a sample of phase pure form II due to the absence of peaks that correspond 
to MA form I.  
 
Figure 71. PXRD patterns of MA from depostion experiments alongside the PXRD patterns of MA form I 
and MA form II. The labels detail the temperature of the evaporation source and the surface of 
deposition. 
MA II 
120 °C -copper 
MA I 
100 °C -glass 
120 °C -glass 
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Figure 71 only shows the PXRD pattern of MA deposited onto the copper surface with 
the evaporation source set to 120 °C. MA grows as form I on the copper surface irrespective of 
the deposition rate. Additional PXRD patterns are shown in Appendix 13, page 213, which show 
that the deposition rate does not affect the phase purity or polymorph selectivity when MA is 
deposited onto a copper surface. 
The PXRD patterns of MA that has been simultaneously deposited onto different 
surfaces are shown in Figure 72 alongside PXRD data for MA form I and MA form II. The results 
of this set of experiments again confirm that when MA is deposited slowly onto glass, it grows 
as MA form II. In comparison, when MA is deposited at the same rate onto a copper surface, it 
grows as form I.  
Additionally, when MA is deposited onto TA VII, the PXRD pattern shows weak 
diffraction peaks that correspond to MA form I. There is no evidence of growth of the predicted 
isostructural form of MA to TA VII, #5MA_510, from the CSP study in chapter 3. The poor quality 
of the PXRD data for MA deposited onto TA VII means the results are ambiguous with regards 
to the presence of TA form VII. However, the presence of TA VII in the same sample has been 
confirmed by infrared spectroscopy (see section 5.3.2.2.2 for more details). 
 
 
Figure 72. PXRD patterns of MA that has been simultaneously deposited (evaporation source set to 100 
°C) onto three different surfaces alongside the PXRD patterns of MA forms I and II.   
MA II 
MA I 
TA VII 
copper 
glass 
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5.3.2.2.2 Infrared Spectroscopy 
As has been mentioned in previous chapters, the position of the N-H stretching band 
in the infrared spectra can be used to help determine the polymorphic form of both MA and 
TA.104, 106, 117, 160 This work has reported that MA forms I and II have peaks at 3308 cm -1 and 3342 
cm-1 respectively and TA forms I and VII have peaks at 3339 cm -1 and 3336 cm-1 respectively. 
The infrared spectra of MA on different surfaces are shown in Figure 73. The infrared 
data supports the observations and conclusions drawn from the PXRD data in section 5.3.2.2.1. 
When MA is deposited onto the copper surface, the infrared data suggests it grows as form I 
irrespective of the deposition rate, as shown by the N-H stretching peaks at 3309 cm-1.  
 
 
Figure 73. Infrared spectra of the N-H stretching band of MA that has been deposited onto a number of 
different surfaces. The spectra are labelled with the temperature of the crucible and the surface the MA 
was deposited onto.  
 
In comparison, when MA is deposited onto a glass surface at the slower deposition 
rate (crucible temperature is 100 °C), the infrared data suggests that it nucleates as MA form II 
as the N-H stretching peak is at 3345 cm-1. There is no evidence of MA nucleating as form I on 
glass at the slower deposition rate from the infrared data. However, when MA is deposited onto 
the glass surface at a faster rate (with a crucible temperature of 120 °C), the infrared spectrum 
shows evidence that both forms I and II are present with N-H stretching bands at 3345 cm-1 and 
100 °C -copper 
120 °C-copper 
100 °C-glass 
120 °C-glass 
100 °C-TA VII 
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3310 cm-1. Additional infrared spectra for three other separate samples of MA onto glass at the 
faster rate of deposition are given in Appendix 14 on page 214. 
When MA is deposited onto TA form VII, the positions of the N-H stretching peaks in 
the infrared spectra suggest that both MA form I and TA form VII are present with bands at 3312 
cm-1 and 3336 cm-1 respectively. The relative intensities of the N-H stretching bands attributed 
to MA form I and TA form VII in the infrared spectrum in Figure 73 indicate that significant 
amount of both MA I and TA VII are present. 
 
5.3.2.2.3 Thermal Analysis 
Figure 74 shows the DSC scans carried out on the MA that was deposited 
simultaneously onto copper, glass and microcrystalline TA form VII in the temperature range 0 
– 250 °C at a heating rate of 10 °C min-1. The DSC scan of MA onto copper shows an endothermic 
phase transition at around 156 °C followed by a melting endotherm at 230.9 °C. In comparison, 
the DSC trace for MA that has been deposited onto the glass shows a single melting endotherm 
at 231.4 °C. Comparison of the DSC scans in Figure 74 with literature102 and previous DSC results 
in this work, confirms that MA grows as form I on the copper surface and as form II on the glass 
surface. MA form I has been reported to transform to MA form II by heating to around 150 °C – 
160 °C.35, 101, 102, 104, 105 The DSC results reported here are in agreement with the PXRD, infrared 
and Raman data. 
 
 
Figure 74. DSC scans of MA deposited simultaneously onto different surfaces. (a) MA onto copper, (b) 
MA onto glass and (c) MA onto TA form VII. The scans were carried out at a heating rate of 10 °C min -1.  
(a) 
(b) 
(c) 
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Evidence of both MA form I and TA form VII would be expected in the DSC scan of MA 
deposited onto microcrystalline TA form VII, following analysis of the infrared data on the same 
sample. For MA form I, an endothermic phase transition would be expected as MA form I 
transforms to MA form II at around 150 °C – 160 °C35, 101, 102, 104, 105 followed by a melting 
endotherm for MA form II. Additionally, as discussed in section 5.3.2.1, an exothermic phase 
transition would be expected as TA form VII transforms to TA form I at around 125 – 133 °C 
(heating rate of 10 °C min-1), followed by a melting endotherm around 213.7 °C.  
The DSC scan for MA deposited onto TA form VII in Figure 74 shows a small exothermic 
transition at 119 °C followed by an endothermic phase transition at 167 °C followed by a melting 
endotherm at 220.6 °C. The endothermic phase transition is different to that observed for pure 
MA deposited onto copper, but in line with li terature36, 103, 104, 106, 162 and with DSC scans on MA 
form I reported earlier in this thesis (Figure 11, page 45) which show that MA form I transforms 
to MA form II at 168.5 °C. The melting endotherm at 220.6 °C does not relate to any known form 
of MA or TA, but is consistent with DSC data collected for the MA:TA solid solution series where 
the temperature of the melting endotherm is linearly dependent on the ratio of MA:TA . The 
MA:TA solid solution series have melting endotherms at temperatures between pure MA and 
pure TA (see chapter 4, section 4.2.2.3). Thus it is suggested that as the sample of MA on TA 
form VII is heated, a solid solution is formed at some point in the DSC. 
 
5.3.2.2.4 Raman Spectroscopy 
Raman spectra were collected for MA that had been deposited onto different surfaces 
as well as MA form I. Comparisons of the spectra bands can be used to determine the 
polymorphic form of MA.183 Raman data suggests that when MA is deposited onto a glass surface 
it grows as form II. In comparison, when MA is deposited onto a copper surface or onto a surface 
covered in TA, MA grows as form I. The Raman data is in agreement with the PXRD, infrared and 
DSC data.  
Figure 75 shows the Raman spectrum, in the region 550 cm -1 – 950 cm-1, of MA 
deposited onto different surfaces. When MA is deposited slowly onto the glass surface 
(evaporation source set to 100 °C) the Raman spectrum has peaks at 573, 632, 693, 771 and 805 
cm-1 in agreement with literature values for MA form II.101, 106, 183 In comparison, the spectra 
bands for all other preparations of MA are observed at 578, 623, 703, 774, 809 cm -1, again in 
agreement with literature on MA form I.101, 106, 183  
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Figure 75. Raman spectra of MA form I (red), MA deposited onto TA form VII (green), MA deposited onto 
copper (orange) and MA deposited onto a glass microscope slide (blue). 
 
5.3.2.2.5 Summary 
The deposition experiments involving MA in this section have shown that the surface  
has a role in the polymorphic selectivity of the deposited MA. Results from PXRD analysis, 
infrared spectroscopy, DSC data and Raman spectroscopy confirm that when MA is deposited 
onto a copper surface (held at room temperature, under vacuum) it grows as MA form I. In 
comparison, the results show that when MA is deposited onto a glass surface (at room 
temperature, under vacuum) it grows as phase pure MA form II if the deposition rate is slow 
enough. When MA is deposited onto TA form VII (at room temperature, under vacuum) it 
nucleates as MA form I, not as the predicted isostructural polymorph (#5MA_510), that was 
generated during the CSP study on MA in chapter 3. 
In addition to the role of the surface on the polymorphic selectivity of MA, the 
deposition rate has also been shown, by analysis of PXRD data, to affect the polymorphic phase 
purity of MA deposited onto a glass surface, but not a copper surface. Depending on the 
deposition rate, MA that was deposited onto the glass surface either nucleated as phase pure  
form II (evaporation source set to 100 °C) or a mixture of forms I and II (evaporation source set 
to 120 °C).  
Although the deposition rate has been shown to affect the phase purity, the exact 
deposition rate has not been quantified or analysed in this work. The different deposition rates 
were assessed only by setting the evaporation source to two different temperatures, 100 °C and 
120 °C. The higher the temperature of the evaporation source, the greater the vapour pressure 
and the faster the deposition.   
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5.3.3 Discussion 
This section has investigated the behaviour of both MA and TA as they are deposited 
under vacuum using the bespoke sublimation apparatus described in section 5.3.1.1. Deposition 
is too fast to observe the nucleation of single crystals, thus much of the analysis in this section 
was carried out using PXRD. Further analysis and results were obtained using 1H NMR 
spectroscopy, infrared spectroscopy, thermal gravimetric analysis, differential scanning 
calorimetry, Raman spectroscopy as well as simultaneous DSC-XRD. 
The results have shown that MA and TA exhibit different behaviour from one another. 
The deposition of TA onto both copper and glass surfaces produces a new polymorph, TA form 
VII. In comparison, when MA is deposited onto copper or TA form VII it nucleates as MA form I 
and when it is deposited onto a glass surface it nucleates as MA form II. In both TA and MA, the 
phase purity of the deposited product is affected by the deposition rate with TA form VII showing 
evidence of increased phase impurity when the deposition rate increases. Similarly, the phase 
purity of MA form II from deposition onto a glass surface has been shown to decrease as the 
temperature of the evaporation source is increased and thus the deposition rate increases. The 
phase purity of MA form I on the copper surface is not affected by the deposition rate which 
suggests that the phase purity of the prepared sample is only affected if a metastable form 
nucleates.  
The results have shown that the polymorphic form of TA is not influenced by the 
surface upon which the TA is deposited, although it should be noted that only copper and glass 
were investigated. In comparison, the choice of surface (be it copper, glass or TA form VII) affects 
the polymorphic selectivity of deposited MA.  
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5.4 Conclusion 
This chapter has investigated the nucleation behaviour of both MA and TA from the 
vapour phase using two very different series of experiments. The series of experiments used a 
static vacuum of around 3.0 x 10-2 mbar and the deposition surfaces were held at an elevated 
temperature. In comparison, the second series of experiments involved the use of a dynamic 
vacuum of around 5.0 x 10-6 mbar and the deposition surfaces were held at room temperature. 
Results from both sets of experiments suggest that the nucleation behaviour of MA is 
dependent upon the identity of the surface. When MA grows on a metallic surface (copper) from 
the vapour phase, it grows as MA form I irrespective of whether the surface is held at an elevated 
temperature (above the transition temperature when MA form I transforms to MA form II) or at 
room temperature. These results were confirmed by SCXRD from the first series of experiments 
and by PXRD from the second. Similarly, when MA is deposited on a glass surface, at both 
ambient and elevated temperatures, MA grows as MA form II. However, fast deposition rates 
can lead to concomitant growth of MA form I as well as MA form II. Lastly, deposition of MA 
onto TA surface templates, a single crystal of TA form I in the first series of experiments and 
microcrystalline TA form VII in the second series of experiments, produces MA form I. Although 
the above observations can be drawn from the data, the specific role of the surface remains 
unknown. 
In comparison, the nucleation and growth behaviour of TA from the vapour phase does 
not appear to be affected by the surface. Two different polymorphs of TA were obtained from 
the two series of experiments, TA form I from the first and TA form VII from the second, 
irrespective of the surface. Observations suggest that the polymorphic form of TA is influenced 
by the sublimation procedure. The results do not eliminate the role the temperature of the 
surface may have in determining the polymorphic form of TA. Due to the experimental setup, 
the deposition surfaces in the original series of experiments were held at elevated temperatures 
which were likely to be above the transition temperature for conversion of TA form VII to TA 
form I. 
The results reported in this chapter yet again highlight the different nucleation 
behaviour exhibited by TA and MA. Under the same conditions, the two molecules behave very 
differently. When deposited from the vapour phase onto the same surface, the two compounds 
nucleate as non-isostructural crystal structures. This suggests that the geometrical and/or 
chemical functionality of the surface influences the nucleation of TA and MA in different ways. 
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6 Validation of Crystal Structure Prediction methods through 
participation in The Sixth Blind Test of Organic Crystal Structure 
Prediction Methods organised by the CCDC 
 
6.1 Introduction 
Previous computational work in this thesis on the crystal structure prediction of MA 
was aided by prior knowledge of the three known polymorphs. These experimental structures 
helped validate the methodology and the results of the CSP study were used as a complement 
to experimental work. This is rather different from using CSP to decide whether a molecule will 
crystallise as a useful material, i.e. prediction of crystal structure prior to synthesis. This chapter 
further tests the crystal structure prediction methodology, followed previously in this thesis  
(chapter 3), through participation in the Sixth Blind Test of Organic Crystal Structure Prediction 
Methods organised by the CCDC. The Blind Tests assess how current methods of crystal structure 
prediction fare when given only the atomic connectivity of a compound/system as a starting 
point. 
 
6.2 Previous Blind Tests 
Following on from the success of the initial, invitation only, crystal structure prediction 
workshop held in 1999184, the CCDC has organised five further blind test challenges (held in 
2001185, 2004186, 2007187, 2010188 and this current test) that have been open to the international 
crystal structure prediction community. Each blind test has a number of target crystal structures 
that have been chosen to fit certain criteria and designed to test the ability of CSP methods to 
successfully predict increasingly challenging organic crystal systems. The CCDC blind tests have 
provided research groups across the globe with a unique opportunity to rigorously test different 
CSP methods for a range of organic molecules from small rigid molecules to larger, more flexible 
systems including salts and cocrystals. The molecular systems that have been submitted by the 
CCDC as candidate molecules in each test reflect the current perceived areas of interest and 
claimed capabilities in modelling organic crystal structures. It is for this reason that the most 
recent blind tests targets have increased in complexity and reflect the growth in the crystal 
structure prediction community.  
Compared to current day challenges and capabilities, the targets in the first blind tests 
could now be considered on the simple side of crystal structure prediction indicating just how  
far the field has come in the past 17 years since the introduction of the CCDC blind tests. The 
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systems in the first three bind tests had no more than 40 atoms yet successes were limited and 
it wasn’t until 2007 that there was a significant level of success with small molecules.187  
As crystal structure prediction methods have progressed, the blind tests have involved 
more and more challenging test systems. The first three blind tests included molecules that 
belonged to one of the first three categories as described in Table 25. For the first time, the 
fourth blind test included a two component system (category 4, Table 25) that represents the 
growth in interest multiple component systems which present a more challenging search, as it 
is necessary to also include the relative positions and orientation of the molecules in the 
asymmetric unit. The inclusion of the cocrystal in the fourth test reflects the considerable 
interest in using salts and cocrystals of pharmaceuticals to improve the physical properties of 
the solid forms.189, 190 Interest in the CSP studies of cocrystals has increased following the finding 
of an elusive predicted cocrystal of caffeine benzoic acid by heteronuclear seeding .191 A 
pharmaceutically relevant molecule, i.e. one of sufficient size and flexibility that it was 
approaching the size of small molecule drugs in development, was considered for the first time 
in the fifth blind test (category 5, Table 25). A polymorphic system (category 6, Table 25) was 
also considered. 
 
Table 25. Categories in the previous CCDC Blind tests. 
 
CATEGORY DESCRIPTION 
1 a small, rigid molecule with only C,H,N,O atoms and less than 25 atoms 
2 a small, rigid molecule with some less common elements  
3 a molecule with some small amount of conformational freedom 
4 multiple independent rigid molecules, e.g. solvates, cocrystals,  salts or Z’ = 2 
structures; any space group; up to 30 atoms  
5 a molecule with 4–8 internal degrees of freedom in any space group and with 
50–60 atoms and either one or two independent molecules in the asymmetric 
unit 
6 a molecule for which there is more than one known polymorph, that is also 
relevant to one of the first four categories 
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Though the successes in the first blind tests were limited, the fourth blind test in 2007 
saw successful predictions from 13 of the 14 participating groups187 for the small rigid system 
and finally, the fifth blind test saw two successful predictions of a highly flexible model 
pharmaceutical.72 The CCDC determine a prediction in the blind tests as successful if a good 
representation of the experimental crystal structure was submitted as one of three structures 
that were allowed for each molecule for each participating group.  
 
6.3 Sixth Blind Test of Crystal Structure Prediction 
In September 2014, the CCDC announced the start of the sixth blind test that would 
yet again provide a standard platform upon which different collaborations and research groups 
could test their CSP methodologies. In preparation, the CCDC had retained the crystal structures 
of five different systems that were then released to the CSP community as molecular diagrams. 
The molecules were chosen to fit categories (Table 26) as determined by the CCDC and were 
similar, but not the same, as those that featured in the previous blind tests. 
Participants were allowed to submit a list of 100 structures compared to just three in 
the previous five blind tests. Additionally, participants were allowed to submit a second list using 
different ranking criteria. This change in the submissions represents the more recent focus of 
CSP studies highlighting the importance of the solid form landscapes of a molecule or compound 
and not just the prediction of ‘the’ crystal structure. Furthermore, to reflect the use of different 
methods in calculating final lattice energies, structures that were generated by one group were 
allowed to be re-ranked by another research group to provide insights into the uses of 
developing more specific ranking methods of lattice energies.  
 
6.3.1 Target System XXV 
The calculations reported in this chapter are on candidate system XXV which is shown 
in the diagram alongside the category description in Table 26. System XXV is a two component 
system containing 3,5-dinitrobenzoic acid (molecule 1) and 2,8-dimethyl-6H,12H-5,11-
methanodibenzo[b,f][1,5]diazocine (molecule 2) which is also known as Tröger’s Base. 3,5-
dinitrobenzoic acid (3,5-DNBA) is known to be a corrosion inhibitor and is also used in 
photography192 and Tröger’s Base has a number of applications as building blocks in fields 
including new materials, enzyme inhibitors, molecular recognitions, catalysis and 
supramolecular chemistry193.  
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Table 26. Criteria for each system in the sixth blind test  
 
XXII 
Rigid molecules, with 
functional groups restricted 
to CHNO, halogens, S, P and 
B; one molecule in the 
asymmetric unit; up to about 
30 atoms  
XXIII 
Partially flexible molecule 
with two to four internal 
degrees of freedom; one 
molecule in the asymmetric 
unit; up to about 40 atoms 
 
XXIV 
Partially flexible molecule 
with one or two internal 
degrees of freedom as a salt; 
two charged components in 
the asymmetric unit, in any 
space group; up to about 40 
atoms 
 
XXV 
Multiple partially flexible 
(one or two degrees of 
freedom) independent 
molecules as a co-crystal or 
solvate in any space group; 
up to about 40 atoms 
 
XXVI 
Molecules with 4-8 internal 
degrees of freedom; no 
more than two molecules in 
the asymmetric unit, in any 
space group; 50-60 atoms 
 
 
 
There are 19 entries on the CSD (refcode CUKCAM) of two known polymorphs of 3,5-
DNBA which crystallises in space groups P21/c and C2/c from benzene and ethanol 
respectively.194 Both polymorphs exist as carboxylic acid dimers that form via two hydrogen 
bonds in an R𝟐
𝟐
(8) arrangement. Crystal structures of the P21/c polymorph, determined with X-
ray diffraction, have shown a degree of proton disorder within the carboxylic acid dimer of the 
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structure at room temperature but not at 100 K.195 The different positions of the protons in the 
carboxylic acid dimer have been further investigated using neutron diffraction on crystals of the 
C2/c polymorph and high resolution X-ray diffraction on the P21/c polymorph.196 Thirteen 
redeterminations of the two polymorphs of 3,5-DNBA, as well as diffraction data on the 
homodimers of 3,5-DNBA in binary complexes with 4-dimethylaminobenzoic acid, support the 
previous results that show at low temperatures there is no evidence of proton disorder, but as 
temperatures increase, proton disorder is evident (Figure 76). 
 
 
 
Figure 76. Evolution of the anisotropic displacement parameter of the hydrogen atom in the 3,5-DNBA 
homodimer in a binary complex with 4-dimethylaminobenzoic acid, determined from neutron 
diffraction data. A single, well localized position is observed at 30 K moving to an average central 
position with a significantly greater mean square displacement along the direction of the hydrogen bond 
as the temperature is increased.196  
 
 
The known experimental structures of 3,5-DNBA show that the molecule adopts two 
different conformations in the two different polymorphs (Figure 77). The different 
conformations are due to rotation of the carboxylic acid and nitro groups away from planar.  
 
 
Figure 77. Molecular overlay of 3,5-DNBA in CUKCAM04 (grey) and CUKCAM22 (red) showing the 
rotation of the carboxylic acid and nitro groups that gives rise to different conformations in the crystal 
structures. 
151 
In comparison to 3,5-DNBA, Tröger’s Base has just one racemic crystal structure 
determination on the CSD (refcode DILLEP197) and two determinations of enantiopure (R,R)-
Tröger’s Base (refcode AXAGEL198 and redetermination, AXAGEL01199). There is only a 13 
molecule overlay, rmsd13 = 0.112 Å, of AXAGEL with AXAGEL01 of which the latter is a better 
determination, carried out at 100 K, with a lower R-factor than AXAGEL which was determined 
at room temperature. Furthermore, the hydrogen atoms in AXAGEL01 were observed in 
difference electron density maps and were refined isotropically whereas they were fixed in the 
AXAGEL structure based on stereochemical considerations. Although there is no single crystal 
data for the (S,S)-Tröger’s Base enantiomer on the CSD, this enantiomer cocrystallises with (S,S)-
2,8-dichloro-6H,12H-5,11-methanodibenzo[b,f][1,5]diazocine in the same unit cell as the (R,R) 
enantiomer (refcode YOGDAB).200 The (S,S)-Tröger’s Base component of the cocrystal YOGDAB 
is crystallographically the same as the structure of the (R,R) enantiomer with a 30 molecule 
overlay, rmsd30 = 0.081 Å (Figure 78). 
 
 
 
Figure 78. 30 molecule overlay of the (S,S)-Tröger’s Base component of the cocrystal YOGDAB (coloured 
by element) with the crystal structure of (R,R)-Tröger’s Base AXAGEL01 (green). 
 
The chirality of Tröger’s Base arises from the blocked conformation of the two N -atoms 
of the methanodiazocine bridge which gives the molecule a C2 axis of symmetry.198 A CSP search 
on Tröger’s base alone would only have to consider the chiral space groups had it been known 
prior to calculations that Tröger’s base was enantiopure. In the case of cocrystal XXV, the CCDC 
specified that target system XXV was crystallised from a racemic mixture of both enantiomers. 
However, only one enantiomer of Tröger’s Base is required as the input in  the search, reducing 
the potential computational cost of the calculations. The other enantiomer is automatically 
generated by inversion or mirror plane symmetry in racemic space groups.   
152 
The major conformational difference between the known experimental conformations 
(Figure 79) of Tröger’s Base is due to the methyl group rotation which rotates to maximise the 
intermolecular interactions within the crystal lattices. 
 
 
Figure 79. Molecular overlay of one molecule of Tröger’s Base from DILLEP (coloured by element) with 
AXAGEL01 (green). 
 
 
6.4 Computational Methodology 
The computational methodology in this chapter is largely similar to that followed when 
carrying out the CSP study on MA (see chapter 3). The main difference in this chapter is that the 
target system is a cocrystal with two molecules in the asymmetric unit. Therefore, the search 
needs to take into consideration the relative orientations of the different components and as 
such, small amendments to the methodology have been made in line with previous CSP studies 
on cocrystals.126, 127 
 
6.4.1 Verification of Chosen Level of Theory 
As with chapter 3 in this thesis, the appropriate level of theory was tested prior to the 
CSP study. In this case, an indication of how appropriate the intermolecular forces were 
modelled for the XXV system, was given by analysis of the reproduction of experimental crystal 
structures of both the individual components of the cocrystal as well as related structures taken 
from the CSD.  
Different levels of theory were initially tested to see how well the crystal structures of 
DILLEP, AXAGEL, AXAGEL01, CUKCAM04 and CUKCAM22 were reproduced. CUKCAM04 and 
CUKCAM22 were chosen from the 19 structures on the CSD of 3,5-DNBA as they were both low 
temperature determinations with small R-factors of the P21/c and C2/c polymorphs respectively. 
Reproduction of the crystal structure YOGDAB was not carried out due to the crystallographic 
similarity with AXAGEL01. Once an appropriate level of theory was chosen for the individual 
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components, the reproduction of crystal structures of related single component and cocrystal 
systems were tested using that same level of theory. 
 
6.4.2 Conformational Analysis 
The next step in the approach to the blind test was to determine which molecular 
conformations of the molecule should be considered in the search and to identify the potential 
degrees of freedom and flexibility of both components. In the case of the cocrystal XXV, the 
starting molecular conformations were extracted from the CIF files of known experimental 
crystal data of the two polymorphs of 3,5-DNBA (CUKCAM04 and CUKCAM22) and both the 
racemic (R,S)-Tröger’s Base (DILLEP) and enantiopure (R,R)-Tröger’s Base (AXAGEL01). 
Ab initio, calculations were carried out on the isolated molecule of  3,5-DNBA using 
GAUSSIAN09 at the PBE0/6-31+G(d) level of theory to provide a relaxed conformational scan of 
the torsion angles that relate to the rotation of the carboxylic acid and nitro groups.  
Additionally, CrystalOptimizer135 was used to assess the conformational flexibility of 
both molecules by carrying out fully atomistic minimisations on the known experimental crystal 
structures of the individual components. This provided information about which degrees of 
freedom changed the most and should therefore be considered as flexible in latter stages of the 
production of the crystal energy landscape. 
 
6.4.3 Crystal Structure Prediction 
The crystal energy landscape for the cocrystal XXV was obtained in a series of steps. At 
each step the number of structures considered was reduced in line with the increasing 
computational cost of more accurately calculating the lattice energy of putative structures.  
Initially, the conformations of both 3,5-DNBA and Tröger’s Base were optimised to the 
gas phase minimum using GAUSSIAN09138 at the PBE0/6-31+G(d) level of theory. The optimised 
rigid conformations of each component were then used as the input conformations in the 
CrystalPredictor133 search that was used to generate potential cocrystal structures with two 
molecules in the asymmetric unit. The CrystalPredictor search generated structures in the 
following 59 space groups; P1, P-1, P21, P21/c, P21212, P212121, Pna21, Pca21, Pbca, Pbcn, 
C2/c, Cc, C2, Pc, Cm, P21/m, C2/m, P2/c, C2221, Pmn21, Cmc21, Aba2, Fdd2, Iba2, Pnna, Pccn, 
Pbcm, Pnnm, Pmmn, Pnma, Fddd, Ibam, P41, P43, I-4, P4/n, P42/n, I4/m, I41/a, P41212, P43212, 
P-421c, I-42d, P31, P32, R3, P-3, R-3, P3121, P3221, R3c, R-3c, P61, P63, P63/m, P213, Pa-3, 
Cmcm and Cmca. The lattice energies of the generated structures were calculated using the FIT, 
exp-6 atom-atom repulsion-dispersion, potential with empirically fitted parameters145 and 
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atomic charges. A total of 2,000,000 structures were produced in two lots of 1,000,000 and 
structures that were the same were clustered using the criteria built into the CrystalPredictor 
program.  
The energy rankings of the most stable 40,000 structures were evaluated with more 
accuracy by replacing the atomic charges with the distributed multipoles of the rigid gas phase 
conformations of both molecules and minimising the lattice energy using DMACRYS.139, 140 The 
crystal structures were then clustered to remove duplicates. This was done by  consideration of 
potential small energy and density differences between the same structures, calculated powder 
pattern similarity and finally rmsdn values67 where n = 30. Routine clustering for Z’ = 1 structures 
normally looks at an overlay of 15 molecules, but in the case of the cocrystal XXV this was 
increased to 30 to account for the fact that there are two molecules in the asymmetric unit. 
Full CrystalOptimizer runs were carried out on the most stable unique crystal 
structures allowing the most flexible degrees of freedom, as determined in the fully atomistic 
CrystalOptimizer runs on the individual components, to vary as expected under packing forces. 
The converged CrystalOptimizer calculations are minima on the crystal energy landscape and 
are checked to be so by consideration of the Hessian matrix. In a small number of cases , the 
structures needed to be changed to Z’ = 4 structures (two molecules of each component in the 
asymmetric unit) and re-minimised.  
The CrystalOptimizer minima were then clustered again to remove structures that had 
minimised to the same structure and were therefore duplicates. The resulting lowest 100 
structures formed List 1 that was submitted to the CCDC. After this step, the lowest 1000 
structures were sent to Tkatchenko and Brandenberg for re-ranking using periodic dispersion-
corrected electronic structure methods that were mentioned in chapter 3. 
Uncertainties in the relative energy estimates of thermodynamically plausible 
structures following CrystalOptimizer were roughly estimated by looking at the sensitivity of the 
relative lattice energy to small changes in the energy model. The changes made to the energy 
model included estimating the effect of the crystal environment by applying the polarizable 
continuum model (PCM)147 as well as estimating the Helmholtz free energy at 298 K from the 
rigid-body k=0 phonon modes and elastic constants for the unit cell 149. The Williams potential, 
W99,150 was also tested.  
The PCM was applied to the unique crystal structures following CrystalOptimizer. The 
bulk crystalline environment was modelled using GAUSSIAN09 to calculate the wave function of 
the molecular structures in a dielectric of Ɛ = 3.0 (shown to be typical of organic crystals) .146 
DMACRYS was used to calculate the lattice energy and estimate the Helmholtz free energy at 
298 K. The 100 lowest unique structures following the free energy calculations formed the 
second list of structures submitted to the CCDC, List 2. 
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6.5 Results and Discussion 
6.5.1 Verification of Chosen Level of Theory 
Table 27 shows the results of the reproductions of the unit cells of the individual 
components of the cocrystal XXV as calculated at different levels of theory (HF, B3LYP, PBE and 
PBE0) with the 6-31+G(d) basis set and the FIT potential. The unit cells of DILLEP, CUKCAM04 
and CUKCAM22 were well reproduced at all levels of theory with low rmsd15 values. Of the four 
levels of theory tested, the PBE0/6-31+G(d) level of theory gave the lowest rmsd15 values and 
the best reproductions of the experimental unit cells.  
 AXAGEL, the first determination of the (R,R)-Tröger’s Base, was poorly reproduced at 
all levels of theory. However, the subsequent redetermination AXAGEL01, released later on 
during this blind test study in version 5.36 of the CSD, was reproduced well at the PBE0/6-
31+G(d) level of theory. The release of AXAGEL01 showed that the poor modelling of AXAGEL 
was because of the poor quality crystal structure, and removed some doubts about the 
suitability of the chosen model for the intermolecular forces.  
The W99 potential was also tested at different levels of theory and whilst results for 
DILLEP and AXAGEL01 were satisfactory, the W99 potential fused the carboxylic acid dimers 
together in both CUKCAM04 and CUKCAM22. It was decided that the W99 potential was not 
suitable. This problem has been observed previously,144 including for a carboxylic acid - pyridine 
hydrogen bond,201 and appears to be due to insufficient repulsion from the polar hydrogen when 
the electrostatic forces are modelled by distributed multipoles.  
The PBE0/6-31+G(d) level of theory with the FIT potential was then further validated 
by reproducing the crystal structures of 18 single and multicomponent systems that were 
related to the components of cocrystal XXV. All the related structures were well reproduced at 
the PBE0/6-31+G(d) level of theory with the FIT potential as shown in the table in Appendix 15 
on page 215. In each case the rmsd15 values are low which suggests that the chosen level of 
theory is an adequate choice for the cocrystal XXV.  
Hence, the CSP study was carried out using distributed multipoles calculated at the 
PBE0/6-31+G(d) level of theory and using FIT potential. The confidence that this model was 
appropriate rather than just the best within our capabilities increased following the good 
reproductions of the related crystal structures and with the publication of the better crystal 
structure of Tröger’s base, AXAGEL01. 
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Table 27. Reproduction of the experimental crystal structures of the individual components of the cocrystal XXV using the experimental conformation and the distributed 
multipoles of the specified level of theory with the 6-31+G(d) basis set and the FIT parameters for the exp-6 potential. 
 
  Lattice Parameters Lattice Energy Density n(rmsdn) 
  a (Å) b (Å) c (Å) α (°) β (°) γ (°) (kJ mol-1) (g cm-3) (Å) 
CUKCAM04          
 expt 9.761(2)  8.9192(4)  9.444(2) 90 97.55(1) 90    
 HF 10.32      8.88      9.15 90 97.33 90 -150.55 1.69 15(0.269) 
 B3LYP 10.38        8.92      9.17     90 97.39 90 -136.40 1.67 15(0.285) 
 PBE 10.36      8.95      9.19 90 97.31 90 -130.20 1.67 15(0.276) 
 PBE0 10.34      8.94      9.19 90 97.30 90 -134.04 1.67 15(0.267) 
CUKCAM22          
 expt 20.080(5)  8.700(5)  9.600(5) 90 109.750(10) 90    
 HF 21.11      8.66      9.37     90 108.33 90 -152.68 1.73 15(0.251) 
 B3LYP 21.14      8.72     9.39     90 108.32 90 -138.82 1.71 15(0.249) 
 PBE 21.11      8.76      9.41     90 108.56 90 -132.56 1.71 15(0.236) 
 PBE0 21.09      8.74      9.41     90 108.56 90 -136.38 1.71 15(0.233) 
DILLEP          
 expt 12.774(2)  30.290(5)  10.386(2) 90 90 90    
 HF 12.74     29.72     10.88 90 90 90 -120.13 1.21 15(0.224) 
 B3LYP 12.76     29.72     10.88 90 90 90 -117.87 1.21 15(0.227) 
 PBE 12.76     29.73    10.88 90 90 90 -118.47 1.21 15(0.224) 
 PBE0 12.75     29.74     10.88 90 90 90 -119.80 1.21 15(0.221) 
AXAGEL          
 expt  6.110(6) 7.934(7) 28.33(6) 90 90 90    
 HF 6.19      7.99     27.44 90 90 90 -121.50 1.23 13(0.119) 
 B3LYP 6.18      8.00     27.48 90 90 90 -119.17 1.22 13(0.117) 
 PBE 6.18      8.00     27.48 90 90 90 -119.22 1.22 13(0.117) 
 PBE0 6.19      7.99     27.47 90 90 90 -120.54 1.23 13(0.117) 
AXAGEL01          
 expt  6.04092(12)  7.95113(18)  27.2870(6) 90 90 90    
 PBE0 6.13     8.11    27.46 90 90 90 -119.99 1.22 15(0.137) 
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6.5.2 Determining the conformational flexibility to be used in the CSP study 
The torsion angles of the COOH and NO2 groups in CUKCAM04 and CUKCAM22 are 
reported in Table 28. As the largest reported torsion angle is only 23.38 ° away from planar, it 
suggests that rotation of either group away from planar is minimal in the known polymorphs. 
This information is supported by the torsion angle scans (Figure 80) which show that the relative 
conformational energy increases significantly, to a maximum at 90 °, as either substituent group 
rotates more than 40 ° away from planar. 
 
Table 28. Torsion angles for the COOH and NO2 groups in the experimental crystal structures of 
CUKCAM04 and CUKCAM22. 
 
 
Torsion Angle (°) 
CUKCAM04 CUKCAM22 
COOH 7.76 9.21 
NO2 2.35 3.29 
NO2 23.38 19.09 
 
As the substituent groups on 3,5-DNBA are unlikely to rotate significantly away from 
planar, it was decided that it would be sufficient for 3,5-DNBA to be held rigid in the search, with 
the input molecule fixed in the near planar, gas phase optimised, conformation. The small 
conformational flexibility of 3,5-DNBA could then be accounted for in the subsequent 
CrystalOptimizer calculations.  
 
 
Figure 80. The relative conformational energy as a function of the torsion angles of the COOH and NO2 
groups in 3,5-DNBA (with the rest of the molecule kept planar) calculated at the PBE0/6-31+G(d) level 
of theory. 
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Tröger’s Base can also be kept rigid in the search as the molecule shows very limited 
conformational flexibility illustrated by the fact that the conformations of the molecules in the 
known crystal structures of DILLEP and AXAGEL01 are very close to the gas phase optimum 
conformation (Figure 81). For this reason, a fully rigid search was carried out for cocrystal XXV 
which minimised the computational cost of the CrystalPredictor search as it reduced the number 
of conformational regions that needed to be searched to just one. The search variables covered 
in this CrystalPredictor search are the orientation and position of the two component molecules 
relative to each other and the unit cell parameters.  
 
Figure 81. (a) Molecular overlay of Tröger’s Base in DILLEP (coloured by element) with the gas phase  
optimum conformation (blue), rmsd1 = 0.0820 Å. (b) Molecular overlay of Tröger’s Base in AXAGEL01 
(coloured by element) with the gas phase optimum conformation (purple), rmsd1 = 0.0436 Å. 
 
The next stage of conformational analysis involved determining the degrees of 
freedom that would require optimisation in the CrystalOptimizer calculations that follow the 
CrystalPredictor search. In order to do this, fully atomistic CrystalOptimizer calculations on the 
individual components CUKCAM04, CUKCAM22 and AXAGEL01 were carried out where every 
degree of freedom (bond lengths, angles and dihedrals) in the molecule was optimised. Fully 
atomistic CrystalOptimizer calculations were not possible on DILLEP as it is a Z’ = 3 structure and 
therefore has too many degrees of freedom for the program to compute at the atomistic level. 
AXAGEL and AXAGEL01 minimised to the same structure. 
The results of the fully atomistic CrystalOptimizer runs indicated the angles and 
dihedrals that were likely to be the most flexible and require optimisation in subsequent 
CrystalOptimizer calculations on the generated structures. Angles that changed by more than 
0.5 ° and dihedrals that changed by more than 1.0 ° in the polymorphs of 3,5-DNBA (Appendix 
16, page 220) were considered flexible. Angles and dihedrals that affected the conformation of 
the phenyl ring in 3,5-DNBA were not considered flexible as the conformational change resulting 
from these optimisations brought the conformation of the phenyl ring closer to the gas phase 
optimum which was used as the input in the CrystalPredictor search. A total of 9 degrees of 
freedom (Figure 82) were chosen as flexible degrees of freedom for the CrystalOptimizer 
calculations. Fully atomistic CrystalOptimizer calculations on AXAGEL and AXAGEL01 identified 
8 degrees of freedom that required optimisation (Figure 82). 
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Table 29. Reproduction of the experimental crystal structures of some of the individual components of the cocrystal XXV following CrystalOptimizer calculations. The table 
provides the results of both fully atomistic CrystalOptimizer runs where all degress of freedom were optimised as well as runs where only selected degrees of freedom were 
optimised. Fully atomistic calculations were not carried out on DILLEP as it is a Z’ = 3 structure and therefore has too many degrees of freedom for the CrystalOptimiser program. 
 
  
Lattice Parameters Lattice 
Energy 
Density n(rmsdn) 
with experimental 
structure 
n(rmsdn) 
with atomisitic 
CrystOpt model 
  a (Å) b (Å) c (Å) α (°) β (°) γ (°) (kJ mol -1) (g cm-3) (Å)  
CUKCAM04           
Experimental 9.761(2)  8.9192(4)  9.444(2) 90 97.55(1) 90     
Fully atomistic CrystalOptimizer 10.37 8.98 9.07 90 97.88 90 -137.01 1.68 15(0.317)  
CrystalOptimizer (9 DOFs) 10.33 8.99 9.108 90 97.92 90 -121.61 1.68 15(0.322) 15(0.068) 
CUKCAM22                    
Experimental 20.080(5)  8.700(5)  9.600(5) 90 109.750(10) 90        
Fully atomistic CrystalOptimizer 21.26 8.83 9.26 90 107.64 90 -140.08 1.70 15(0.316)  
CrystalOptimizer (9 DOFs) 21.32 8.82 9.27 90 107.92 90 -125.06 1.70 15(0.322) 15(0.025) 
DILLEP           
Experimental 12.774(2)  30.290(5)  10.386(2) 90 90 90     
CrystalOptimizer (8 DOFs) 12.83 30.05 10.80 90 90 90 -115.79 1.20 15(0.199)  
AXAGEL                    
Experimental 6.110(6) 7.934(7) 28.33(6) 90 90 90        
Fully atomistic CrystalOptimizer 6.14 8.02 27.83 90 90 90 -118.03 1.21 13(0.136)  
CrystalOptimizer (8 DOFs) 6.19 8.02 27.71 90 90 90 -117.23 1.21 13(0.140)  
AXAGEL01           
Experimental 6.04092(12)  7.95113(18)  27.2870(6) 90 90 90     
Fully atomistic CrystalOptimizer 6.14 8.02 27.83 90 90 90 -117.98 1.21 15(0.177)  
CrystalOptimizer (8 DOFs) 6.17 8.05 27.69 90 90 90 -117.34 1.21 15(0.179) 15(0.054) 
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Figure 82. Diagram showing both the numbering of the atoms in cocrystal XXV and the degrees of 
freedom that were optimised by CrystalOptimizer. Dihedrals (red): H4-O1-C7-C1, O1-C7-C1-C2, O3-N1-
C3-C2, O5-N2-C5-C4, C22-N3-C8-C13, C21-N3-C8-C13, C15-C20-C21-N3, N4-C14-C13-C8, H17-C23-C11-
C10 and H20-C24-C18-C17. Bond angles (green): H4-O1-C7, O1-C7-C1, O2-C7-C1, N1-C3-C2, N2-C5-C4, 
C24-C18-C17 and C23-C11-C10. 
 
CrystalOptimizer calculations were then carried out on the individual components 
CUCKAM04, CUKCAM22, DILLEP, AXAGEL and AXAGEL01 optimising only the selected degrees 
of freedom as shown in Figure 82. Table 29 reports the results of the fully atomistic 
CrystalOptimizer runs as well as the calculations where only the selected degrees of freedom 
were optimised. The results show a good agreement between the fully atomistic 
CrystalOptimizer runs and the runs optimising only the selected degrees of freedom which gives 
us confidence that the chosen degrees of freedom (totalling 17) for cocrystal XXV will give us an 
adequate model. 
 
6.5.3 Rigid Body Crystal Energy Landscape 
Analysis of how frequently CrystalPredictor generated the crystal structures, showed 
that most structures had only been found a few times when 1,000,000 structures were initially 
generated. To try and make sure the search space was covered adequately, an additional 
tranche of another 1,000,000 structures were generated which included some important new 
structures together with the structure that was eventually matched to the experimental 
structure. However, even after 2,000,000 structures, it was not clear that the search was 
complete as many low energy structures were still only found once or twice in the search. Due 
to time constraints on the blind test, no further searches were carried out and further 
calculations were carried out on the lowest energy structures from the 2,000,000 generated.  
Refinement of the rigid CrystalPredictor structures by adding multipoles produced the 
crystal energy landscape shown in Figure 83. All structures contained the same D1
1
(2) hydrogen 
bonding motif with a hydrogen bond forming between the acidic proton on 3,5-DNBA and a 
nitrogen atom on Tröger’s Base. There were three structures grouped  at the global minimum of 
which two were very similar P-1 structures and the other was a P21/c structure.  
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Figure 83.  The lowest 20 kJ mol-1 of the rigid body crystal energy landscape of cocrystal XXV where each 
symbol represents a crystal structure of the specified space group which is a minimum in the lattice 
energy calculated using DMACRYS. 
 
6.5.4 Crystal Energy Landscape Following Refinement of the Flexible Degrees of 
Freedom 
 
Figure 84. The lowest 100 structures, covering around 20 kJ mol-1 of the crystal energy landscape of 
cocrystal XXV where each symbol represents a crystal structure of the specified space group which is a 
minimum in the lattice energy following CrystalOptimizer. The 17 degrees of freedom shown in Figure 
83 were optimised using CrystalOptimizer. The P21/c global minimum structure is 5.4 kJ mol-1 more 
stable than the next most thermodynamically stable structure. 
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The optimisation of the angles and dihedrals by CrystalOptimizer changed the relative 
rankings of the hypothetical crystal structures. The lowest P21/c structure on Figure 83 increases 
in density and significantly lowers its energy by 7.5 kJ mol -1, in comparison the two low energy 
P-1 structures merged to the same structure and only lowered in lattice energy by about 2 kJ 
mol-1. Hence, there is now a clear, thermodynamically favoured structure of P21/c symmetry 
that is more stable than the others by 5.4 kJ mol -1 (Figure 84).This energy gap is comparable to 
that observed on the crystal energy landscape of isocaffeine (6.05 kJ mol -1) where calculations 
helped to highlight the difference between the crystallisation tendencies of caffeine and 
isocaffeine and helped to explain the singular solid form of isocaffeine compared to the 
disordered and multiple forms of caffeine.83 The top 100 structures from calculations at this 
point were submitted as List 1.  
 
6.5.5 Choice of Structures for Submission 
(a) 
 
(b) 
 
Figure 85. Comparing the relative lattice energies of hypothetical crystal structures of blind test target 
XXV using different methods of calculation. (a) The energies resulting from CrystalOptimizer calculations 
plotted against the results from DMACRYS+PCM calculations show a good agreement between the two 
methods with an average residual of 1.13 kJ mol-1. (b) The energies resulting from CrystalOptimizer  
calculations plotted against the results from DMACRYS+PCM+Free Energy calculations again show a 
good agreement between the two methods with an average residual of 1.46 kJ mol-1. 
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To establish whether or not the large energetic preference for the P21/c structure was 
an artefact of the choice of method, the sensitivity of the calculated lattice energies to two 
additional, different methods were tested. Figure 85 shows regression analysis comparing the 
lattice energies resulting from the CrystalOptimizer calculations with lattice energies calculated 
using (a) the PCM and (b) the PCM and the Helmholtz free energy estimation at 298 K. The strong 
correlation between the lattice energies calculated using different methods in the graphs in 
Figure 85 shows that there is no significant re-ranking in the structures when the method of 
lattice energy calculation is changed. This is supported further by the low average residual lattice 
energies of 1.13 kJ mol -1 and 1.46 kJ mol-1, that result when comparing the CrystalOptimizer 
lattice energies with the PCM and Helmholtz free energies respectively. The ranking of the low 
energy generated structures of cocrystal XXV is not very sensitive to the choice of method for 
lattice energy evaluation and the P21/c structure is the global minimum structure in all three 
energy models following the CrystalOptimizer calculations. 
 
  
Figure 86. The crystal energy landscape of cocrystal XXV showing the lowest 100 structures where each 
symbol represents a crystal strcuture of the specified space group which is a minimum in the lattice 
energy calculated using the polarizable continuum (Ɛ = 3.0) and estimating the free energy. The P2 1/c 
global minimum structure is 4.7 kJ mol-1 more stable than the next most thermodynamically stable 
structure.  
 
In comparison to List 1 which was the 100 lowest unique structures following 
CrystalOptimizer calculations, for List 2, the PCM and the Helmhol tz free energies were 
additionally calculated. The packings of the CSP generated structures were also manually 
examined to remove structures that were so closely related to a lower energy structure that it 
seemed unlikely that they would crystallise as separate polymorphs. The free energy could not 
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be calculated for roughly 10% of the structures, which were therefore omitted from List2. As 
only a handful of duplicate structures were manually removed from List 2 and the generated 
structures were not sensitive to the choice of method of evaluation of lattice energy , there is a 
large overlap between the two lists of submitted structures. Hence, Figure 86 (the crystal energy 
landscape of List 2) and Figure 84 (the crystal energy landscape of List 1) look fairly similar. 
Both List 1 and List 2 suggest that the energetically favourable P21/c structure (first 
entry in Table 30) should be the experimental structure. The submission was expected to be 
successful as long as the search space was adequate and the experimental structure was found 
in our original search that generated 2,000,000 structures.  
Inspection of the low energy hypothetical structures of the cocrystal XXV from List 1 
(partly displayed in Table 30) shows that all of the structures contained the expected COOH···N 
hydrogen bond (the same D1
1
(2) hydrogen bonding motif) and almost all of the cocrystals had 
layers of Tröger’s Base molecules linked by layers of the 3,5-DNBA coformer. Within the layers 
of Tröger’s Base, the molecules adopt the same packing motifs as observed in the individual 
component crystal structures and other derivatives of Tröger’s Base found on the CSD ( Figure 
87).200  
 
 
 
Figure 87. Packing motifs of Tröger’s Base molecules and derivatives identified from inspection of the 
CSD (Version 5.35, November 2013) by Cross et al. 2014.200 Motifs M2, M3 and M4 are often found within 
the hypothetical cocrystal structures of XXV. 
 
There was a large variety of π···π stacking geometries within the layers of the individual 
components and also between the different components in the generated crystal structures. 
There was also a large range of different orientations of the molecules relative to the 
approximately linear O-H···N hydrogen bond which is the reason only a few structures were 
eliminated when considering structures (on List 2) that were too similar to be able to remain 
distinct during crystallization.  The cocrystal was estimated to be significantly more stable than 
the components (by almost 25 kJ mol -1), and the slow evaporation conditions suggest 
thermodynamic control of the crystallization. 
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Table 30. The nine lowest energy hypothetical structures of cocrystal XXV on List 1 following CrystalOptimizer calculations showing the ranking of the structures and their space  
groups. All structures have the same D𝟏
𝟏
(2) hydrogen bonding motif.  
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P-1 
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6.5.6 Revelation of the experimental structure 
 
(a) 
 
Cell 
parameters  
  a (Å) 
10.7 
b (Å) 
27.9 
c (Å) 
7.8 
β (°) 
69.2 
  
(b) 
 
Cell 
parameters  
  a (Å) 
10.408(3) 
b (Å) 
27.547(7) 
c (Å) 
8.112(2) 
β (°) 
109.58(2) 
  
 
Figure 88. Diagrams and unit cell data for (a) the global minimum structure from List 1 of our predictions 
and (b) the experimental structure provided to partipicants by the CCDC at the end of the blind test. 
Both structures have P21/c symmetry.  
 
The prediction for cocrystal XXV was successful as the global minimum predicted 
structure matched the experimental structure with not only a good 20 molecule overlay (rmsd20 
= 0.310 Å), as per the criteria from the CCDC for a successful prediction, but also a good 30 
molecule overlay, rmsd30 = 0.361 Å (Figure 89). These results are the rmsdn values from the 
comparison of the experimental structure with the global minimum P21/c structure from List 2, 
following PCM and Helmholtz free energy estimation calculations. The global minimum 
structure from List 1 also has a good overlay with the experimental structure (rmsd 20 = 0.317 Å 
and rmsd30 = 0.367 Å), but as the rmsdn values are slightly greater. It can be concluded that 
performing the PCM and Helmholtz free energy estimation calculations in the case of this 
cocrystal XXV, alters the structure minimally so that it is closer to the observed experimental 
structure. 
167 
 
Figure 89. 30 molecule overlay of the experimental structure revealed by the CCDC (by element) with 
the hypothetical global minimum P21/c structure from both List 1 and List 2, rmsdn30 = 0.361 Å. 
 
During the year of the blind test, additional experimental work was performed on 
some of the systems. A low temperature (100 K) redetermination of the structure of XXV 
revealed that there was a significant amount of proton transfer from the carboxylic acid group 
to the amine. A competitive refinement determined proton occupancie s of 0.58 on the 
carboxylic acid oxygen and 0.42 on the nitrogen.202 Our method could not predict anything other 
than a cocrystal and the prediction of a salt was not attempted. 
In principle, period electronic structure calculations could show proton transfer, and 
indeed some participants generated some salt structures, but not the observed salt 
components. Previous CSP studies of pyridine carboxylic acid cocrystals and the corresponding 
pyridinuium carboxylate salts have shown that the crystal energy landscapes are very different, 
with proton disorder only being observed when both the salt and cocrystal have the same 
structure low in energy on the crystal energy landscape.59 Proton transfer will only occur in 
lattice energy minimisation if there is no barrier to transfer. It is therefore not surprising that 
this disorder was not predicted, and indeed if the disorder in cocrystal XXV had been known 
prior to the start of the blind test, it may not have been selected as a target.  
 
6.5.6.1 Discussion of Results of Other Participants  
14 other CSP methods were applied to XXV, plus three attempts to re-rank structures 
generated from this work or another group. Only five full CSP studies found the observed 
structure within their top 100, emphasising the difficulty in two component searches. 
The Imperial group which used the same CrystalPredictor and CrystalOptimizer codes 
also found the experimental structure as the global minimum. Their approach differed by 
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including flexibility in the search and by using a different functional M06/6-31G(d,p) for the 
distributed multipoles and intramolecular energy penalties. Van Eijck used the UPACK 203, 204 
search method, but used a method of lattice energy minimisation that was very similar to this 
work (based on distributed multipoles and the FIT potential ), thus also had the experimental 
structure as the global minimum. A new search method, USPEX,205 and the commercial program 
GRACE75 also found the experimental form. However, these submissions used periodic 
electronic structure methods to re-rank the structures, placing the experimental structure 2nd 
and 6th respectively.  
The re-ranking of structures from this work by the Tkatchenko group resulted in the 
known form being the global minimum, stable by about 4 kJ mol -1, but Brandenburg’s method 
placed it 2nd, being about 1 kJ mol -1 higher in energy than their global minimum structure. Thus, 
the energy gap between the experimental form and other alternative structures is quite 
sensitive to the method of evaluating the lattice energy, with a surprising range of rankings 
amongst the expensive periodic electronic structure calculations.  
The rival structures to the global minimum structure that were generated vary 
considerably in density, over the range of packing coefficients (0.66 – 0.74) seen for organic 
crystals. Since periodic electronic structure methods differ in their dispersion corrections and 
the dispersion contribution is a major component of the lattice energy, this may be a major 
factor in their difference in rankings comparing Tkatchenko’s many body dispersion correction, 
which is theoretically the most realistic, and single point energy evaluations. Since the 
empirically fitted FIT potential also ranked the experimental structure as the most stable, it 
appears that its dispersion coefficients are rather appropriate for cocrystal XXV.  
 
6.5.6.2 Other Blind Test Results. 
The success in predicting the structure of XXV cannot be taken in isolation. The rest of 
the UCL group, using essentially the same methodology, found the crystal structures of XXII as 
2nd, and XXVI as 1st in their second lists, failed to find the salt XXIV, and found the Z’=1 
polymorphs of XXIII though some were rather high in energy. Overall, the CrystalPredictor search 
appears to be a very competitive method, probably the strongest alternative to the commercial 
code GRACE. The lattice energies evaluated from ab initio calculations on one molecule and the 
empirically fitted potentials appear to be reasonably good, though need calibrating against 
alternative methods for each application.   
The 6th blind test showed that there is considerable advance in CSP. The full description 
is being published202 and has already attracted considerable publicity.206 
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7 Conclusions and Future Work 
As chloro and methyl groups have similar van der Waals volumes, they are thought to 
be interchangeable within crystal lattices following the Kitaigorodsky principle of close 
packing.62 This thesis aimed to explore the consequences of chloro-methyl replacement on 
crystal structures and solid form landscape of MA and TA using a joint computational and 
experimental approach.  
The joint computational and experimental approach not only explored any simi larities 
and differences in the polymorphs and nucleation behaviour of MA and TA, but also aimed to 
develop the idea of targeting the growth of unobserved, thermodynamically plausible, 
polymorphs using isostructural heteroseed surfaces. The use of template surfaces in targeting 
unobserved solid forms is a useful technique because the ability to first nucleate a polymorph is 
a function of both thermodynamics and kinetics. The presence of a template crystal surface can 
change the kinetics of nucleation and can catalyse overcoming the barrier to change the 
polymorphic form of a compound. For example, template crystal surfaces have successfully been 
used to target the growth of CBZ V and CYH III by vapour deposition onto isostructural DHC II. 84, 
88 Additionally, the phenomenon of disappearing polymorphs has largely been attributed to the 
presence of template seeds.8  
7.1 Results Summary 
To complement an earlier CSP study on TA,89 computational work first focused on 
carrying out a CSP study on MA. The CSP study generated a number of low energy crystal 
structures of MA that were competitive in energy with known polymorphs. Comparisons of both 
experimental and low energy, generated crystal structures of MA with observed crystal 
structures of the similar compound, TA, identified a number of isostructural relationships 
including MA I – TA  IV and MA II – TA V as well as TA III – #6MA_288 and TA I – #19MA_5643, 
where #6MA_288 and #19MA_5643 are computationally generated structures. The results of 
the CSP study on MA initially indicated that there were two low energy, hypothetical crystal 
structures that were isostructural with known forms of TA. However, following the vapour 
deposition experiments and the nucleation and growth of a new polymorph of TA (form VII) an 
additional isostructural relationship was identified between #5MA_510 and TA form VII (section 
5.3.2.1.7 in chapter 5). 
The relative stabilities of the putative structures of MA have been shown to be 
sensitive to the choice of computational model which is an added complication when 
considering if #6MA_288, #19MA_5643 and #5MA_510 could be found experimentally. 
#6MA_288 was not targeted experimentally as isostructural TA form III can only be obtained 
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using PIHn32 and attempts to use TA form I to template #19MA_5643 and TA form VII to template 
#5MA_510 were unsuccessful (chapter 5, sections 5.2.2.3.1 and 5.3.2.2).  
The isostructural relationship between MA form I and TA form IV appeared to satisfy 
the conditions for a solid solution, as stated by Kitaigorodsky.63 Cocrystallisation of MA and TA 
from ethanol produced solid solution crystals that are isomorphous to MA form I with a bulk 
composition representative of the intended molar ratio of MA:TA. The MA-TA solid solution 
series (chapter 4) showed that TA was soluble in MA form I up to around 80 %. The identification 
of the MA-TA solid solution series led to heteroseeding experiments where MA form I seeds 
facilitated the first nucleation of TA form VI from a supersaturated solution of TA in ethanol. TA 
form VI is isomorphous with MA form I and has crystallographic similarities with TA form IV with 
rmsd14 values around 0.3 Å. TA form VI was not found on the crystal energy landscape for TA 
produced by Uzoh89 which emphasised the need for a greater number of computationally 
generated structures to be minimised than were evaluated by Uzoh.170  
The isostructural relationships that exist between both hypothetical and 
experimentally observed crystal structures of MA and TA provided rationale for investigating the 
sublimation behaviour and vapour deposition of MA and TA. The sublimation experiments were 
guided by the initial successes of the methods used to first nucleate CBZ V84 and were carried 
out at the same time as further experiments targeted the growth of CBZ V and CYH III on 
isostructural DHC II88 as part of a project investigating templating by sublimation. Sublimation 
of TA onto a MA form I template crystal (section 5.2.2.3.2) grew single crystals of TA form I and 
not isomorphous TA form VI that was obtained from the solution seeding experiments (chapter 
4, section 4.3).  
The experiments highlighted how difficult analysis of deposition onto single crystals 
can be. As the template and target crystals are isomorphous, epitaxial growth might be expected 
to give rise to a uniform layer of the target crystal structure covering the template seed which 
would be hard to characterise.88 It would also be difficult to distinguish new forms obtained from 
the deposition of different microcrystalline layers, one on top of another, of TA and MA. 
Additionally, as was evident with TA forms IV and VI, subtle differences between polymorphs of 
a compound can be hard to characterise. 
The sublimation experiments that used the bespoke apparatus described in section 
5.3.1.1 produced a new form of TA (form VII) when TA was deposited onto both copper and glass 
surfaces that were held at room temperature (section 5.3.2.1). TA form VII is related to TA form 
I and both crystal structures have the same double layer of molecules consisting of carboxylic 
acid dimers, but the structures differ in the stacking of the double layers. The simultaneous DSC-
XRD experiments carried out at the Diamond Light Source proved to be a powerful tool in 
analysing the thermal behaviour of TA form VII, confirming that it transforms to TA I  upon 
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heating in the DSC. TA form VII was not found on the crystal energy landscape for TA produced 
by Uzoh.89 
TA form VII is isostructural with #5MA_510 from the CSP study on MA, however, 
deposition of MA onto the same copper surface under the same conditions produced MA form 
I and not the isostructural form. Furthermore, deposition of MA onto a template surface of 
microcrystalline TA form VII failed to nucleate the isostructural form of MA, #5MA_510.  
The vapour deposition experiments showed that under the same conditions, MA and 
TA behave very differently. Results show that the polymorphic form of MA is dependent on the 
identity of the surface with form I growing on copper, TA form I single crystals and 
microcrystalline TA form VII, but form II growing on glass surfaces. In comparison, the identity 
of the deposition surface does not affect the polymorphic form of TA. It is possible that the 
temperature of the surface affects the polymorphic form of TA with TA form I obtained when 
the deposition surface temperature is high and TA form VII obtained when the deposition 
surfaces are held at room temperature.  
Due to the nature of the experimental work in this thesis, analysis of the polymorphic 
form that results from any of the experiments, is limited to the polymorphic form observed at 
the end. Therefore, the growth of any short lived, kinetic polymorphs would not be observed if 
they have transformed to a more stable form even if it is not the most stable form. As of yet 
there is no in situ method of characterising the polymorphic form of a compound from either 
solution based or vapour deposition experiments.  
The computational and experimental results in this thesis highlight the complexity of 
the MA and TA polymorphic systems. The results suggest that even though MA and TA are 
molecularly isostructural and chloro and methyl groups have similar van der Waals volumes, 
these facts alone are not enough to ensure that isostructural crystals will be observed 
experimentally even though a number of isostructural relationships between MA and TA do exist 
and isostructural structures are generated by CSP methods. The extent of polymorphism of MA 
and TA is molecule specific and the differences between chloro and methyl group interactions 
significantly contributes to the differences that are observed in the polymorphs of MA and TA.  
7.2 Revisiting the Crystal Energy Landscape of Tolfenamic Acid 
Even though TA form VI and TA form VII are Z’ = 1 structures, they were not on the 
crystal energy landscape produced for TA by Uzoh.89 The experimental identification of two new 
polymorphs of TA in this thesis highlighted the need to minimise thousands of putative 
structures rather than hundreds to ensure that all structures, that minimise to be competitive 
in energy with known polymorphs or the global minimum, have been refined at the optimum 
level of theory (discussed in section 4.4). With this in mind, the crystal energy landscape of TA 
172 
was recalculated by Louise Price so that the crystal energy landscapes of MA and TA could be 
compared and contrasted to evaluate how chloro-methyl replacement within crystal structures 
affects the relative stability of the crystal structures.  
The recalculated crystal energy landscape of TA is shown alongside the crystal energy 
landscape of MA in Figure 90. The crystal structures on both landscapes (calculated within the 
polarisable continuum) have been evaluated at the same level of theory, PBE0/6-31+G(d), and 
a similar number of structures were optimised using CrystalOptimizer, 1859 for MA and 1872 
for TA. The lattice energies for fewer structures of TA than MA were calculated within the 
polarisable continuum, 659 for TA compared to 1260 for MA, yet the low energy region of the 
crystal energy landscape for TA is more populated than the crystal energy landscape of MA. The 
more populated landscape of TA shows that there appears to be a number of more favourable 
packings of molecules of TA compared to MA which is mirrored experimentally as there are now 
seven forms of TA compared to three for MA.  
In additional to the previously known forms of TA (I – V) both of the new polymorphs 
obtained experimentally in this thesis (VI and VII) were found on the crystal energy landscape of 
TA that was produced by Louise Price. Furthermore, Figure 90b shows that both forms appear 
to be competitive in energy with known forms of TA. 
Figure 90 highlights the isostructural relationships that exist between experimentally 
observed polymorphs of MA and TA with either (a) other experimental ly observed polymorphs 
or (b) CSP generated crystal structures. There are also many additional isostructural 
relationships that exist between hypothetical crystal structures of MA and hypothetical crystal 
structures of TA. Upon replacement of a methyl group with a chloro group, the relative stabilities 
and rank order of the crystal structures are significantly altered.  
The cluster of structures around the global minimum on the crystal energy landscape 
for MA that relate to MA form I are not isostructural with the global minimum structure for TA. 
However, MA form I is isostructural with known forms of TA (IV and VI) that are relatively low in 
energy on the crystal energy landscape in Figure 90. In comparison, TA form I is isostructural 
with a hypothetical crystal structure of MA (#19MA_5643) which is relatively high in energy, 
around 5 kJ mol-1 less stable that TA form I. If the respective lattice energies of MA and TA from 
this computational model are to be believed, it could help explain the existence of the MA-TA 
solid solution that is isomorphous to MA form I and not TA form I  even though both MA form I 
and TA form I crystallise from ethanol. 
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Figure 90. Comparison of the crystal energy landscapes of (a) MA and (b) TA. Each symbol represents a crystal structure of the specified space group which is a minimum in the 
lattice energy (calculated within the polarizable continuum). In total, 1260 lattice energy minimisations were carried out for MA in comparison to 659 for TA. The dashed green 
circles group isostructural crystal structures where one structure is observed experimentally. The green lines link isostructural MA and TA structures where at least one structure 
is observed experimentally. Two ordered structures are included for the disordered crystal structures MA II, TA V and TA VI. 
(a) (b) 
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Figure 91. Comparison of the relative energies of different structures of TA (left hand side, blue box) and MA (right hand side, pink box) calculated using four different 
computational models. All energies are relative to the most stable experimental structure which are TA I and MA I. Filled marke rs represent experimental structures and unfilled 
markers represent hypothetical structures that are isostructural to known polymorphs of the other compound. Data for the figure was collated by Louise Price. 
MA I 
MA II  major 
#MA_510 
#MA_288 
MA III  
#MA_5643 
MA II  minor 
TA I  
TA II  
TA II I  
TA VII  
TA IV 
TA VI major 
TA VI minor 
#TA_3074 
TA V major 
TA V minor 
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It is important to evaluate the lattice energies using different computational models 
so that the sensitivity of the structures to the method of calculation can be evaluated. Figure 91 
shows the energies of structures of MA and TA relative to the energy of MA form I and TA form 
I respectively. The lattice energies were evaluated using four different computational models: 
by using CrystalOptimizer (CrystOpt); by applying the polarisable continuum and estimating the 
Helmholtz free energy (PCM + fe); by carrying out periodic DFT+D calculations with the 
Tkatchenko-Scheffler dispersion correction (PBE-TS); by recalculating the lattice energy of the 
PBE-TS structures with the Grimme, G06, dispersion correction (PBE-TS/G06). The PBE-TS and 
PBE-TS/G06 calculations were carried out by Rui Guo on the UK National High Performance 
Computing Facility, ARCHER (as in chapter 3). 
The relative energies and ranking of the crystal structures in Figure 91 are shown to be 
dependent on the choice of computational model which has implications when isostructural 
templates are identified to target the nucleation of predicted forms. For example, the three 
unobserved, predicted forms of MA, appear to increase in energy when calculated using periodic 
electronic structure calculations, so that they may be too high in energy to be found 
experimentally.  
The stability of TA form II is of particular interest because it significantly increases when 
calculated using periodic electronic structure calculations. As the hydrogen bonding is the same 
amongst all the generated structures, the dispersion contribution is a major component of the 
lattice energy. Dispersion corrections tend to favour more dense structures and TA form II is the 
most dense observed polymorph of TA. The effect of the dispersion correction on the lattice 
energies of putative structures has already been discussed in chapter 6 in the context of the 
blind test. Dispersion corrections are empirical and many research groups are continually 
developing and improving dispersion corrections such as Tkatchenko-Scheffler,154, 207 Grimme208 
and Neumann-Perrin209 to name but a few. Hence, the stability of TA form II may be an artifact 
of using early models for the dispersion correction. Otherwise, the calculations are broadly in 
agreement with each other and experiment, confirming that the ordered polymorphs are very 
close in energy. 
7.3 Conclusions in Light of the Recalculated Crystal Energy Landscape of 
Tolfenamic Acid 
It is important to note that CSP studies only consider the thermodynamics of a system 
and do not take into account the kinetics of nucleation. Therefore, although all structures on the 
crystal energy landscapes in Figure 90 might be considered thermodynamically feasible for 
conformational polymorphs,2 not all structures will be observed experimentally due to kinetics. 
Price suggests that predicted polymorphs might not be observed experimentally because the 
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right crystallisation experiment is yet to be carried out.210 The serendipitous discovery of TA form 
VII from vapour phase deposition under vacuum could be seen as an example of this.  
The successful prediction of the XXV cocrystal in the blind test increases the confidence 
in the CSP methodology that was used for the calculation of crystal energy landscapes of MA 
and TA. Furthermore, Uzoh’s crystal energy landscape for TA was reproduced when the CSP 
study was revisited and recalculated by Louise Price which confirmed that the only issue with 
the initial CSP study was the limited number of crystal structure minimisations.  
In this thesis, the CSP calculations on MA and TA have helped to evaluate the 
experimental results with regards to the identification of TA VI and TA VII and the MA-TA solid 
solution. The calculated lattice energies of structures of MA and TA show that chloro-methyl 
replacement within crystal structures affects the relative stability of isostructural crystal 
structures, whatever the method of calculation or computational model . However, the relative 
stabilities of the MA and TA structures are sensitive to the choice of computational model which 
highlights the difficulties faced by the CSP community in accurately modelling the lattice 
energies of compounds that are considered ‘small molecules’. Even greater challenges are faced 
for larger, more pharmaceutically relevant, molecules.  
7.4 Future Work 
Although generated crystal structures of MA were found to be isostructural with 
observed forms of TA, template surfaces failed to nucleate new polymorphs of MA in the 
experiments carried out in this thesis. This could be due to lack of control in the experiments, 
because the correct experiment has yet to be carried out or because of limitations on the CSP 
theory which can’t account for factors such as molecular rearrangement during nucleation, 
thermal effects and disorder components.210 
The bespoke sublimation apparatus (section 5.3) provides control over the 
temperature of the evaporation source, the distance between the deposition plate and the 
starting material and the temperature of the deposition plate. Thus, further development of this 
sublimation technique could prove useful as many experimental variables can be changed and 
different surfaces can be investigated. An initial deposition experiment would look at the effect 
of changing the temperature of the deposition surface on the polymorphic form of TA as the 
original set of sublimation experiments nucleated TA form I, but the more sophisticated 
sublimation experiments nucleated TA form VII. 
Another interesting series of sublimation experiments would be to deposit a layer of 
TA on top of microcrystalline MA form I to target isostructural TA form VI (or IV) in the absence 
of a solvent. Additionally, single crystals of observed polymorphs of MA and TA could be 
introduced into the sublimation experiments as template seeds. TA form III would be a template 
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seed of interest as the computational work suggests it was one of the most promising template 
crystals. If deposition onto single crystals or microcrystalline layers was carried out then much 
thought would be required in order to develop methods that enable detection and 
characterisation of the polymorphic form of the deposited material.  
Overall, this comparison of MA and TA shows that chloro-methyl replacement 
produces some isostructural polymorphs, but also results in sufficient e nergy differences to 
affect the relative stability of the known and competitive computer generated structures. 
Further polymorphs of either system may well be found, with the work in this thesis illustrating 
the challenges in controlling their crystallisation.   
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Appendix 1 
Comparison of the relative conformational energy of MA, as a function of the ξ1 torsion angle, calculated 
at the PBE0/6-31+G(d) level of theory using GAUSSIAN (blue) and at the B3LYP/6-31G(d,p) level of 
theory using GAMESS (red). The GAMESS calculations at the B3LYP/6-31G(d,p) level of theory were used 
as the input for CrystalPredictor, and the PBE0/6-31+G(d) level of theory was used in the 
CrystalOptimiser refinements. 
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Appendix 2 
MA lattice minima of the 23 structures with the lowest lattice energies following the PCM calculations. Structures with two entries in the ξ1 torsion column are Z’ = 2 structures 
produced by a reduction in symmetry when the Z’=1 structure was found to correspond to a transition state. 
 
Structure Space 
Group 
ξ1 torsion 
(°) 
a 
(Å) 
b 
(Å) 
c 
(Å) 
α 
(°) 
β 
(°) 
γ 
(°) 
Density 
(g cm-3) 
Lattice Energy 
(kJ mol-1) 
#1MA_128 P-1 117.15 6.9638 7.4392 13.9823 103.237 99.545 64.113 1.2668 -147.717 
#2MA_978 P-1 134.19 7.2107 20.5931 7.0497 118.403 113.72 43.67 1.2661 -147.148 
#3MA_237 P21/c 140.06 13.2989 7.0209 15.8495 90 59.41 90 1.2581 -146.482 
#4MA_889 P-1 83.38 9.8269 7.95 8.7544 97.883 70.662 84.472 1.2682 -145.970 
#5MA_510 P-1 60.66 5.1175 8.3861 14.8621 80.231 93.907 81.999 1.2931 -145.867 
#6MA_288 C2/c 140.98 7.8511 11.8101 27.3939 90 85.791 90 1.2653 -145.064 
#7MA_1666 P-1 70.02 8.2988 11.1219 7.812 81.065 117.808 103.032 1.2919 -144.785 
#8MA_2853 P21 138.13, 138.03 7.0665 28.205 7.0058 90 66.794 90 1.2488 -144.663 
#9MA_1592 P21 138.68, 138.92 7.0013 28.1836 7.0742 90 66.824 90 1.2489 -144.626 
#10MA_5611 P21 138.24, 138.24 7.7504 28.1702 7.0087 90 56.976 90 1.2491 -144.595 
#11MA_1069 Pbca 138.42 23.1487 15.6265 7.0746 90 90 90 1.2525 -144.223 
#12MA_1090 Pbca 139.00 23.1594 15.5654 7.0976 90 90 90 1.2528 -144.081 
#13MA_664 Pbca 133.58 22.9546 16.1393 7.0044 90 90 90 1.2352 -143.377 
#14MA_318 C2/c 124.50 24.5861 6.8828 16.3127 90 67.575 90 1.2561 -143.269 
#15MA_538 P21/c 120.83 11.8977 6.8978 16.293 90 72.737 90 1.2551 -143.122 
#16MA_1055 A2/n 137.84 19.2644 7.0779 19.5909 90 73.845 90 1.2493 -143.111 
#17MA_540 C2/c 126.61 11.5628 7.5673 30.0694 90 80.49 90 1.2352 -142.791 
#18MA_1918 P-1 76.43 11.4466 5.5602 11.6628 99.929 61.94 89.819 1.2478 -142.760 
#19MA_5643 P21 65.48, 65.51 5.0085 31.1164 8.7911 90 67.221 90 1.2687 -142.656 
#20MA_333 P-1 131.17 8.8122 10.208 7.7088 86.728 71.557 101.68 1.2546 -142.453 
#21MA_3317 P21/c 148.83 7.868 7.2532 23.1917 90 73.505 90 1.2629 -141.723 
#22MA_223 P-1 157.07 7.5172 7.4275 12.6161 87.759 64.676 85.162 1.263 -140.938 
#23MA_497 P-1 93.65 8.138 8.5174 9.9067 70.081 96.146 82.731 1.2678 -140.695 
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Appendix 3 
Distribution of ξ1 tosion angles in the 23 most stable structures on the crystal energy landscape of MA. 
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Appendix 4 
The calculated crystal energy landscapes of MA after (a) DMAfelx-Quick, (d) CrystalOptimizer and (c) 
PCM calculations. Note in (b) there are two energetically similar P-1 structures that are the most stable 
computationally generated structures which are separated following the PCM calculations in (c). 
 
 
 
 
 
(a) 
(b) 
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(c) 
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Appendix 5 
Comparisons of the generated crystal structures of MA with the crystal structures of known fenamates. 
The table only shows comparisons that matched 7 molecules or above. 
 
MA structure 
Comparison 
structure from CSD 
Number of similar 
molecules within 
coordination 
sphere (n) 
rmsdn (Å) 
PXRD 
similarity 
#48MA_480 SURMOI 15 0.19065 0.981188 
#6MA_288 KAXXAI02 15 0.343126 0.962881 
#1MA_128 KAXXAI03 15 0.395037 0.952818 
#19MA_5643 KAXXAI01 15 0.420326 0.943436 
#4MA_889 KAXXAI04-major 15 0.421761 0.950993 
#23MA_497 KAXXAI04-minor 15 0.585146 0.951515 
#5MA_510 PEFNAQ 15 0.634555 0.928514 
#2MA_978 KAXXAI03 14 0.465334 0.938267 
#17MA_540 KAXXAI02 13 0.198347 0.924293 
#8MA_2853 KAXXAI02 13 0.279487 0.950537 
#9MA_1592 KAXXAI02 13 0.28105 0.950866 
#10MA_5611 KAXXAI02 13 0.282975 0.951031 
#2MA_978 KAXXAI02 13 0.382087 0.938069 
#19MA_5643 PEFNAQ 13 0.461693 0.95004 
#1MA_128 KAXXAI02 13 0.541632 0.939676 
#39MA_1682 KAXXAI02 13 0.590419 0.964251 
#5MA_510 KAXXAI01 13 0.728654 0.846431 
#32MA_747 KAXXAI02 13 0.759515 0.935314 
#17MA_540 PEFMET 12 0.21235 0.926023 
#8MA_2853 PEFMET 12 0.31153 0.958896 
#9MA_1592 PEFMET 12 0.31207 0.959583 
#10MA_5611 PEFMET 12 0.314911 0.959433 
#17MA_540 KAXXAI03 12 0.370597 0.928148 
#6MA_288 PEFMET 12 0.383979 0.951777 
#2MA_978 PEFMET 12 0.397873 0.944525 
#8MA_2853 KAXXAI03 12 0.414948 0.925942 
#10MA_5611 KAXXAI03 12 0.416233 0.92622 
#9MA_1592 KAXXAI03 12 0.420174 0.925834 
#6MA_288 KAXXAI03 12 0.428786 0.931182 
#39MA_1682 PEFMET 12 0.443817 0.927677 
#1MA_128 SURMEY 12 0.473674 0.920983 
#1MA_128 PEFMET 12 0.513751 0.923492 
#32MA_747 KAXXAI03 12 0.575143 0.89928 
#17MA_540 SURMEY 12 0.604147 0.91974 
#2MA_978 SURMEY 12 0.610812 0.903335 
#32MA_747 SURMEY 12 0.663033 0.936945 
#8MA_2853 SURMEY 12 0.679809 0.94479 
#6MA_288 SURMEY 12 0.68142 0.94463 
#10MA_5611 SURMEY 12 0.681536 0.945093 
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#32MA_747 PEFMET 12 0.682244 0.947314 
#39MA_1682 KAXXAI03 12 0.683284 0.940686 
#9MA_1592 SURMEY 12 0.687273 0.944758 
#24MA_282 KAXXAI04-minor 12 1.10724 0.918475 
#4MA_889 KAXXAI04-minor 10 0.709745 0.955898 
#48MA_480 KAXXAI 10 0.720254 0.959321 
#23MA_497 KAXXAI04-major 10 0.926142 0.934797 
#57MA_50 BIXGIY02 10 1.41026 0.88956 
#57MA_50 SURMOI 9 0.238512 0.938812 
#55MA_44 SURMOI 9 0.361787 0.949408 
#55MA_44 KAXXAI 9 0.447587 0.920401 
#41MA_3896 SURMOI 9 0.45763 0.932419 
#57MA_50 KAXXAI 9 0.567763 0.897208 
#41MA_3896 PEFNAQ 9 0.868828 0.810622 
#41MA_3896 KAXXAI01 9 1.0591 0.723262 
#57MA_50 PEFNAQ 9 1.07345 0.780808 
#46MA_109 KAXXAI 8 0.236007 0.921364 
#46MA_109 SURMOI 8 0.350944 0.942459 
#48MA_480 BIXGIY02 8 0.465538 0.922441 
#33MA_5471 KAXXAI01 8 0.520056 0.658909 
#34MA_3912 SURMOI 8 0.546015 0.914474 
#33MA_5471 PEFNAQ 8 0.553461 0.73157 
#36MA_3365 SURMOI 8 0.580582 0.90793 
#36MA_3365 PEFNAQ 8 0.794415 0.811371 
#41MA_3896 KAXXAI 8 0.801068 0.886662 
#34MA_3912 PEFNAQ 8 0.806843 0.809947 
#55MA_44 BIXGIY02 8 0.826653 0.86816 
#34MA_3912 KAXXAI 8 0.888886 0.872906 
#36MA_3365 KAXXAI 8 0.921631 0.867465 
#36MA_3365 KAXXAI01 8 0.938324 0.720654 
#34MA_3912 KAXXAI01 8 0.960238 0.720369 
#48MA_480 PEFNAQ 8 1.04391 0.774013 
#25MA_1982 PEFNAQ 8 2.18761 0.695255 
#40MA_1556 FPAMCA 7 0.374772 0.945777 
#3MA_237 KAXXAI03 7 0.374941 0.856619 
#45MA_550 KAXXAI04-minor 7 0.708799 0.880248 
#39MA_1682 SURMEY 7 0.712997 0.955145 
#41MA_3896 BIXGIY02 7 0.959515 0.882072 
#56MA_440 KAXXAI03 7 1.12181 0.776292 
#7MA_1666 KAXXAI04-minor 7 1.20951 0.888203 
#26MA_14 KAXXAI04-major 7 1.24578 0.92187 
#55MA_44 FPAMCA13 7 1.28649 0.869014 
#31MA_1249 KAXXAI03 7 1.32405 0.832632 
#7MA_1666 PEFNAQ 7 1.76383 0.809215 
#22MA_223 FPAMCA12 7 2.48996 0.78989 
#28MA_638 FPAMCA12 7 2.64786 0.848497 
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Appendix 6 
The unit cell similarities of #6MA_288 with TA form III and #19MA_5643 with TA form I. 
 
 TA form III #6MA_288 
Space Group P21/c C2/c 
a 7.6356(15) 7.9 
b 11.305(2) 11.8 
c 28.065(6) 27.4 
α 90 90 
β 93.03(3) 85.8 
γ 90 90 
 
  
 
 
 
 TA form I #19MA_5643 
Space Group P21/c P21 
a 4.826(2) 5.0 
b 32.128(11) 31.1 
c 8.041(4) 8.8 
α 90 90 
β 104.88(3) 67.2 
γ 90 90 
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Appendix 7 
1H NMR spectra of the MA-TA solid solution series. The spectra show the integration values of the methyl peaks used to determine the relative ratio of TA:MA in the crystals.  
 
Target mole fraction of TA – 0.5 
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Target mole fraction of TA – 0.6 
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Target mole fraction of TA – 0.7 
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Target mole fraction of TA – 0.8 
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Appendix 8 
Raman spectrum of three different crystals of TA form VI alongside the peak list in the range 3200 cm -1 to 100 cm-1.  
 
TA form VI 
 
3075 
2921 
1626 
1602 
1581 
1570 
1513 
1463 
1407 
1383 
1335 
1285 
1276 
1250 
1234 
1204 
1162 
1143 
1085 
1072 
1043 
908 
898 
835 
809 
796 
774 
723 
702 
658 
621 
606 
571 
558 
546 
519 
503 
488 
432 
396 
349 
320 
283 
245 
229 
208 
162 
141 
209 
Appendix 9 
 
Screen grab of the QTZ program used to monitor the deposition of sublimed MA/TA onto the QCM. The 
program shows that the resonant frequency of the crystal decreases as the mass on the crystal increases.  
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Appendix 10 
 
PXRD patterns of TA that has been deposited onto both glass and copper surfaces with the evaporation 
source set to different temperatures. The PXRD patterns are labelled with the temperature of the 
evaporation source and the surface the TA was deposited onto. For each evaporation source 
temperature, 100 °C and 150 °C, the TA was deposited onto both the glass and copper surfaces 
simultanesouly. 
 
 
 
  
150 °C - glass 
150 °C - copper 
100 °C - copper 
100 °C - glass 
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Appendix 11 
 
Infrared spectra of multiple preparations of TA that has been deposited onto both glass (top three 
spectra) and copper surfaces (bottom five spectra). All the spectra have a N-H stretching peak at 3336 
cm-1 with a slight shoulder to lower wavenumbers which could be due to the phase purity of the sample. 
 
 
 
glass 
copper 
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Appendix 12 
 
PXRD patterns of an additional sample of TA VII collected in situ as the sample is heated at a heating rate of 10 °C min-1.  
 
120 °C 
 
100 °C 
 
110 °C 
 
125 °C 
130 °C 
 
140 °C 
 135 °C
 
150 °C 
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Appendix 13 
 
PXRD patterns of three separate experiments where MA was onto deposited onto the copper depostion 
plate at 120 °C (blue), at 100 °C (orange) and at an unknown temperature (green). The top two diffraction 
patterns are experiments where the temperature of the evaporation source could be set, the bottom 
diffraction pattern is from the apparatus where the temperature is unkown. 
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Appendix 14 
 
Infrared spectra of the N-H streching band in three different samples of MA that has been deposited 
onto the glass microscope slide with a crucible temperature set to 120 °C. The figure suggests that the 
proportion of MA I:MA II varies depending on the sample. 
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Appendix 15 
Reproduction of the experimental crystal structures of crystal structures that are closely related to the cocrystal XXV using the experimental conformations and the distributed 
multipoles at the PBE0/6-31+G(d) level of theory and the FIT pasratters for the exp-6 potential. The results show that this method gives a good reproduction of all the crsytal 
structures that were tested as all reproductions give a good overlay of 15 molecules with the experimental structures.  
 
CDC 
Refcode 
Molecular structure Unit Cell 
 
a 
/ Å 
b 
/ Å 
c 
/ Å 
α 
/ ° 
β 
/ ° 
γ 
/ ° 
n(rmsdn) 
/ Å 
DEFQAG 
  
exp 
comp 
6.454 
6.4705 
9.45 
9.4771 
27.15 
27.5199 
90 
90 
90 
90 
90 
90 
15(0.106638) 
DORJEA 
  
exp 
comp 
8.3118 
8.4232 
14.586 
14.6078 
12.386 
12.5547 
90 
90 
95.854 
96.2126 
90 
90 
15(0.139514) 
DUWBON 
 
 
exp 
comp 
10.9907 
11.0531 
13.8123 
14.0963 
17.224 
17.3523 
71.469 
71.5858 
88.621 
88.2927 
70.319 
70.2999 
15(0.153361) 
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DUWBUT 
 
 
exp 
comp 
7.6347 
7.7262 
15.454 
15.5889 
15.936 
15.9618 
66.214 
66.4686 
82.257 
84.0388 
85.37 
87.1388 
15(0.187412) 
DUWCII 
 
 
exp 
comp 
15.529 
15.397 
12.186 
12.3226 
10.764 
10.9792 
90 
90 
110.147 
109.7788 
90 
90 
15(0.153968) 
DUWCOO 
 
 
exp 
comp 
28.37 
28.7087 
6.6841 
6.7985 
21.6271 
21.621 
90 
90 
105.94 
105.246 
90 
90 
15(0.139802) 
FUPKUW 
 
 
exp 
comp 
14.9491 
14.7396 
12.5597 
12.6856 
8.3034 
8.3225 
90 
90 
92.276 
92.9298 
90 
90 
15(0.126623) 
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FUPLEH 
 
 
exp 
comp 
21.661 
21.5122 
5.486 
5.637 
14.906 
14.806 
90 
90 
122.04 
122.1036 
90 
90 
15(0.169719) 
LUDROS 
  
exp 
comp 
7.9017 
7.8716 
10.4132 
10.7351 
11.0932 
11.2236 
103.385 
104.4191 
98.365 
98.1104 
110.022 
107.8512 
15(0.320331) 
RELCUH 
  
exp 
comp 
8.1272 
8.1516 
18.1103 
18.1001 
10.4433 
10.4465 
90 
90 
90.568 
90.0221 
90 
90 
15(0.113515) 
XICRIK 
 
 
exp 
comp 
20.273 
20.1053 
10.6934 
10.9586 
18.936 
19.0589 
90 
90 
94.567 
95.287 
90 
90 
15(0.180958) 
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XIFTAI 
 
 
exp 
comp 
12.266 
12.498 
7.362 
7.4329 
12.759 
13.0345 
90 
90 
104.457 
104.3953 
90 
90 
15(0.150596) 
YEYNAS 
 
 
exp 
comp 
7.526 
7.6432 
8.057 
8.1542 
13.932 
13.9122 
92.944 
93.0203 
92.93 
92.6623 
115.649 
116.2737 
15(0.109832) 
ABUNOA 
  
exp 
comp 
7.7752 
7.7834 
18.2049 
17.7316 
18.6065 
18.4737 
90 
90 
101.444 
101.7816 
90 
90 
15(0.282457) 
 
KIZQIT 
 
 
exp 
comp 
8.414 
8.2518 
15.763 
15.8157 
6.991 
7.1082 
91.82 
92.1886 
99.91 
97.1876 
81.59 
79.7187 
15(0.235907) 
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KIZQUF 
 
 
exp 
comp 
16.723 
16.3594 
16.784 
17.0274 
8.4129 
8.4012 
102.36 
100.9691 
92.34 
91.7013 
109.91 
110.965 
15(0.244149) 
KIZREQ 
  
exp 
comp 
8.212 
8.251 
31.924 
31.4749 
8.438 
8.3647 
90 
90 
106.54 
104.635 
90 
90 
15(0.199687) 
NEMSUT 
  
exp 
comp 
10.908 
10.9503 
11.001 
11.0468 
7.159 
7.0355 
106.02 
108.361 
94.47 
95.9533 
65.78 
66.6832 
15(0.269362) 
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Appendix 16 
The bond lengths, angles and dihedrals that changed as a result of the fully atomistic CrystalOptimizer  
calculations of CUKCAM04 and CUKCAM22. The rows highlighted in grey refer to the degrees of freedom 
that were chosen to be optimised in subsequent CrystalOptimizer calculations. The criteria for choosing 
a degree of freedom was angles and dihedrals with a change in value greater that 0.5° and 1.0° 
respectively. In general, changes within the phenyl ring were ignored as they were tending towards the 
gas phase optimised molecular conformation which is the input in the search. 
 
CUKCAM04 
Name   (as input) Start -
> 
New  Change 
 (Å,°)  (Å,°)  (Å,°) 
      
bnd2(C2_C1) 1.394545 -
> 
1.395879  0.001334 
      
bnd3(C3_C2) 1.382907 -
> 
1.389116  0.00621 
ang3(C3_C2_C1) 118.2872 -
> 
118.4928  0.2056 
      
bnd4(C4_C3) 1.383194 -
> 
1.386677  0.003483 
ang4(C4_C3_C2) 123.309 -
> 
122.7253  -0.5838 
dih4(C4_C3_C2_C1) 0.7956 -
> 
-1.4376  -2.2331 
      
bnd5(C5_C4) 1.382529 -
> 
1.388995  0.006466 
ang5(C5_C4_C3) 116.3074 -
> 
116.9802  0.6728 
dih5(C5_C4_C3_C2) 0.5753 -
> 
1.7372  1.1619 
      
bnd6(C6_C1) 1.390217 -
> 
1.395027  0.00481 
ang6(C6_C1_C2) 120.5172 -
> 
120.4936  -0.0236 
dih6(C6_C1_C2_C3) -1.176 -
> 
1.0605  2.2365 
      
bnd7(C7_C1) 1.490009 -
> 
1.489612  -0.0004 
ang7(C7_C1_C2) 120.3718 -
> 
121.3765  1.0047 
dih7(C7_C1_C2_C3) 176.5042 -
> 
178.3795  1.8753 
      
bnd8(N1_C3) 1.473546 -
> 
1.463751  -0.0098 
ang8(N1_C3_C2) 117.9376 -
> 
118.5249   0.5873 
dih8(N1_C3_C2_C1) -177.536 -
> 
-179.881  -2.3457 
      
bnd9(N2_C5) 1.474017 -
> 
1.46409  -0.00993 
ang9(N2_C5_C4) 118.192 -
> 
118.2155   0.0235 
dih9(N2_C5_C4_C3) -179.388 -
> 
-179.42  -0.0325 
      
bnd10(O2_C7) 1.305315 -
> 
1.335664  0.030349 
ang10(O2_C7_C1) 114.3164 -
> 
113.0159   -1.3005 
dih10(O2_C7_C1_C2) 7.7572 -
> 
6.0831   -1.6741 
      
bnd11(O1_C7) 1.231707 -
> 
1.219626  -0.01208 
ang11(O1_C7_C1) 120.649 -
> 
122.5087   1.8597 
dih11(O1_C7_C1_C2) -171.764 -
> 
-173.664   -1.8999 
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bnd12(O3_N1) 1.225995 -
> 
1.218319  -0.00768 
ang12(O3_N1_C3) 117.6912 -
> 
117.3039  -0.3872 
dih12(O3_N1_C3_C2) -23.3795 -
> 
-22.0085   1.3711 
      
bnd13(O4_N1) 1.224963 -
> 
1.219023  -0.00594 
ang13(O4_N1_C3) 117.5165 -
> 
117.3836  -0.1329 
dih13(O4_N1_C3_C2) 155.1213 -
> 
157.3187   2.1974 
      
bnd14(O5_N2) 1.221965 -
> 
1.220478  -0.00149 
ang14(O5_N2_C5) 117.3374 -
> 
117.1275  -0.2099 
dih14(O5_N2_C5_C4) -0.0287 -
> 
-2.0638   -2.0351 
      
bnd15(O6_N2) 1.22375 -
> 
1.219965  -0.00379 
ang15(O6_N2_C5) 118.3935 -
> 
118.0287  -0.3647 
dih15(O6_N2_C5_C4) -179.802 -
> 
-182.259   -2.4567 
      
bnd16(H1_C2) 0.921787 -
> 
1.083998  0.162211 
ang16(H1_C2_C3) 120.4631 -
> 
120.3005  -0.1626 
dih16(H1_C2_C3_C4) 178.4868 -
> 
177.8576  -0.6292 
      
bnd17(H2_C4) 0.950219 -
> 
1.08385  0.133631 
ang17(H2_C4_C3) 121.5509 -
> 
121.7014  0.1505 
dih17(H2_C4_C3_C2) 178.8642 -
> 
181.5405  2.6764 
      
bnd18(H3_C6) 0.952448 -
> 
1.084924  0.132476 
ang18(H3_C6_C1) 120.6794 -
> 
120.1596  -0.5199 
dih18(H3_C6_C1_C2) 177.8938 -
> 
179.1398  1.246 
      
bnd19(H4_O1) 0.960258 -
> 
0.971458  0.0112 
ang19(H4_O1_C7) 111.2888 -
> 
110.4004   -0.8884 
dih19(H4_O1_C7_C1) -178.314 -
> 
-179.353   -1.0385 
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CUKCAM22 
Name   (as input) Start -
> 
New  Change 
 (Å,°)  (Å,°)  (Å,°) 
      
bnd2(C2_C1) 1.387831 -
> 
1.395784  0.007953 
      
bnd3(C3_C2) 1.38059 -
> 
1.389143  0.008553 
ang3(C3_C2_C1) 118.3237 -
> 
118.506  0.1823 
      
bnd4(C4_C3) 1.37792 -
> 
1.386698  0.008778 
ang4(C4_C3_C2) 123.0281 -
> 
122.7046  -0.3235 
dih4(C4_C3_C2_C1) -2.2834 -
> 
0.3398  2.6232 
 
     
bnd5(C5_C4) 1.383298 -
> 
1.389005  0.005707 
ang5(C5_C4_C3) 116.4606 -
> 
117.0415  0.5809 
dih5(C5_C4_C3_C2) 1.5875 -
> 
0.1587  -1.4288 
      
bnd6(C6_C1) 1.385043 -
> 
1.39507  0.010027 
ang6(C6_C1_C2) 120.7762 -
> 
120.4798  -0.2963 
dih6(C6_C1_C2_C3) 0.6102 -
> 
-1.4473  -2.0575 
      
bnd7(C7_C1) 1.479656 -
> 
1.488628  0.008972 
ang7(C7_C1_C2) 120.5219 -
> 
121.4447  0.9228 
dih7(C7_C1_C2_C3) -178.461 -
> 
-180.479  -2.018 
      
bnd8(N1_C3) 1.459842 -
> 
1.46346  0.003618 
ang8(N1_C3_C2) 118.078 -
> 
118.6131  0.5352 
dih8(N1_C3_C2_C1) 177.2856 -
> 
180.6524  3.3668 
 
     
bnd9(N2_C5) 1.45792 -
> 
1.461989  0.00407 
ang9(N2_C5_C4) 118.4848 -
> 
118.4023  -0.0825 
dih9(N2_C5_C4_C3) 179.8969 -
> 
179.7117  -0.1853 
      
bnd10(O2_C7) 1.299281 -
> 
1.335558  0.036277 
ang10(O2_C7_C1) 113.9344 -
> 
113.1053  -0.8291 
dih10(O2_C7_C1_C2) -9.2136 -
> 
-7.4467  1.7669 
      
bnd11(O1_C7) 1.221099 -
> 
1.219975  -0.00112 
ang11(O1_C7_C1) 120.9827 -
> 
122.2623  1.2796 
dih11(O1_C7_C1_C2) 171.2998 -
> 
173.1587  1.8589 
      
bnd12(O3_N1) 1.213933 -
> 
1.218409  0.004476 
ang12(O3_N1_C3) 117.6916 -
> 
117.2908  -0.4008 
dih12(O3_N1_C3_C2) 18.1402 -
> 
17.4328  -0.7074 
 
     
bnd13(O4_N1) 1.217854 -
> 
1.220335  0.002482 
ang13(O4_N1_C3) 117.7782 -
> 
117.6294  -0.1489 
dih13(O4_N1_C3_C2) -160.502 -
> 
-162.434  -1.9317 
      
bnd14(O5_N2) 1.217319 -
> 
1.219748  0.002429 
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ang14(O5_N2_C5) 117.3995 -
> 
117.1836  -0.2159 
dih14(O5_N2_C5_C4) 4.5182 -
> 
5.5932  1.075 
      
bnd15(O6_N2) 1.218622 -
> 
1.220494  0.001872 
ang15(O6_N2_C5) 118.0171 -
> 
117.9147  -0.1024 
dih15(O6_N2_C5_C4) -175.847 -
> 
-174.734  1.1131 
      
bnd16(H1_C2) 1.074548 -
> 
1.083945  0.009397 
ang16(H1_C2_C3) 121.0064 -
> 
120.2954  -0.7111 
dih16(H1_C2_C3_C4) 179.6346 -
> 
180.2227  0.5881 
      
bnd17(H2_C4) 1.080961 -
> 
1.083876  0.002916 
ang17(H2_C4_C3) 121.9237 -
> 
121.6865  -0.2372 
dih17(H2_C4_C3_C2) -177.711 -
> 
-179.421  -1.7098 
 
     
bnd18(H3_C6) 1.079081 -
> 
1.084871  0.00579 
ang18(H3_C6_C1) 121.0138 -
> 
120.2621  -0.7517 
dih18(H3_C6_C1_C2) -177.814 -
> 
-178.959  -1.1446 
      
bnd19(H4_O1) 1.00634 -
> 
0.971707  -0.03463 
ang19(H4_O1_C7) 110.3293 -
> 
110.0085  -0.3208 
dih19(H4_O1_C7_C1) -179.995 -
> 
-180.274  -0.2783 
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CIF Files 
 
The following CIF files can be found on the CD ROM found inside the back cover of this thesis: 
 
File name Description 
MA_I MA form I redetermination 
MA_II MA form II redetermination 
Prelim_MA-TA Solid solution - preliminary cocrystall isation experiment 
0.5-TA Solid solution – target mole fraction of TA = 0.5 
0.6-TA Solid solution – target mole fraction of TA = 0.6 
0.8-TA Solid solution – target mole fraction of TA = 0.8 
TA_VI(a) TA form VI – crystal (a) from seeding with MA form I  
TA_VI(b) TA form VI – crystal (b) from seeding with MA form I 
TA_VII TA form VII – vapour deposition onto copper. Refinement by Jeremy Cockcroft 
 
